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The greatest diversity of Influenza A viruses (IAV) is found in waterfowl species 
from numerous geographic locations. In addition, multiple IAV are, and continue to be, 
perpetuated in swine populations around the globe. Due to the zoonotic potential of IAV, 
and to respond more effectively to potential agricultural and public health threats, there is 
a need to increase surveillance in avian and swine hosts in understudied geographical 
regions. In Latin America, avian influenza surveillance has been scarce, localized only to 
places where outbreaks in poultry have occurred. Similarly, active swine influenza 
surveillance was implemented only after the emergence of the 2009 pandemic strain 
(pH1N1). The main objective of the project presented here was to investigate the 
circulation of IAV in wild birds and pigs in Guatemala. Over 2200 birds were sampled 
during six consecutive migration seasons from 2007 to 2013 in different locations. Virus 
prevalence detected by rRT-PCR in positive species ranged from 5.2% to 38%. 
Preliminary data indicates temporal variation of IAV prevalence in migratory waterfowl. 
Eighty-three viruses were recovered with 22 different subtype combinations. Through 
phylogenetic inferences and the analysis of virus genotypes and gene constellations of 60 
fully sequenced genomes, we provide a detailed description of the genetic structure of 
avian IAV circulating in Guatemala. Our results suggest that the virus diversity in this 
location is sourced from multiple migration flyways from North America. Overlap of 
these flyways, in a natural geographical bottleneck such as the Neotropics, may 
contribute to the patterns of extensive genetic reassortment observed at a continental 
scale.  
In addition, the results from two nationwide multistage random surveys in pigs 
demonstrated circulation of swine influenza in commercial and peridomestic herds in 
Guatemala. Herd prevalence of IAV was 36.3% in 2010 and 34.6% in 2011. Viruses of 
the H1N1 and H3N2 subtypes and antibodies against viruses of distinct genetic lineages 
of these subtypes were detected. Our results indicate that human-animal contact likely 
plays a role in the IAV epidemiology in local swine populations. The findings from this 
research constitute the most abundant data on the ecology and epidemiology of animal 
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Chapter 1. Introduction 
1.1. Literature review: Influenza A virus 
1.1.1. Classification 
Influenza A viruses (IAV) belong to the virus family Orthomyxoviridae, that 
comprises 6 genera: Influenzavirus A, B and C, Isavirus, Quaranjavirus and Thogotovirus 
(1). All members of this family have negative-sense, single-strand RNA viruses with a 
segmented genome (between six to eight segments depending on the virus genera) (2).  
IAVs are further classified into subtypes based on the antigenic properties of their 
surface proteins Hemagglutinin (HA) and Neuraminidase (NA) with amino acid sequence 
divergences of ≥30% among different subtypes (3, 4). IAVs belonging to 16 HA and 9 
NA different subtypes have been isolated from birds and other animal hosts (5). More 
recently, two novel subtypes, H17N10 and H18N11 were detected in bats (6, 7). The 
nomenclature of the influenzavirus genera is based according to their type, the host 
species origin, the geographical location, a sample or isolate identification number, the 
year when the sample was obtained and, in the case of IAVs, the HA and NA subtypes 
(3). For example, A/Victoria/361/2011 (H3N2) would be a human influenza A virus 
isolated in Victoria, Australia in 2011 of the H3N2 subtype, and 
A/mallard/Gurjev/263/82 (H14N5) would be a virus strain recovered from a mallard duck 




1.1.2. Virus structure 
IAVs are enveloped viruses enclosed in a host-derived lipid membrane. Virus 
particles vary in morphology and can be spherical and/or filamentous. Spherical particles 
are typically 100 nm in diameter and filamentous particles may be up to 300 nm in 
length. The lipid membrane displays the two surface proteins spikes, HA and NA (8). 
Underneath the lipid membrane, the virion is constituted of matrix protein (M1) and the 
viral ribonucleoprotein complexes (vRNPs) in which each viral RNA segment is looped 
and wrapped around multiple units of nucleoprotein (NP) in a rod-like structure (9). The 
end of each one vRNP is bound to a single polymerase complex comprised of polymerase 
basic 1 and 2 (PB1, PB2) and polymerase acid (PA) protein subunits. vRNPs 
incorporation into virions seem to follow a selective packaging mechanism during virus 
assembly that ensures that most virions obtain one set of all 8 gene segments (10) 
(explained below). The exact arrangement of the vRNPs inside the virus particle is still a 
controversial subject. The most recent model based on electron microscopy studies 
suggests that the distribution in space inside the virion of individual vRNPs may vary, 
where some will have the polymerase-binding ends oriented towards the budding tip of 
the budding virions, and others will be inversely oriented at the opposite side at the 
bottom of the budding virus (11).  
1.1.3. Genome structure 
The genome of IAV viruses is ~13.6 kb, fragmented into eight negative-sense 
single stranded RNA segments (8). The viral RNA segments are conventionally 




each RNA segment is flanked by segment-specific untranslated regions (UTR) of 
variable length. The terminal ends of the UTR of all gene segments share conserved 
sequences partially complementary between the 5’ and 3’ ends. These regions are 
important for the formation of the vRNP complex and packaging of RNA segments into 
virions during virus assembly, and also as regulatory cis-elements for vRNA, mRNA and 
cRNA synthesis during virus replication (8).  The genome codes for 11 to 12 proteins; 
segments 1, 4, 5 and 6 encode one protein per segment and the remaining segments 
produce two proteins each from different open reading frames (ORF) using multiple 
mechanisms.  Segment 2, encodes for PB1 and a second protein, PB1-F2 from the 
overlapping +1 ORF (12). Segment 3, encodes for PA and PA-X through frameshifting 
from the PA ORF (13). Segments 7 (matrix protein and M2) and 8 (non-structural protein 
1 and nuclear export protein) express their secondary products by using an alternative 
splicing mechanism (14). In addition, other viral protein products have been recently 
discovered, although their functions remain to be further elucidated; such proteins include 
PB1-N40, PA-N155, PA-N182, M42 and NS3 (13, 15-19). The role of the most-well 
studied proteins is explained in the following section. 
1.1.4. Viral proteins 
IAVs encode for non-structural and structural proteins. As explained above, the 
vRNP subunits are constituted by the viral RNA, the nucleoprotein (NP) and the 
polymerases PB2, PB1 and PA. The PB2 is an mRNA cap-binidng protein, the PB1 has 















Name and protein function 
1 PB2 2341 759 Polymerase basic 2. Subunit of the 















Polymerase basic 1. Subunit of the 
polymerase complex with RNA-dependent 
polymerase activity. 
 









716 Polymerase acid. Subunit of the polymerase 
complex with endonuclease activity. 
 
PA-X. PA-endonuclease activity with C-





539-550 Hemagglutinin. Type-III transmembrane 
glycoprotein. Receptor recognition, mediates 
fusion of virus membrane into infected cells. 
Surface antigen. 
 
5 NP 1565 498 Nucleoprotein. RNA binding activity. 




454-468 Neuraminidase. Sialic-acid destroying enzyme 















Matrix protein 1. Oligomeric protein viral 
capsid underneath viral envelope. Determinant 
of virus morphology, involved in packaging of 
RNPs and virus assembly. 
 
M2, ion-channel for dissociation of viral 















Non-structural protein 1. RNA-binding 
domain. Antagonist of host-immune response 
(Interferon, and interferon signaling). 
Suppressor of gene expression in nucleus. 
 
Nuclear export protein. Regulates production 
of viral RNA species (vRNA, cRNA and 





The HA is a Type-I transmembrane glycoprotein that recognizes sialic acid (SA) 
residues on the surface of susceptible cells and mediates fusion of the viral and cell 
membranes during infection.  The HA is a determinant of the species host range and 
tissue tropisms as will be discussed later. The HA protein is a homotrimer, in which each 
subunit is synthesized as a single polypeptide from the single ORF of segment 4. Each of 
these chains is subsequently cleaved into two chains, HA1 and HA2. In the trimer 
structure, each monomer consists of one HA1 chain covalently attached to one HA2 
chain by a disulfide bond; the monomers are associated via noncovalent interactions to 
form the trimeric protein. The tridimensional trimer displays a globular head that contains 
the receptor-binding site (HA1) and a stalk (HA2). The HA1 and most of the HA2 
constitute the extracellular domains, whereas the membrane-anchoring region and the 
cytoplasmic tail reside in the C terminus of the HA2. The HA protein is further modified 
by glycosylation of multiple asparagine residues (21).  The glycosylation of the HA 
protein is thought to be important in modulating receptor binding, fusion activity, 
antigenicity and replication (and transmissibility) of the virus (22-24).  
The NA is a type II integral membrane protein with sialic-acid destroying 
enzymatic activity that cleaves the surface sialic-acid receptors to release new viral 
particles after budding from the cell (8).  The NA protein is a homotetramer with each 
subunit arranged in a circular mushroom-like conformation. The head is displayed 
towards the outer surface of the lipid membrane and contains the active site in the center; 
the stalk is attached to the membrane via N-terminal transmembrane domain and a 
cytoplasmic tail (25). The length of the stalk can vary between different NA subtypes and 




virulence in different hosts (26-28). Like the HA, the NA is glycosylated in specific 
asparagine residues, although the role of glycosylation in NA is less understood but it has 
been implicated in stability, antigenicity, replication and virulence (29, 30). The HA and 
NA are the major antigenic determinants of virus and their plasticity leads to evasion of 
the host immune pressure, a process known as antigenic drift (discussed in section 1.1.6).   
The matrix protein M1 constitutes the viral capsid protein, and it is largely 
implicated in virus morphology (filamentous or spherical particles). In a virus particle, 
M1 is in contact with the enclosed vRNPs, through interactions with NP. Similar 
interactions occur during vRNP packaging and with the cytoplasmic tails of the surface 
proteins (HA and NA) for its recruitment to the cell surface during virus assembly.  
The ion-channel M2 protein is a tetrameric integral membrane protein, with 
multiple functions during the replication cycle. During its transition in the endosome, the 
M2 unidirectional proton pump activity leads to acidification of the virus interior, a step 
necessary for dissociation of M1 from the vRNPs and release of the latter into the 
cytoplasm. The M2 protein participates in virus assembly and budding through 
interactions between its cytoplasmic tail and M1 and HA (31-33). In addition, the M2 
protein acts as an antagonist of apoptosis, blocking fusion between autophagosomes and 
lysosomes, counteracting the host-immune response during infection (34).  
Non-structural proteins include the NS1, found during infection in the nucleus and 
the cytoplasm where it exerts its anti-interferon activity via multiple mechanisms 
(reviewed in (35)). The NS1 protein contains an RNA binding domain at the first 73 
amino acids of the N-terminal, which interacts with RIG-I like receptors (RLR) to 




stimulated genes (ISG). NS1 is also known to directly inhibit the activity of multiple 
ISGs, by the same mechanisms of RNA sequestration. The NS1 also inhibits host mRNA 
processing in the nucleus through binding of host transcription factor PSF (reviewed in 
(35)). The nuclear export protein NS2/NEP mediates export of RNPs together with M1 
via interaction with nuclear export machinery, and blocking nuclear localization signals 
contained in the vRNP complexes. In addition NEP is a regulating factor of viral, 
complementary and mRNA synthesis during virus replication, and also participates in 
later stages of the replication cycle during the budding process (36).  
The viral protein PB1-F2 is an 87 amino acid, pro-apoptotic viral factor that 
stimulates release of cytochrome c from the mitochondria, which ultimately leads to cell 
death (12). However PB1-F2 is expressed as a truncated product or not expressed at all in 
some virus strains. Human influenza viruses evolve into strains with truncated PB1-F2 
open reading frames. PB1-F2 pro-apoptotic activity is controversial and appears to be 
strain specific, due to its role in regulation of polymerase activity (37-41). The last and 
most recently described protein of IAV is PA-X, of 61 amino acids. It contains the PA 
endonuclease activity and a C-terminal domain that is thought to be involved in 
modulation of host immune response, through repression of cellular gene expression (13). 
With the exception of the viral proteins that are involved in specific interactions with host 
immune responses and other factors that are not necessary during viral replication, 
additional functions and interactions of viral proteins are explained in the next section.  
1.1.5. Replication cycle 
When influenza viruses enter the respiratory or gastrointestinal tract of susceptible 




surface of susceptible cells. Sialic acids are acid sugars with a nine-carbon skeleton that 
are ubiquitously distributed in vertebrates. The most common SA is N-acetylneuraminic 
acid (Neu5Ac) (42).  The recognition of SA by the receptor-binding site of the viral HA 
depends on the configuration of the linkage of the SA to the adjacent galactose. IAVs can 
recognize the α-2,3 and α-2,6 conformations of Neu5Ac distributed along the mucosa of 
the intestinal and respiratory tract of birds and mammals. The distribution of α-2,3 and α-
2,6 SA vary among different hosts and tissues, being an important determinant of cell, 
tissue and hosts tropism for the virus (43, 44). As an example, avian influenza viruses 
have preference for α-2,3 SA present in the gastrointestinal mucosa, whereas mammalian 
adapted viruses recognize α-2,6 SA mainly present in the upper respiratory tract (45-47). 
In addition to epithelial cells, other susceptible cells may include immune cells such as 
alveolar macrophages and dendritic cells recruited during infection; however the specific 
SA or other lectin receptors that may confer susceptibility to infection of these types of 
cells remains unknown (48, 49). 
HA attachment to the SA triggers fusion of the virus and cell membranes, mostly 
via clathrin-mediated endocytosis [although other entry mechanisms have been described 
(50)]. Upon internalization, a low pH-mechanism mediates conformational change in the 
HA molecule (cleavage into HA1 and HA2 subunits) that exposes the fusion peptide, 
making it accessible for fusion of the viral and endosomal membranes, necessary for the 
release of the viral RNPs into the cytoplasm. During this step the stability of the 
glycosylated HA molecule appears to determine the pH of fusion and whether uncoating 
will occur in the early or late endosomes. The internal acidification of the virus during 




mediated by M2's proton-pump activity (8). Once the vRNPs are released into the 
cytoplasm, nuclear localization signals present in protein components of the vRNP 
complex interact with the cellular machinery for nuclear import. As an exception for 
RNA viruses, viral replication of IAV occurs in the nucleus, where cellular replication, 
transcription and splicing components and mechanisms are exploited by the viral 
polymerase complex for the production of different viral RNA species (vRNA, cRNA 
and mRNA). Viral mRNAs are transported to the cytoplasm for translation into viral 
proteins. Newly synthesized RNP proteins are transported back into the nucleus to 
promote viral replication, and assembly of new vRNP complexes with each gene 
segment. The NS2/NEP in conjunction with M1 protein interacts with nuclear 
localization signals, masking them and allowing the export of vRNPs from the nucleus to 
the cytoplasm to initiate virus assembly. Timing of protein expression and accumulation 
of protein products determines initiation of virus assembly during later stages of the viral 
replication cycle. Virus assembly is triggered by a combination of aggregation of 
processed (multimerized and glycosylated) structural and surface proteins (M2, HA and 
NA) in the cell membrane, and protein-protein interactions of surface components among 
themselves and M1. In addition, oligomerization of M1 triggered by interactions with 
lipids from the cell membrane ensure multilevel interactions between viral proteins 
during this process (51). Selective packaging of all eight viral RNAs segments occurs via 
segment-specific signals at the 3’ and 5’ ends for 1) bundling of each RNA segment with 
each other in a full set of 8 gene segments and 2) incorporation of gene segments into the 
budding virus (52). The vRNPs are thought to interact with M1 protein for its recruitment 




required for viral egress and the budding of IAV occurs in the apical side of the infected 
epithelial cells. Once the viral particle is completely formed, it will remain attached to SA 
molecules on the cell surface. The SA destroying activity of the NA is obligatory for the 
release of readily infectious virus to the extracellular space to complete the final step of 
the virus replication cycle. After release of infectious viruses, the surface HA is cleaved 
by mucosal trypsin-like proteases making it readily available to recognize cellular 
receptors for the next round of infection (8). 
The multiple barriers that IAV encounters during its replication, i.e. compatibility 
of cellular components with viral proteins in each step of the replication cycle, determine 
the success or failure of an infection. Consequently, virus-host interactions have shaped 
the evolution of IAV within its multiple hosts.  
1.1.6. Evolution of Influenza A Virus 
Antigenic drift, antigenic shift, reassortment and recombination in IAV 
Two major mechanisms are known to drive IAV evolution (53), particularly at the 
level of surface gene segments. There is stronger selective pressure on the surface gene 
segments in comparison to internal gene segments due to their constant exposure to the 
host humoral response. This interaction imposes a bottleneck for selection of escape 
variants, where accumulation of point mutations occurs at antigenic sites, a process 
known as antigenic drift. The second mechanism is antigenic shift resulting from 
reassortment of gene segments from two or more IAV strains, resulting in variants with 
alternative HA and NA combinations. Horizontal gene transfer through this mechanism 
has conferred an evolutionary advantage to IAV viruses not only to counteract the effect 




conquer newer niches for replication (by increasing the virus tissue tropism or host 
range). Reassortment is the underlying mechanism that allows the emergence of novel 
influenza strains from avian and swine origin in the human population (54).  Among 
other mechanisms of evolution, less known for IAV, is genetic recombination. There is 
evidence that non-homologous recombination occurs, but it has only been observed with 
the HA segments of H7 subtype viruses, resulting in strains of increased pathogenicity in 
poultry (55, 56).  
Gene flow, adaptation and evolution of Influenza A virus 
As an RNA virus, IAVs evolve quickly under a spectrum of intrinsic (nature of 
RNA genomes) and extrinsic (host and environmental) selective pressures. The RdRp of 
IAV is a low fidelity enzyme with no proofreading activity (estimated error rate of 
7.63x10-5) (57), therefore, IAV viruses like other RNA viruses, subsist at the limit of an 
error threshold (i.e. functional RNA genomes can still be produced despite the 
accumulation of mutations). It is commonly accepted that IAV exists as a population of 
genetically diverse variants during infection (58-60). These variants are represented by 
dominant populations selected for improved fitness under particular conditions. Changes 
in conditions (i.e. during infection of new hosts or tissues), can quickly change the 
composition of viral populations (as other variants are selected and become dominant). 
Evolution of RNA viruses through this mechanism can occur very quickly, and the 
plasticity of this process is reflected in the diversity of IAVs (multiple subtypes and 
genetic lineages) and their ability to infect and adapt to a variety of host species in nature 
(60). The main drivers of evolution of IAV are 1) the ability of the virus to establish 




transmit and perpetuate in a host population (adaptations for between-hosts transmission) 
and 3) host behavior, as spatial and temporal distribution of susceptible species has 
shaped evolution of IAV viruses according to their hosts and geographic location, the last 
one particularly noticeable in avian hosts.  
Influenza A viruses are known to infect multiple vertebrate hosts, including birds 
and mammals (see section 1.1.7). The existence of host-specific genetic lineages 
represents the within-host adaptations of IAV throughout prolonged periods of time.  
However, IAV from different hosts are still capable of crossing the species barrier and 
adapting to new hosts. An IAV needs to overcome two host-specific barriers: 1) To be 
able to infect and initiate a productive infection in the new host, which will depend on a 
number of within-host selective pressures that include receptor specificity, compatibility 
of the viral proteins and the host-cell machinery, and the ability of the host to 
counterattack the infection. The second barrier requires the virus to acquire sustainable 
transmissibility within members of the new hosts species. Host behavior and 
environmental conditions may allow contact between species in sufficient numbers for 
the virus to be introduced to new hosts, and to persist and spread over multiple 
transmission events (61). Such selective pressures combined with the plasticity of the 
IAV genome, have resulted in the diversity of strains that co-circulate in animal and 
human populations, each one contributing to a larger pool of genetic variants as IAVs 
continue to evolve.  
Parallel virus-host evolution, influenced by host behavior and physical separation 
of ecological niches, has led to established host-specific lineages. For example, avian 




mammalian viruses and their respective lineages (specifically, human, canine, equine and 
swine lineages). Phylogenetic analysis of IAV diversity, demonstrates that all IAV derive 
from a genetically common ancestor of avian origin (62, 63), consistent with the higher 
diversity of subtypes (16 HA and 9 NA) that has been found in these hosts. The origin of 
IAV HA and NA subtypes has been traced back to around 1000 years ago (58, 63, 64). In 
contrast, the origin of the genetic diversity of the internal genes, with the exemption of 
NS-B lineage, has been dated to less than 200 years (58, 65). A recent study, employing 
more refined phylogenetic inference under a host-specific local clock model (with the 
assumption that viruses evolve at different rates in different host species), suggest that a 
spill over event and spread of viruses from an outbreak in horses into domestic birds, may 
have played a major role in shaping the evolution of contemporary influenza viruses late 
in the 19th century, explaining the recent evolutionary history of the internal gene 
segments (64). Global replacement of gene constellations through periodic sweeps has 
been proposed to explain the patterns of evolution, and persistence of IAV throughout the 
years. Similar patterns of gene replacement are observed in seasonal human influenza on 
a global scale and within specific geographic lineages of avian influenza (66-69). 
In addition to host-specific genetic lineages, geographic separation of host species 
in nature has resulted in the diversification of IAV of avian origin into distinguishable 
lineages associated to specific geographic locations, including the Eurasian, North 
American, and more recently described the South American, and potentially Oceania and 
Antarctica lineages (53, 70-72). The frequency of intercontinental or inter-lineage 
exchange of viruses may depend on spatial and temporal overlap of two or more 




contact with other bird populations harboring viruses from a separate genetic lineage 
(73). Recent surveillance studies in Alaska and Iceland document co-circulation of 
viruses from two different genetic lineages (North American and Eurasian) in ducks and 
shorebirds (74). Through phylogenetic analysis, limited numbers of reassortant genomes 
have been found and limited inter-lineage reassortment has been documented (75-78). It 
remains to be further explored whether functional compatibility of viral gene segments 
from different lineages impact reassortment in nature.   
1.1.7. Influenza A viruses in animal hosts 
From the three genera of influenza viruses (Type A, B and C), type A influenza 
viruses are recognized for their wide host range and their ability to cross interspecies 
barriers and, eventually infect humans (79-81). Other hosts of IAVs include natural avian 
hosts, mainly Anseriformes (ducks, geese, and swans) and Charadriiformes (gulls, terns, 
and shorebirds). Non-natural avian hosts include poultry species (chickens, quails and 
turkeys). Among the known mammalian hosts, are humans, pigs, carnivores (dogs, 
minks, civet, ferrets, raccoons, felines), marine mammals (whales, dolphins, seals), with 
accumulating evidence of some fruit bat species (5-7, 53). In avian hosts influenza A 
infection is predominantly an asymptomatic infection of the gastrointestinal tract in the 
majority of its natural reservoirs (waterfowl). Depending on the virus strain and host 
species (i.e. domestic birds), infection may occur via the respiratory tract and become 
systemic with involvement of the nervous system (53). In mammalian hosts, IAV is 
transmitted through direct contact or aerosols and respiratory droplets between hosts, and 
the infection is primarily respiratory. The spectrum of disease and pathogenicity in 




tissues in the respiratory tract, such as bronchi and lungs and also become systemic (5). 
Wild birds and pigs have been recognized as two of the most important animal reservoirs. 
These hosts are the main focus of this work and their roles in IAV transmission are 
described in the following sections. 
1.1.8. Influenza A viruses in wild birds 
Influenza A viruses have been isolated from over a 100 species of wild birds, 
from 12 different orders. Despite the diversity of reported avian hosts, the majority of 
records and isolates come from species of the orders Anseriformes and Charadriiformes 
(79, 82). Avian species from both orders are broadly distributed around the world. Many 
of their member species are known to perform seasonal migrations and travel across long 
distances between different geographical areas and countries every year. The nature of 
this behavior has been linked to the role of these species to allow the movement and 
geographical spread of AIVs viruses around the world (82, 83). Specific bird species vary 
across geographical locations, but IAVs are able to infect a broad spectrum of genera (43, 
45).  
Influenza A viruses that infect birds can be classified as low pathogenicity (LPAI) 
and high pathogenicity avian influenza (HPAI) viruses based on the severity of disease 
signs in gallinaceous birds. The high pathogenicity phenotype is associated with the 
insertion of a polybasic amino acid sequence at the cleavage site of the HA molecule 
(84). The presence of a polybasic-motif in the HA (e.g. PQRESRRKK/GLF) exposes the 
cleavage site to other ubiquitously-expressed proteases in the intracellular and 
extracellular environments, expanding the cell tropism of the virus and making it more 




tested in the laboratory, in viruses that grow in cell culture in the absence of trypsin (a 
protease that cleaves and activates the HA), and through the intravenous pathogenicity 
index (IVPI) in chickens (86). In this test a HPAI virus is classified as such if it has an 
IVPI greater than 1.2. Viruses of the H5 and H7 subtypes are known to mutate and 
generate HPAI strains in nature (79). Disease caused by HPAI viruses involves acute 
infection of the respiratory tract and can be generalized with mortality rates ranging from 
75% to 100% (87, 88). HPAI viruses cause important economic losses in the poultry 
industry due to high susceptibility of domestic bird species. 
Low pathogenicity viruses preferentially infect the epithelial cells of the intestinal 
tract in birds. Field and experimental evidence suggest that under certain conditions, or 
perhaps virus strains, infection in wild birds with LPAI may have a physiological impact 
in their fitness and behavior during migration, with changes in their returning rates, 
feeding rate and body weight, the length of traveling distances and reproductive success 
(89). However clinical signs of disease are rarely seen in wild infected birds, possibly as 
a result of co-adaptation between the virus and its natural avian hosts (79). High virus 
titers are produced and the virus is excreted in high concentrations in the feces. Excreted 
viruses persist in the water maintaining the transmission cycle within susceptible bird 
species. The fecal-oral route is thought to be the primary mode of transmission; while 
respiratory secretions as well as fecal-cloacal transmission have been proposed as 
alternative routes (90-92).  
Circulation of LPAI in wild bird populations varies seasonally and temporally in 
relation to the behavior of its multiple avian hosts. Most of the available information of 




zones in North America and Europe for more than 30 years (53, 93, 94). In nature, ducks 
from different species share aquatic habitats where they are exposed to multiple LPAI 
viruses, mixed infections and co-circulation of multiple subtypes are common in these 
habitats, although variations in prevalence of LPAI and subtypes may exist in individual 
bird species. In general, prevalence of LPAI in migrating ducks tends to peak late in the 
summer to early autumn in the breeding grounds (82, 95, 96) most likely due to the 
presence of an immunologically naïve population of juvenile birds (83). Prevalence 
decreases later in fall, before migration begins. Depending on the species, migration 
distances may vary, but the majority of birds will make multiple stops before arriving to 
their wintering grounds. This behavior is important for LPAI transmission, as infected 
birds from one population congregate with other species at these stop-over habitats, 
where mixing and new infections of LPAI may occur, and new viruses may be carried to 
other places as birds continue to migrate (91). Prevalence of LPAI at the wintering 
grounds tends to be low in comparison to peak prevalence at the breeding grounds (97, 
98). Surveillance data at the wintering grounds in the south suggest that the relative 
proportion of individual subtypes co-circulating at a time seems to be subjected to 
seasonal patterns associated with the geographical location, host species and host biology 
(99, 100).  
In terms of the host biology, experimental infection in mallards and other duck 
species show that antibody immune response to LPAI infection in serum is weak and 
transient, re-infection with homosubtypic viruses seem to be limited and infection with 
heterosubtypic viruses may be prevented in some cases (101, 102). Higher susceptibility 




nature (94, 97, 103), supports that pre-existing immunity may limit re-infection in adult 
ducks.  The duration of the antibody response in serum has been estimated to last less 
than a year (104), and it has been hypothesized that environmental stressors associated 
with a long-distance migration may compromise the immunological status of ducks, 
making them susceptible to multiple infections throughout their lives (105). Population 
immunity may play a role in determining the prevalence of different subtypes co-
circulating in flocks at a time (106).  In this context, the role of mucosal immunity in 
modulating infection in ducks remains unknown.  
IAVs of the H13 and H16 subtypes appear confined to Charadiiriformes (82), 
(107, 108), specifically in gull populations, although viruses from other subtypes have 
been isolated from these and other shorebirds (including H1-7, H10-12) (93, 109). 
Waders play an important role in perpetuating certain subtypes of LPAI in nature (H1 and 
H12) with distinct seasonal patterns. Gulls and shorebird species are of interest for 
performing long-distance intercontinental migrations, and playing a potential role in 
spreading viruses to other geographic locations (67, 75, 110, 111). LPAI viruses have 
been isolated from wild geese, swans, rails, petrels and cormorants. IAV isolations have 
occurred also from Passeriformes and Columbiformes but prevalences in these birds are 
lower than those observed in dabbling ducks and shorebirds (112-114), and their role in 
LPAI epidemiology remains to be established, as evidence of sustained transmission in 
these populations is lacking (115, 116).     
Zoonotic potential of avian influenza viruses 
Transmission of circulation of IAV in avian reservoirs to mammalian hosts is very 




a transmission event during exposure, wholly avian viruses may infect humans, without 
prior reassorment with other mammalian strains (5). Viruses of avian origin have 
contributed genes for the generation of multiple pandemic strains throughout history, 
such as the 1918 H1N1 in which many of its gene segments had ancestors of avian origin 
(117-119). Subsequent pandemic strains are thought to be descendants of the 1918 H1N1 
virus that reassorted with other avian viruses: the H2N2 in 1957, contained novel HA, 
NA and PB1 gene segments of avian origin, and the pandemic strain from 1968 was a 
reassortant of the H2N2 virus that acquired novel avian-origin H3 and PB1 gene 
segments. The 1977 pandemic was caused by re-emergence of the human 1957 H1N1 
virus, likely the result of unintended release from a laboratory. Lastly, the most recent 
2009 pandemic virus originated from a reassortant swine virus that acquired the PB2 and 
PA genes from an avian source (54).  
In addition, other viruses from different subtypes are known to have caused 
infection in humans, including the H5, H6, H7, H9 and H10 with different levels of 
disease severity (120). The most notable of these is the H5N1 virus that became highly 
pathogenic after its introduction to domestic poultry, causing devastating outbreaks in 
Asia and other parts of the world since 1997. The same virus has been the cause of 667 
human cases and 393 deaths since 2003 (as of July 27, 2014 (121)). Although these 
viruses have been able to cross the species barrier, they have failed to adapt to the human 
hosts and become transmissible between mammals; however their ability to infect human 
hosts increases their pandemic potential, representing a constant threat to public health 




Many outbreaks of LPAI and HPAI that have occurred in poultry have been 
traced to viruses that spilled over from wild birds (122-127). Outbreaks of influenza in 
poultry are thought to be a risk factor for transmission of avian strains into humans, 
probably as a result of increased exposure to infected hosts. Although several molecular 
changes have been proposed as determinants of virus transmission from birds to humans, 
the factors that are required for complete mammalian adaptation including acquisition of 
airborne transmissibility are still poorly understood (128). The recognition of the role of 
avian-viruses in the evolution of pandemic influenza, and the multiple spillover events 
from birds to humans observed in recent decades highlights the importance of reinforcing 
surveillance in avian hosts in nature. In order to minimize the risk of zoonotic 
transmission to domestic animals and humans it is necessary to monitor virus diversity 
and better understand the global patterns of virus transmission and evolution in nature 
(120, 129).  
1.1.9. Influenza A viruses in pigs 
Reports of an outbreak of respiratory disease in pigs in 1892 have been proposed 
as the first indication of influenza in pigs, coinciding with an epidemic in humans; 
historical references do not provide evidence of prior circulation of influenza viruses in 
pigs (130). Influenza A infection in pigs was later reported in 1918, by clinical 
observations in herds in the U.S, Hungary and China, during the same period when the 
Spanish influenza pandemic emerged in humans (131). Although viruses from pigs were 
not recovered at that time, analysis of the first swine influenza virus isolated in 1930, 
revealed similar pathogenicity in animal models (132), and later studies linked the origin 




diverged (133, 134). Through phylogenetic and seroarcheological analyses, it has been 
established that the causative agent was a reassortant human H1N1 that acquired a N1 
gene of avian origin (119, 135, 136). It is speculated that this virus was introduced to pigs 
from humans, and persisted in the pig population establishing a genetically distinct 
lineage, currently known as the classical swine H1N1 lineage (137). This lineage 
persisted until the 1990s as a single H1N1 lineage in pigs in North America. In 1998 an 
outbreak in pigs in North Carolina was reported where the etiologic agent was confirmed 
to be a H3N2 virus, a novel reassortant of a human H3N2 virus and the H1N1 swine virus 
(138). At the same time other outbreaks were reported in Texas, Minnesota and Iowa, 
caused by H3N2 viruses, which were characterized as reassortants of other H3N2 viruses, 
the H1N1 swine virus and a virus of avian origin. This “triple reassortant” gene 
constellation of human (HA, NA, PB1), swine (NS, NP, and M) and avian (PB2 and PA) 
origin, resulted in stable viruses that quickly spread and became endemic among swine 
populations in North America (139). Co-circulation of H1N1 and H3N2 viruses in the US 
and Canada has resulted in emergence of multiple viruses (H1N1, H1N2 and H3N2) that 
have evolved independently through mutation and antigenic drift from their parental 
viruses into distinct genetic and antigenic lineages. As a result, swine influenza H1 
viruses are now classified based on the genetic and antigenic properties of the HA 
molecule into alpha, beta, gamma and delta genetic clusters, and similarly the H3 viruses 
have been classified in four (I – IV) genetic clusters (139-142). 
Serological evidence suggested that the classical swine H1N1 lineage also 
circulated in Northern Europe between the 1940s and 1950s.  After a 20-year period of 




northern Italy in 1976, most likely introduced from the US at that time (131). The virus 
spread to other countries in subsequent years and became endemic in many European 
countries (143). In addition to the classical swine lineage, a human-like H1N1 circulated 
in pigs in Europe between 1938 and 1940 (144, 145). Other human-like viruses were 
isolated from pigs after the Russian pandemic of H1N1 in 1977, and avian-like H1N1 
viruses, genetically and antigenically different from the classical swine H1N1 lineage, 
have circulated in Europe since 1979 (Kuntz-Simon & Madec, 2009). The avian-like 
viruses have been the predominant viruses, but introduction of human-like H3N2 swine 
viruses from Asia has resulted in co-circulation of reassortant strains with different 
genetic and antigenic properties (146-148).  In Asia, infections in pigs with human-like 
viruses of the H3N2 subtype have been documented since the 1970s (149) and similarly 
in Europe and North America, introduction of North American and Eurasian swine 
viruses has provided a pool of genes for reassortment and generation of multiple strains 
that currently circulate in these areas (150-152). In addition to the subtypes H1N1, H1N2 
and H3N2, other virus subtypes detected in pigs include the H4N6 in Canada, the H2N3 
in pig farms in the US, and a number of H9N2 avian-like reassortant viruses in Asia; 
however the circulation of these virus subtypes has been limited to sporadic outbreaks in 
those regions (153-156).  Historical evidence of circulation of swine viruses in pigs is 
limited in other geographical regions. Retrospective phylogenetic analyses have shown 
that viruses from humans have been introduced to pigs around the world in multiple 
occasions in the last century (131, 157).  
In 2009, zoonotic transmission of a triple reassortant virus from pigs, resulted in 




a triple reassortant virus of North American origin from the gamma cluster that acquired 
the NA and M segments from a Eurasian avian-like H1N1 swine lineage, and was the 
first evidence of introduction of Eurasian origin genes into swine of the North American 
viruses. The virus was speculated to have emerged and circulate silently in swine 
populations before crossing into humans. After the rapid spread and establishment of the 
pandemic lineage in the human population, multiple independent introductions of the 
viruses back into pigs have been documented around the globe (160). Circulation of the 
pandemic lineage in the swine populations has increased the genetic pool of the viruses 
available for generation of novel reassortants in pigs (161, 162). Some of these 
reassortant viruses still hold the potential to transmit back to humans, such as the H3N2 
variant that contains the M segment from pandemic H1N1 (163).  
Influenza A virus infection in pigs 
Influenza A viruses in pigs can cause an acute respiratory infection with clinical 
presentation similar to human infections (164). Infected pigs may present a combination 
of signs including fever, anorexia, inactivity and respiratory signs (including shortness of 
breath, sneezing, coughing, nasal discharge and conjunctivitis) (132). The incubation 
period is 1 to 3 days and the infection may last up to 7 days when animals start to recover 
after disease onset. Virus shedding can be detected up to 29 days. Depending on the virus 
strain and the immunological status of infected pigs, infections vary in severity, and may 
progress to pneumonia with infiltration of lymphocytes, that resolves with clearance of 
infection (137). 
Influenza infection in pigs is considered a herd disease due to its rapid spread 




low mortality (<1%). Infection of pigs with influenza viruses is considered a risk factor 
for concomitant bacterial or viral infections; consequently swine influenza viruses are 
part of the porcine respiratory disease complex (PRDC) with other respiratory pathogens 
including the porcine reproductive and respiratory syndrome (PRRSV), type 2 porcine 
circovirus (PCV-2), Pasterella multocida, Mycoplasma hyopneumoniae and 
Actinobacilus pleuroneumoniae (137). Thus, influenza infection in pigs can have a 
negative impact in the development and desirable weight gain in production animals, 
representing a significant economic burden to the pig industry.   
Incidence and patterns of infection of influenza in pigs are associated with the 
nature of pig production systems. Risk factors for the introduction of influenza into a 
herd include movement of animals from infected to susceptible herds, and contact with 
other infected species such as birds or humans. Once introduced, the virus can spread 
through direct contact and aerosol or respiratory droplets between animals. Confinement 
and overcrowding of animals, environmental conditions (e.g. cold weather) and some 
husbandry practices can propitiate virus spread (165-167). Influenza virus infections can 
be maintained in herds though multiple cycles of the production system with the 
periodical exposure of immunologically naïve piglets. After becoming endemic, the 
viruses may circulate as subclinical infections, becoming difficult to detect, unless active 
surveillance to detect IAV is conducted (131).  
As described in the previous section, IAV of avian and human origin can infect 
pigs. It has been hypothesized that the presence and distribution of both α-2,3 and α-2,6 
SA virus receptors in the respiratory mucosa of these animals provide favorable 




infection. Therefore the pig has been proposed to be an intermediate host or “mixing 
vessel” for reassortment between avian (α-2,3 binding) and mammalian (α-2,6 binding) 
viruses (168). However studies using differential glycan staining, and determining the 
binding preference and localized replication of avian and mammalian viruses in these 
animals showed that the distribution patterns of both type of receptors were similar to 
those of the human respiratory tract (169-171). These later observations have failed to 
support the “pig as a mixing vessel” hypothesis; suggesting that similar to pigs, humans 
may be equally likely to be infected with avian viruses and serve as hosts for 
reassortment (172, 173).  
It is unquestionable that viruses from human and avian origin have contributed to 
the diversity of IAVs in pigs around the world. The spectrum of genetically and 
antigenically different viruses that have evolved in pigs represents a constant challenge 
for the development of successful control measures and strategies for outbreak 
prevention.  
Control and prevention of influenza A in pigs 
Depending on their transmissibility, some viruses may spread rapidly once 
introduced into a herd, making it difficult to control. Among the control strategies are 
isolation of animals to prevent contact between uninfected animals. This includes 
separating sources of water, food, etc. and disinfection of areas and equipment to prevent 
further spread.  If the virus becomes persistent in a farm, depopulation and disinfection of 
the affected farms is the only way to completely eliminate the disease (131). 
Vaccination against influenza viruses has been established as a practice to prevent 




systems (137). Vaccination against swine influenza has mostly relied on the use of 
inactivated viruses, as single or multivalent adjuvanted preparations that include strains 
from different genetic clusters that may represent the diversity of circulating viruses in a 
given location (174, 175). 
In a farm, sows are vaccinated to stimulate passive transfer of neutralizing 
antibodies to piglets. Inactivated vaccines provide limited protection against heterologous 
infection, and while they might prevent disease, they may not prevent infection and 
further virus transmission in a herd (137). In addition, the correlates of protection against 
heterologous viruses and broadly neutralizing responses are not fully understood. To 
address these issues, recently there has been more emphasis in the development of Live 
Attenuated Influenza Vaccines (LAIV) that better mimic the natural infection and 
stimulate humoral and cellular responses (176, 177). Other experimentally tested vaccine 
candidates are based on alternative strategies such as vector and DNA vaccines (175). 
Regardless of the vaccination strategy, the main objective of vaccination in a 
population is to decrease virus circulation and disease. Little is known about the diversity 
of viruses, and of genetic and antigenic lineages that circulate in areas of the world where 
surveillance for swine influenza has not been systematically performed. In these areas, 
implementation of vaccination should be based on baseline information on locally 
circulating strains in order to maximize vaccine efficacy (174). To this end, 
characterization of swine influenza viruses is one of the components of this work as 





1.2. Rationale for this work 
Latin America represents an understudied region for influenza viruses in animal 
hosts, including wild birds and pigs. There is little information on which viruses circulate 
and how the interaction between animal reservoirs and humans is shaping their evolution. 
In general, animal raising and handling practices in Latin America resemble those from 
other developing countries (such as Asian countries) that are believed to be associated 
with an increased risk of exposure to zoonotic influenza viruses. Despite this fact, the 
circulation of IAV in animal reservoirs in Latin America is still largely unknown. Central 
America is located in an intermediate point between bird migration routes. Over the past 
20 years there have been two major poultry outbreaks related to avian influenza in the 
region. After a major outbreak in 1994 that started in Mexico and later spread to 
neighboring countries, the H5N2 subtype is now endemic in Mexico, Guatemala and El 
Salvador. The 2012 outbreak caused by a H7N3 strain in Mexico, resulted in significant 
economic losses for one of the biggest egg and poultry producers from Latin America. 
The circulation of this strain in Mexico raises concern about further spread across the 
region. The appearance of the HPAI H5N1 virus in Asia, its unprecedented devastating 
impact in poultry and the pandemic potential of this strain evidenced by hundreds of 
human cases, were the starting points of many surveillance efforts worldwide. As part of 
these efforts, surveillance for animal influenza started in Guatemala in 2007, aiming to 
confirm the presence of avian influenza viruses (IAV), and serve as a platform for the 
early detection of the introduction of HPAIV strains in wild birds (Chapter 2). 
Phylogenetic comparisons were made at a regional level, accompanied by an extensive 




current knowledge of AIV in Latin America, and to analyze phylogenetic relationships 
among publicly available viral genomes (Chapter 3). Our initial findings, justified 
continuation of sampling of waterbirds in Guatemala with focus on the duck species Anas 
discors, to confirm its role as a host for IAV in Central America. Seasonal patterns in the 
circulation of IAV viruses in this host in multiple migration seasons were analyzed 
(Chapter 4). Phylogenetic analysis and characterization of full genomes and gene 
constellations were done, with emphasis in genes that were found to be closely related 
and potential precursors of the HPAI H7N3 outbreak in Mexico. Viruses of the H14 
subtype were found in the western hemisphere for the first time in 2010, and we detected 
this subtype in Guatemala, in 2011. Our findings provide evidence of a potential outbreak 
of H14 viruses, after its introduction in the wintering grounds in Guatemala. The last part 
of this work focuses on the characterization of IAV circulating in the swine population in 
Guatemala (Chapter 5) a work that was started following the appearance of the pandemic 
H1N1 strain in 2009.  
This work presents the results obtained for these studies, recommendations and a 
proposed strategy to further characterize the circulation of influenza of avian and swine 
origin in Guatemala (Chapter 6). The work was performed to address four main research 




1.3. Research objectives  
Specific aim 1. To detect and identify influenza viruses circulating in wild aquatic 
birds from Guatemala. 
• To detect, isolate and identify influenza viruses in different wild bird 
species from the Pacific coast of Guatemala. 
• To establish the subtype diversity and analyze year-to-year variation of 
influenza viruses circulating in wild aquatic bird species during the winter 
migration in Guatemala. 
 
Specific aim 2. To analyze phylogenetic relationships of avian influenza viruses in 
wild birds in Latin America. 
• To perform an extensive literature review for avian influenza in all 
countries from Latin America (Central America, South America and the 
Caribbean). 
• To perform phylogenetic analysis at the regional level to detect 
reassortment events between co-circulating genetic lineages.  
 
Specific aim 3. To establish the origin and genomic diversity of influenza viruses 
circulating in wild aquatic birds from Guatemala.  
• To characterize virus genome constellations and genetic diversity of 




• To obtain full-length genome sequences of representative virus isolates 
and infer the phylogenetic relationships with other influenza viruses 
circulating across the American continent. 
 
Specific aim 4. To identify and characterize the influenza viruses that circulates in 
the swine population from different production systems in Guatemala. 
• To detect, isolate and identify influenza viruses circulating in pigs in 
Guatemala. 
• To detect and identify serological responses to different influenza virus 
subtypes and genetic clusters in pig production units in Guatemala. 
• To characterize the origin of influenza viruses isolated from pigs from 
Guatemala and identify genetic traits associated with transmission and 




Chapter 2. Influenza A viruses from wild birds in Guatemala belong to the 
North American lineage 
 
González-Reiche AS, Morales-Betoulle ME, Alvarez D, Betoulle J-L, Müller ML, 
Sosa SM, and DR Perez. (2012). PLoS ONE 7(3): e32873. 
doi:10.1371/journal.pone.0032873 
2.1. Abstract 
The role wild bird species play in the transmission and ecology of AIV is well 
established; however, there are significant gaps in our understanding of the worldwide 
distribution of these viruses, specifically about the prevalence and/or significance of AIV 
in Central and South America. As part of an assessment of the ecology of AIV in 
Guatemala, we conducted active surveillance in wild birds on the Pacific and Atlantic 
coasts. Cloacal and tracheal swab samples taken from resident and migratory wild birds 
were collected from February 2007 to January 2010. A total of 1913 samples were 
collected and virus was detected by real time RT-PCR (rRT-PCR) in 28 swab samples 
from ducks (Anas discors). Virus isolation was attempted for all positive samples, and 15 
isolates were obtained from the migratory duck species Blue-winged teal. The subtypes 
identified included H7N9, H11N2, H3N8, H5N3, H8N4, and H5N4. Phylogenetic 
analysis of the viral sequences revealed that AIV isolates are highly similar to viruses 
from the North American lineage suggesting that bird migration dictates the ecology of 






The role of wild birds in the transmission of AIVs has become highly significant 
with the introduction and spread of Highly Pathogenic Avian Influenza Viruses (HPAIV) 
of the H5N1 subtype into different countries in Asia, Europe, and Africa (178-181). It is 
generally accepted that aquatic wild birds are the primary reservoirs of AIVs as 
evidenced by the fact that most of the different possible combinations of HA and NA 
subtypes (e.g. H4N2) have been found in these animals (83, 181).  AIVs have been 
isolated from over 100 species of wild birds belonging to 12 different orders, mainly 
Anseriformes and Charadriiformes (79, 82). The virus has also been reported at low 
prevalence in small terrestrial birds (e.g. Passerines) ranging from 0.9% to 6.6% (114, 
182, 183) and it has been proposed that such species can act as bridges between the wild 
aquatic and domestic birds because they co-exist with both ecosystems (184-189).  
Several surveillance studies have provided insight into the evolution of AIVs and its 
relationship with wild bird behavior (70, 93, 94, 190). Information regarding 
intercontinental exchange of viruses and genetic reassortment between Eurasian and 
North American viruses has been reported (65, 75, 191); however, little is known about 
the exchange of genetic material between viruses in the Americas, particularly between 
the Northern and Southern hemispheres.  In Central America, the presence of AIV was 
confirmed with the isolation of the low pathogenic avian influenza virus (LPAIV) of the 
H5N2 subtype from poultry in 2000 in Guatemala and 2001 in El Salvador.  Genetic 
characterization of the H5N2 isolates revealed that the virus was most likely introduced 
from Mexico (192).  Vaccination against H5N2 in Guatemala has been used as the 




Guatemala, and elsewhere in Central America, has not been reported, although it must be 
noted that there has been limited surveillance.  
Guatemala is located on a geographic bottleneck (the Central American Isthmus) 
that funnels millions of migrating birds from several North American flyways 
(Mississippi, Pacific and Atlantic American) through a narrow area. The tropical habitats 
of Central America constitute a terrestrial bridge between North and South America for 
well over 120 species of migratory birds (194). The forests and wetlands of tropical areas 
provide shelter and stopover habitats for several species of terrestrial and aquatic 
migratory birds (195, 196). As it has been hypothesized, these sites could be important 
for AIV transmission and reassortment between different bird species and from different 
migration flyways (83).  To date, there is very little information regarding the circulation 
and ecology of AIV in Central America and only recently information about AIV in wild 
birds from South America has been reported (70, 125, 197, 198). Thus the role of specific 
bird species in the spread of AIVs throughout these regions remains unclear (91, 199, 
200).  
In this study we conducted surveillance of AIV in wild birds in several sites along 
the Pacific and Atlantic coasts of Guatemala. Resident and migratory wild birds 
associated with aquatic habitats were sampled to detect the presence of AIV. The aim of 
the study was to provide an initial assessment of the presence and ecology of AIV in 
Guatemala and serve as a platform for the early detection of the introduction of HPAIV 





2.3. Materials and methods 
2.3.1. Ethics Statement. 
Collection of bird samples were approved by the Institutional Animal Use and 
Care Committee of the Universidad del Valle de Guatemala and reviewed and approved 
by the Institutional Animal Use and Care Committee of the University of Maryland, 
College Park under protocol number R-08-10. Sampling of hunter-killed birds was 
exempt of animal use and care regulations. 
We conducted AIV surveillance in different sites of Guatemala in the Atlantic and 
the Pacific coast. For all sampling activities official permits were approved by the Center 
for Conservation Studies (CECON) and the National Council of Protected Areas 
(CONAP). The Ministry of Agriculture of Guatemala (MAGA) approved the study. 
2.3.2. Sample collection 
Samples were collected by trained veterinarians and technicians from the Center 
of Health Studies of University del Valle de Guatemala (CHS-UVG). Tracheal and 
cloacal swab specimens were obtained from hunter-killed ducks and mist net captured 
birds. Captures with mist nets and sampling were conducted at the study sites of 
Monterrico, Machacas del Mar and Puerto Barrios every 5-6 months, from October 2007 
to July 2009. For mist-net captured birds, cloacal and tracheal swabs were collected from 
all animals, except for small birds in which case only cloacal swabs were collected. In 
addition to mist net captures, sport hunters were contacted for sampling of aquatic birds 
immediately after hunting. Samples from killed birds were obtained during the migratory 




specimen collection, trained ornithologists and technicians identified birds by species, 
sex, and age (adult, juvenile, hatch year or after hatch year). After specimen collection, 
swabs were placed into 1-1.5 mL of freshly prepared viral transport medium (VTM, 
Medium 199 with Hanks balanced salt solution, 2 mM L-glutamine, 0.5% bovine serum 
albumin, 0.35 g/liter sodium bicarbonate) with antibiotics and antimycotics (2 x 106 IU/L 
Penicillin, 200 mg/L Streptomycin, 2 x 106 IU/L Polimyxin B, 250 mg/L Gentamycin, 
0.5 x 106 IU/L Nistatin, 60 mg/L Ofloxacine, and 0.2 g/L Sulphamethoxazol) (201). 
Specimens were transported to the laboratory on ice, frozen in liquid nitrogen or on dry 
ice in double sealed plastic bags depending on availability and estimated time of delivery 
to the laboratory.  Samples were then stored at -70ºC until processed. 
2.3.3. Type A influenza virus detection by rRT-PCR 
For tracheal swabs, RNA was extracted from 200 µL of supernatant with QIAamp 
viral RNA kit (QIAGEN, Valencia, CA). Extracted RNA was eluted from the QIAgen 
columns to a final volume of 100 µL of elution buffer and stored at -70ºC. For cloacal 
specimens, RNA was extracted from 250 µL of supernatant with Trizol LS reagent 
(Invitrogen, Carlsbad, CA) (202). Extracted RNA was then resuspended in 100 µL of 
DEPC treated water, and stored at -70ºC until tested for molecular detection of influenza 
viral RNA (vRNA). 
Prior to sample testing, a formerly reported rRT-PCR assay for Type A influenza 
virus detection (203) was optimized at CHS-UVG. For standardization, influenza type A 
viral RNA was extracted from a clinical sample provided by Dr. A. Estevez (Laboratory 
of Respiratory Diseases, IEIP, CHS-UVG) and was used as positive control to determine 




(A/Guinea/fowl/HK/99/H9N2) in pDP2002 was also used as positive control (204). 
Plasmid DNA was transcribed with the T7 RiboMAX™ Express Large Scale RNA 
Production System (Promega, Madison, WI) in accordance with manufacturer’s 
instructions. Clinical sample RNA and transcribed RNA were quantitated by 
spectrophotometer (GenSpecI, Naka Instruments, Dalian, China).  
All rRT-PCR reactions with matrix gene specific primers and probe were carried 
out using the QuantiTect Probe RT-PCR Kit (QIAGEN, Hilden, Germany) and the ABI 
7300 Real-Time PCR System (Applied Biosystems, Foster City, CA). For a 25 µL 
reaction mixture the following conditions were used: 12.5 µL of kit-supplied 2X RT-PCR 
master mix, 10 pmol of each primer, 0.3 μM probe, 0.25 µL of kit-supplied enzyme mix, 
6.5U RNase inhibitor and 8 µL of RNA template. Thermal cycling conditions comprised 
one cycle of reverse transcription at 50ºC for 30 min and 94ºC for 15 min, followed by 45 
cycles of denaturation at 94ºC for 1s and a combined annealing and extension at 60ºC for 
27s. Fluorescence signal was obtained at the end of each cycle after the 
annealing/extension step. After amplification, quantitation data were analyzed with the 
7300 System SDS Software v1.4.0 (Applied Biosystems).  Positive control RNA was 
calibrated to a Ct value between 25 and 35 for the diagnostic purposes of the assay(202). 
Eight µL of RNA samples extracted from tracheal and cloacal swabs were 
analyzed by rRT-PCR for Type A influenza virus detection. For each rRT-PCR run, 
duplicates of calibrated positive control RNA and a water non-template control (NTC) 
were included. Extracted RNA from cloacal material was analyzed in duplicate and 
samples with Ct value between 20 and 35 were considered positive. For tracheal swabs, 




and 40 were considered presumptive positive and were re-tested for their confirmation. 
All samples that tested positive for the rRT-PCR assay were processed for viral isolation 
and molecular characterization. 
2.3.4. Virus isolation and genetic characterization 
For viral isolation the swab supernatant of each specimen was filtered and BHI 
(brain heart infusion media) supplemented with antibiotics and antimycotics was added to 
a volume of 1.5 mL. A 200µL volume of this mixture was then inoculated into the 
allantoic cavity of three, 9-day-old SPF embryonated chicken eggs (ECE) per sample. 
Following incubation at 37°C for 72 hours, allantoic fluid was collected and tested for the 
presence of virus by HA assay and by Flu Detect (Synbiotics, San Diego, CA). After 
three blind passages in ECE, samples without virus growth were considered negative for 
the presence of viable virus.  
 Viral RNA was extracted from 200 µL of allantoic fluid with RNeasy 
Mini kit (Qiagen), according to manufacturer instructions. Extracted RNA was eluted in 
40 µL of RNase-free water. After cDNA preparation, full-length PCR amplification of 
the influenza virus segments was performed followed by direct sequencing with the 
BigDye terminator kit (Applied Biosystems) on ABI 3100 Avant Genetic Analyzer 
(Applied Biosystems) or ABI 3500 Genetic Analyzer (205). Segments that could not be 
sequenced from PCR products were cloned into pCR 2.1 vector using a TA cloning kit 
(Invitrogen) and were sequenced using vector based M13 primers. At least two 
sequencing reactions were prepared for each gene. Partial and full-length sequences were 
acquired from overlapping partial sequences obtained with forward and reverse primers. 




and CY096621 to CY096724. RNA extracts from original swab samples negative for 
virus isolation, were subjected to direct sequencing by the same method described above, 
in attempt to identify other virus subtypes.  
For each genome segment of each virus isolate, BLAST searches at the nucleotide 
level were initially performed to identify the most closely related viruses. Full-length 
genome segments from North American and selected Eurasian and South American 
viruses available at the Influenza Research database (www.fludb.org) were then obtained 
to be included in the phylogenetic analysis. Sequences of each segment were initially 
aligned by Clustal V (Lasergene v.8.1.5., DNAStar, Madison, WI) and percent identities 
were calculated. Sequences from representative isolates were selected and aligned with 
ClustalW (Lasergene). Rooted phylogenetic trees were generated by Neighbor-Joining 







From February 2007 to January 2010, AIV surveillance was conducted in five 
locations in Guatemala, two sites on the Atlantic coast within the state of Izabal (villages 
of Puerto Barrios and Machacas del Mar), and three sites on the Pacific coast wetlands, in 
the states of Santa Rosa (villages of Monterrico and El Pumpo) and Jutiapa (village of 
Pasaco) (Table 2.1, Figure 2.1). 1913 tracheal and cloacal swabs were collected from 969 
birds from 78 different species, representing 22 different families and 11 different orders 
(Table S1). 50.4% (489/969) were resident and 49.6% (480/969) were migratory bird 
species. Samples were produced from sport-hunter killed aquatic birds or from shorebird 
species of the orders Anseriformes (n=239), Gruiformes (n=4), and Pelecaniformes 
(n=1). The remaining samples (n=725) were collected from live captured terrestrial birds 
that were under study as part of West Nile virus surveillance (Morales-Betoulle, 
unpublished data).  
 
Table 2.1. Sites for AIV surveillance in wild birds, Guatemala, 2007-2010. 
 
 






Izabal Machacas del Mar 15°45'48.10" 88°31'48.60" A 2007-2009 




Santa Rosa Monterrico 13°53'39.00" 90°28'48.00" A / K 2007-2010 
 El Pumpo 13°53'51.80" 90°29'33.20" K 2007-2010 
Jutiapa Pasaco 13°53'8.60" 90°11'45.30" K 2009 







Figure 2.1. Location of sample collection sites in the Atlantic (1 and 2) and the Pacific (3, 4 and 5) 
coasts of Guatemala.  
Geographical coordinates of surveillance sites are provided in Table 2.1 
 
The RNA extracts from collected samples were tested by rRT-PCR assay for the 
detection of type A influenza virus (203). From these, 2 tracheal and 30 cloacal swabs 
tested positive (Table 2.2) corresponding to 28 dabbling ducks (Blue-winged Teal), and 2 
resident terrestrial birds: a Golden-fronted woodpecker (Piciformes) and a Brown-crested 
flycatcher (Passeriformes). In 2ducks, both cloacal and traqueal swabs were positive for 
AIV. The presence of AIV was detected every year of the study. The overall percentage 




To determine factors associated with detection of AIV in wild bird samples, rRT-
PCR results were analyzed by habitat (aquatic vs. terrestrial). Detection of AIV was 
significantly higher in aquatic birds (11.2%) when compared to terrestrial birds (0.3%) 
(p<0.0001). For the aquatic birds, positive results were obtained for the Blue-winged 
Teals, thus comparisons for this species were done by specimen’s age (juvenile vs. adult), 
sex (female vs. male).AIV detection rate was similar for both juvenile (12.5%, n=27) and 
adults (12.8%, n=129), and for females (14.9%, n=87) and males (10.1%, n=129). No 
significant differences were observed between these categories.  
In Blue-winged teals, the percentage of rRT-PCR positive samples varied 
between sampling seasons, 10.0% (2006-07), 7.3% (2007-08), 5.2% (2008-09) and26.6% 
(2009-10). The number of sampled aquatic birds ranged between 61 to 96 birds per 
season, with the exception of the 2006-07 season in which only 10 samples were 
obtained. The proportion of positive samples detected in the 2009-10 season was 
significantly higher (p<0.0009) compared to the previous seasons. To investigate if AIV 
prevalence varied during the migratory season, we compared AIV rRT-PCR detection 
frequencies at the beginning and the end of the seasons. The proportion of AIV positives 
obtained from October through December (Southern migration) compared from January 
to March (Northern migration) was 16.7% and 9.7%, respectively; however, the 
difference was not statistically significant.  
Virus isolation was attempted from positive rRT-PCR samples, in 9-day-old SPF 
ECE; 15 viruses were obtained from either the first (9 viruses), second (5 viruses) and 
third passage (1 virus). After 3 blind passages, no viable viruses were detected in the 




could not be isolated, direct sequencing was attempted in cDNA generated from initial 
RNA extracts; however, no other subtypes could be identified by this method. The 
percentage of recovered viruses from rRT-PCR positive samples by isolation in ECE was 
46.9%.  The viruses were isolated only from duck samples of the species Anas discors 
(Blue-winged Teal) obtained from Santa Rosa (2008, 2010) and Jutiapa (2009).  After 
PCR amplification and sequencing of cDNA, the viruses were classified as H7N9 (n=2), 
H11N2 (n=3), H3N8 (n=1), H8N4 (n=5), H5N3 (n=2), H5N4 (n=2) representing 5 HA 
and 5 NA different subtypes (Table 2.3). The two H5N4 isolates were found to contain 
also N3 NA consensus gene sequences, suggesting a mixed infection in these two 
samples. Sequencing results of complete virus genomes indicated that these viruses 
encode for the 11 protein genes known for IAV, including the 87-90 amino acid protein 
PB1-F2. The H7 and H5 viruses carry the typical low pathogenic cleavage sites 
(PENPKTRGLF and PQRETRGLF respectively)(206). The overall percentage of AIV 
detection in Blue-winged Teals (n=234) based on virus isolation was 6.41%. No rRT-
PCR positives or virus isolates were obtained from other aquatic bird species including 
the northern shoveler (Anas clypeata, n=2), ring-neck duck (Aythya collaris, n=2) and 
black-bellied whistling duck (Dendrocygna autumnalis, n=1). 
Genetic similarity among the internal gene segments of the Guatemalan isolates 
ranged from 72.5% for the non-structural gene (NS) to 100% for the matrix (M) gene. 
For phylogenetic analysis, identical sequences were excluded and only one representative 
of each sequence was used. Sequence comparison by BLAST searches and phylogenetic 
analysis revealed that surface glycoprotein genes of the Guatemalan isolates share 




North American (Figure 2.2 to 2.8). The HA and NA gene segments were found to be 
closely related to strains isolated along the Mississippi (H3N8 subtype) and Pacific 
American flyways (other subtypes). As expected, the internal gene segments were also 
phylogenetically related to North America strains. A single isolate (H3N8) carry a NS 
gene segment corresponding to allele B, whereas the rest carry an allele A (Figure 2.6, 
2.7 and 2.8). 
The Guatemalan isolates were classified among distinct clades of the North 
America lineage. Clade identification was supported by bootstrap values of  >70% (207). 
8 clades were identified for segment M, 9 for segments PB2, PB1 and NP, and 13 clades 
were identified for PA and NS (including alleles A and B) segments. An identification 
number from 1 to “n” (n = 8, 9 or 13) was assigned to each clade of each gene segment to 
allow inference regarding genetic similarities and reassortment events that may have 
occurred within a given viral subtype. Based on this analysis, 9 unique genome 
constellations were identified among the 15 isolates (Figure 2.9), although only on the 
H8N4 viruses (n=5) there was evidence of 4 different gene constellations, indicative of 
reassortment events. The H5N3 viruses (n=2) belonged to the same constellation except 
for the NP gene. For the other strains – H7N9, H11N2, and H5N4 – each subtype 
contained its own constellation of segments. These results suggest multiple introductions 








Table 2.2. Distribution by order and species of wild bird samples collected in Santa Rosa, Jutiapa, 
and Izabal, 2007-2010  
 




Anseriformes Anas clypeata Northern shoveler M 2  
 A. discors Blue-winged Teal M 234 28 (12%) 
 Aythya collaris Red-neck Duck M 2  
 Dendrocygna autumnalis 
Black-bellied Whistling 
Duck R 1  
Ciconiiformes Butorides virescens Green Heron R 1  
Columbiformes Columba sp. Pigeon R 1  
 C. livia Feral Pigeon R 1  
 Columbina inca Inca Dove R 3  
 C. minuta 
Plain-Breasted Ground-
Dove R 7  
 C. passerina Common Ground-Dove R 1  
 C. talpacoti Ruddy Ground-Dove R 63  
 Leptotila plumbeiceps Grey-Headed Dove R 4  
 L. verreauxi White-Tipped Dove R 5  
 Patagioenas cayennensis Pale-Vented Pigeon R 2  
 Zenaida asiatica White-Winged Dove R 1  
 Zenaida macroura Mourning Dove R 6  
Coraciiformes Ceryle torquata Ringed Kingfisher R 1  
 Eumomota superciliosa Turquoise-Browed Motmot R 6  
Cuculiformes Crotophaga sulcirostris Groove-Billed Ani R 29  
 Piaya cayana Squirrel Cuckoo R 2  
Gruiformes Gallinula chloropus Common Moorhen M 2  
 Laterallus ruber Ruddy Crake R 2  
Passeriformes Calocitta formosa White-Throated Magpie-Jay R 2  
 Pachyramphus aglaiae Rose-Throated Becard R 5  
 Euphonia hirundinacea Yellow-Throated Euphonia R 1  
 Oryzoborus funereus Thick-Billed Seedfinch R 9  
 Passerina ciris Painted Bunting M 2  
 P. cyanea Indigo Bunting M 4  
 Piranga rubra Summer Tanager M 3  
 Ramphocelus passerinii Scarlet-Rumped Tanager R 2  
 Saltator atriceps Black-Headed Saltator R 1  
 S. coerulescens Greyish Saltator R 1  
 Sporophila aurita Variable Seedeater R 3  
 S. torqueola White-Collared Seedeater R 30  
 Thraupis abbas Yellow-Winghed Tanager R 1  
 T. episcopus Blue-Grey Tanager R 2  
 Volatinia jacarina Blue-Black Grassquit R 3  
 Dives dives Melodius Backbird R 7  
 Icterus galbula Baltimore Oriole M 8  
 I. gularis Altamira Oriole R 4  








 I. spurius Orchard Oriole M 1  
 Psarocolius montezuma Montezuma Oropendola R 1  
 Quiscalus mexicanus Great-Tailed Grackle R 45  
 Scaphidura oryzivora Giant Cowbird R 5  
 Dumetella carolinensis Grey Catbird M 55  
 Catharus ustulatus Swainson's Thrush M 46  
 Hylocichla mustelina Wood Thrush M 2  
 Turdus grayi Clay-Colored Thrush R 154  
 Dendroica magnolia Magnolia Warbler M 2  
 D. petechia Yellow Warbler M 14  
 Icteria virens Yellow-Breasted Chat M 17  
 Seiurus aurocapillus Ovenbird M 5  
 S. noveboracensis Northern Waterthrush M 70  
 Setophaga ruticilla American Redstart M 1  
 Sphyrapicus varius Yellos-Bellied Sapsucker M 1  
 Campylorhynchus rufinucha Rufous-Naped Wren R 3  
 C. zonatus Band-Backed Wren R 2  
 Thryothorus maculipectus Spot-Breasted Wren R 4  
 T. pleurostictus Banded Wren R 1  
 Contopus cinereus Tropical Pewee R 1  
 Elaenia flavogaster Yellos-Bellied Elaenia R 1  
 Empidonax sp. Flycatcher M 1  
 E. trailli Willow Flycatcher M 3  
 
Mionectes oleaginus 
assimilis Ochre-Bellied Flycatcher R 1  
 Myiarchus crinitus Great Crested Flycatcher M 1  
 M. nuttingi Nutting's Flycatcher R 2  
 M. tuberculifer Dusky-Capped Flycatcher R 1  
 M. tyrannulus Brown-Crested Flycatcher R 4 1 (25%) 
 Myiozetetes similis Social Flycatcher R 4  
 Pitangus sulphuratus Great Kiskadee R 14  
 Tyrannus melancholicus Tropical Kingbird R 6  
 Vireo griseus White-Eyed Vireo M 2  
 V. olivaceus Red-Eyed Vireo M 2  
Psittaciformes Aratinga astec Aztec Parakeet R 2  
Pelecaniformes Phalacrocorax auritus Double-crested Cormoran R 1  
Piciformes Melanerpes aurifrons 
Golden-Fronted 
Woodpecker R 23 1 (4.3%) 
Strigiformes Glaucidium brasilianum Ferruginous Pygmy-Owl R 6  
TOTAL      969 30 (3.1%) 
*Cloacal and tracheal swab samples were taken from each individual, with few exceptions depending on 










Table 2.3. Positive species for influenza type A by rRT-PCR and viral isolates obtained in this study. 
 
 




2006-2007 Santa Rosa Anas discors 10 1(10) - N/D 
2007-2008 Santa Rosa Anas discors 96 7(7.3) 2(2.1) H7N9 








1 1(100) - N/D 
2009-2010 Jutiapa Anas discors 20 4(20) 3(1.5) H11N2 
 Santa Rosa Anas discors 47 13(27.7) 10(21.3) H8N4 (5), H5N3 
(2), H5N4 (2), 
H3N8 (1) 
Total       30 15(1.6) 6 
*Percentage of positive samples obtained by real-time RT-PCR (rRT-PCR) and Virus Isolation (VI) based 









Figure 2.2. Phylogenetic trees for H5 and H7 HA genes. 






Figure 2.3. Phylogenetic trees for H3, H8 and H11 HA genes.  







Figure 2.4. Phylogenetic trees for N3, N4 and N9 NA genes.  





Figure 2.5. Phylogenetic trees for N2 and N8 NA genes.  






Figure 2.6. Phylogenetic trees for internal gene segments PB2 and PB1.  






Figure 2.7. Phylogenetic trees for internal gene segments PA and NP 







Figure 2.8. Phylogenetic trees for internal gene segments M and NS.  

















Figure 2.9. Genome constellations of AIVs obtained from wild birds in Guatemala. 
Nucleotide percent similarities are shown. The different colors represent different clades supported by 
bootstrap values >70%. *Isolate CIP049-01 was used as reference to estimate sequence percent similarities. 
Subtype Virus Percent similarity to reference isolate 
PB2 PB1 PA NP M NS 
H7N9 CIP049-01* - - - - - - 
CIP049-02 99.6 99.7 99.5 99.2 100 99.9 
H11N2 CIP049-03 95.0 95.7 97.3 93.1 97.6 96.6 
CIP049-10 95.0 95.4 97.3 93.1 97.6 96.6 
CIP049-11 95.0 95.3 97.3 93.1 97.6 96.6 
H8N4 CIP049-04 97.0 94.9 97.4 93.2 97.3 96.4 
CIP049-06 92.4 97.2 97.2 96.4 97.6 96.5 
CIP049-07 92.4 96.8 96 94.3 97.5 97.5 
CIP049-14 92.5 97.2 97.2 96.4 97.6 96.6 
CIP049-15 92.4 97.2 97.2 96.4 97.6 96.4 
H3N8 CIP049-05 95.0 96.8 97.3 92.4 97.6 72.5 
H5N3 CIP049-08 92.3 97.2 88.6 93.2 96.9 96.7 
CIP049-09 92.2 97.3 88.6 94.1 97.1 97.5 
H5N4 CIP049-12 96.8 96.8 97.1 96.5 97.6 98.9 
CIP049-13 96.8 96.8 97.1 96.5 97.5 98.9 
Total number of clades 4 6 6 4 2 6 
 





In Central America, the ecology of AIVs is not well understood.  In order to 
collect surveillance data from this understudied region, several variables were considered 
to evaluate the presence/absence, diversity, and seasonality of AIVs. Such variables 
included type of sample(s), target species and study sites. Based on these variables, 
hunter-harvested waterfowl and terrestrial bird species that were under surveillance for 
other zoonotic diseases were chosen as target population. Sampling hunter-harvested 
waterfowl is a convenient method to collect bird samples during the migration season. In 
addition, sampling of terrestrial birds associated with coastal and aquatic habitats may 
provide more insights into the role of these species as vectors between aquatic and 
poultry species.  
In this study, AIV was detected by rRT-PCR in tracheal and cloacal swabs from 
migratory ducks from all the study sites where samples were collected.  The majority of 
rRT-PCR positive samples, and consequently all virus isolates, were obtained from the 
wild duck species Anas discors (Blue-winged teal) sampled in wintering seasons (from 
late October to early March). The hypothesis that dabbling ducks play an important role 
in maintaining AIV transmission in nature by feeding on the water surface is supported 
by surveillance studies in wild ducks and environmental sampling (53, 91).  In our case, 
the overall proportion of rRT-PCR positive birds obtained in this study is in agreement 
with findings reported for other geographical regions. Specifically, we found rRT-PCR 
positive samples in 11.2% of waterfowl. The reported prevalence of LPAI in sampled 
waterfowl ranges between 0.03 to 22.2% (93, 208, 209). In the case of waterfowl, this 




late summer and early fall before migration occurs (82). Our results are in agreement 
with other studies, particularly for Blue-winged teals, reported prevalence estimates 
ranges from 6.6% to 10.9% in temperate zones (96) and from 4.2% up to 22% in 
wintering grounds in North America(97, 98, 210).  In our study, the proportion of AIV 
Blue-winged teals detected in the early months of the migratory season was apparently 
higher than the proportion of positives at the end of the season. Although the difference 
was not statistically significant this finding could support the previous observations that 
the AIV prevalence decreases during migration (93). However, approximately 10% of the 
ducks were infected close to the end of the migration period, suggesting that these birds 
could still carry a significant amount of AIV prior to returning to the temperate zones. 
Our findings are further supported by other studies in wintering areas in the United 
States, where late winter infection in this particular species at relatively high prevalence 
(>10%) has been observed (98). 
When the prevalence values for AIV in Blue-winged teals were compared by age 
groups (juvenile or adult), no significant differences were observed, which is in contrast 
to what has been reported elsewhere where juvenile birds tend to harbor higher 
prevalence of infection than adults (93, 97, 211). This discrepancy may be explained by 
the limited sample size of our study (n=27 for juvenile and n=129 for adult teals), which 
may have resulted in low power in the statistical analyses. The Blue-winged teal is a 
dabbling duck species that performs a long-distance migration to Central America, the 
Caribbean, and some areas of South America.  It is one of the first species to migrate 
south and one of the last to return to the north (212, 213). In Guatemala, the blue-wing 




counts as high as 8,000 individuals during the last months of the wintering season (214).  
Their early migration to the south together with other behavioral and ecological factors 
may influence the role of blue winged teals as reservoirs for AIV (215, 216). The impact 
that long-distance traveling may have on their immunological status (216) may also 
contribute to explain the fact that adults in this study were found infected in a similar 
proportion to juvenile birds. This could be important as this may increase the number of 
available reservoirs for virus infection at the migration sites.   
An increase in virus detection was observed in the 2009-10 sampling season, in 
which one sampling site was added (Jutiapa). However, the majority of positive samples 
came from the site in Santa Rosa, where no significant changes occurred in the number of 
collected samples compared to the previous years. As it has been described previously, 
the increase in virus detection/prevalence could be related to a seasonal pattern followed 
by some influenza viruses (93). Only long-term surveillance together with the 
implementation of more systematic sampling methodologies will provide more and better 
surveillance data to support this finding. 
In this study, a wide diversity of virus subtypes was observed in Blue-winged 
teals in3 out of the 4 sampling seasons. Interestingly, even though the AIV subtypes 
isolated in Guatemala have been isolated in North America with the same HA/NA 
combinations, most of them have been isolated only sporadically or at low frequencies. 
Some of these subtypes, such as the H5N4 has been reported only once (93).  Here the 
most detected subtype combination was H8N4 (5 out of 15 isolates). In contrast, other 
subtypes more prevalent in North America, such as H4 and H6, were not detected in our 




as well as the adaptation of the viruses to different environmental conditions may 
influence the diversity and prevalence of isolated subtypes. Despite the limited number of 
sampled birds and isolates obtained, the fact that these “low prevalent” subtypes for 
North America were most frequently detected in Guatemala warns of the possibility that 
stopover habitats could function as repositories for maintenance of subtypes and genetic 
diversity.   Our findings are supported by other studies at wintering areas in Texas, where 
the subtype diversity was mainly represented by non-frequently occurring subtypes, 
including the H8 (98).  
Both H5 and H7 subtypes were isolated during this study. Although H5N1 and 
H7N3 subtypes are of most interest for their association with emergence of HP strains 
(207), other combinations such as the ones isolated here (e.g. H5N3) have been related to 
outbreaks of LP AIV in turkey farms and other poultry species(217). Further 
characterization of the pathogenicity of the viruses in chickens and other avian models in 
the laboratory could help address the significance and potential impact on poultry 
population of the circulation of H5 and H7 subtypes in the region.  
As revealed by phylogenetic analysis the Guatemalan isolates are more closely 
related to recent isolates from the Mississippi and Pacific American flyways. Although 
there is limited sequence data and information of AIV viruses circulating in wild bird 
populations of adjacent territories (Mexico and other Central and South American 
countries), this observation bolster the possibility that the viruses are being introduced or 
more likely in constant exchange by migratory birds coming from the North. 
For the internal genes (PB2, PB1, PA, NP and NS) the nucleotide sequences 




observation suggests that there have been multiple AIV introductions into the coastal 
sites in Guatemala. In addition, the finding of two H5 strains with similar HA genes but 
with different NA subtypes (N3 and N4), represents potential evidence for reassortment 
between viruses at the site of sample collection. These observations are consistent with 
other studies where frequent reassortment has been found to occur between viruses 
recovered from the same sites (207) over several years (65, 218), and supports the idea of 
independent reassortment between gene segments and continuous virus introduction and 
exchange by wild birds.  
Recently, several AIV isolates from North and South American countries 
including Mexico, Argentina, Chile, and Bolivia have been described (70, 125, 197, 219) 
. In addition, there is evidence that South American viruses constitute a genetic subgroup 
distinct from other influenza viruses (55).  The occurrence and frequency of reassortment 
between these two lineages or genetic groups and/or the exchange of virus between North 
and South American territories remains unknown. The high frequency of detection and 
genetic diversity reflects multiple AIV introductions from numerous waterfowl 
populations from North America occurring each year. Virus exchange between migration 
flyways at wintering grounds could result in virus reassortment upon bird’s arrival to 
temperate zones. In the case of Blue-winged teals, it is not entirely clear whether 
conspecific populations breed in the tropics, as it has been observed that some small 
groups of ducks do not return north after the fall migration (220, 221). As competent 
reservoirs, these conspecific populations could play an important role in not only 




among local bird populations during the non-migration seasons. Further sampling during 
the non-migration season is essential to confirm this hypothesis. 
In addition to AIV detection and isolation from wild aquatic birds, two positive 
samples were obtained from a single flycatcher and a woodpecker, both of which are 
non-migratory species. However, virus presence in these samples could not be confirmed 
by virus isolation or direct sequencing of cDNA. The significance of AIV RNA detection 
in two non-aquatic resident species needs further investigation, including virological and 
serological surveillance in these species could provide more insights on the importance of 
these birds as reservoirs of AIV.  
The tropical wetlands and forest of Guatemala are regions with great diversity of 
avian species (222).  The impact of AIV circulation in a high species diversity ecosystem 
such as the neotropics needs further study.  Only prolonged research of influenza viruses 
in Central America and other South American territories will provide insight into the 
seasonality, molecular evolution and exchange of genetic material between South and 
North American viruses carried by avian hosts. Moreover, the study sites are located near 
rural communities with scarce resources where the habitants often depend on poultry 
farming and live in close contact with their domestic and free-ranged animals, as well as 
wild animals. Summed to this, cultural background and limited resources hinder the 
establishment of adequate biosecurity practices.  In this context, considering the 
geographic spread of HPAI H5N1 (223), and the frequency of outbreaks of H5 and H7 
(LPAI and HPAI) viruses in different regions worldwide (55, 91, 224-233), the presence 
of H7 and H5 viruses in wild birds crossing into Central America represents a threat to 




In summary, 15 isolates of LPAI from 6 different subtypes including H5 and H7 
were recovered from wild aquatic birds in Guatemala. Most of the isolated subtypes 
constitute a group of viruses that have been sporadically found in other geographical 
regions. Phylogenetic analysis suggests that these viruses are genetically similar to North 
American strains. Our findings provide the first description of LPAI isolated from wild 
birds in Central America, and provide clear evidence of frequent introduction and 
exchange of AIV in the Neotropical ecosystems by migratory birds. These findings 
highlight the importance of continued surveillance efforts of AIV not only in wild but 
also domestic birds in the central and southern western hemisphere.  
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Chapter 3. Where do avian influenza A viruses meet in the Americas? 
 
 
Gonzalez-Reiche, A. S. and D. R. Perez (2012) Avian Diseases: December 2012, 
Vol. 56, No. 4s1, pp. 1025-1033.  
3.1. Abstract 
Avian influenza virus (AIV) surveillance has been scarce in most countries of 
Latin America and the Caribbean. Historically, surveillance efforts of avian influenza in 
Central and South America have been localized in places where outbreaks in poultry have 
occurred. Since the emergence of the H5N1 subtype in Asia, active surveillance in wild 
birds has increased in a number of Latin American countries including Barbados, 
Guatemala, Argentina, Brazil, Mexico and Peru. A broad diversity of virus subtypes has 
been detected; however, nucleotide sequence data is still limited in comparison to other 
regions of the world. Here we review the current knowledge of AIV in Latin America, 
including phylogenetic relationships among publicly available viral genomes. Overall 
AIV reports are sparse across the region and the co-circulation of two distinct genetic 
lineages is puzzling. Phylogenetic analysis reflects bias in time and location where 
sampling has been conducted. Increased surveillance is needed to address the major 







In North America, particularly in the United States and Canada, AIV surveillance 
programs were developed in the 1970’s and are currently well established.  A large 
number of samples is collected every year and significant nucleotide sequence data is 
available. In contrast, in Latin America and the Caribbean1, AIV surveillance has been 
scarce, localized mainly in places where outbreaks in commercial poultry have occurred.  
The earliest report of AIV in Latin America and the Caribbean dates from 1970s 
from Brazil (234-237) where the presence of virus was detected in resident and migratory 
birds, and in domestic fowl, by the hemmaglutination inhibition (HI) assay. Later, the 
virus was detected in wild ducks (Dendrocygna viduata, white-faced whistling duck) and 
in exotic birds, and isolated from samples collected between 1997 and 1998 from resident 
and migratory birds (238, 239). There is no virus subtype or sequence data associated 
with these reports. The limited number of AIV sequences available from Brazil comes 
from a large-scale sequence analysis study, from which sample collection methodologies 
are not described (218).  
In 1994, in Mexico, a strain of the H5N2 subtype of low pathogenicity avian 
influenza (LPAI) emerged in poultry farms (240). The virus evolved into a highly 
pathogenic avian influenza (HPAI) strain, which has been controlled mostly by the use of 
vaccination. Although to date there is no evidence of circulation of the HPAI H5N2 strain 
in Mexico, the LPAI H5N2 strain continues to circulate, which ultimately resulted in spill 
1 In this article, the United Nations definitions for the sub-regions of Latin America and the 
Caribbean were used, in which Latin America comprises all countries of Central America (from 




                                                 
over neighboring Central American countries including Guatemala and El Salvador 
(192).  
In 2002, an outbreak of HPAI H7N3 in poultry occurred in Chile. The same virus 
subtype isolated from a species of wild duck (Anas cyanoptera, Cinnamon Teal) in 
Bolivia provided evidence that the outbreak strain had originated from a LPAI virus in 
wild birds and transmitted to poultry before acquiring the HPAI phenotype (55) and that 
the virus contained genetically divergent sequences from avian viruses from the North 
American lineage (125, 197).   
The emergence of HPAI H5N1 subtype in Asia and its unprecedented geographic 
spread triggered the interest of countries in Latin America and the Caribbean into 
programs aimed at early detection of the virus. Such mechanisms were set in motion at 
the Latin America and the Caribbean Hemispheric Conference on Avian Influenza that 
took place in Brasilia, Brazil from November 30 to December 2, 2005. In some countries, 
this initial interest expanded into more active surveillance efforts. For example, a two 
year surveillance study in Barbados (241) yield the presence of a H4N3 subtype virus that 
was isolated from Blue-Winged Teal (Anas discors). More recently, two active 
surveillance studies were initiated in Guatemala and Argentina, aimed at detecting and 
identifying circulating AIVs in wild birds. In these two countries, sample collection 
included hunter-killed and captured wild birds (70, 242). The first virus isolate reported 
from Argentina provided evidence of a potential unique phylogenetic sub-lineage in 
South America. This finding was later confirmed as more isolates were obtained from 
other subtypes and bird species (190, 243). In contrast, the viruses identified in 




American Lineage.  Additionally, virus isolates from Peru (198, 244) were also reported 
to be more closely related to the North American lineage. Additional reports of AIV from 
wild birds in Chile and Brazil have been published, however the molecular characteristics 
of those viruses have not been described (233). Overall these studies have provided 
evidence of AIV circulation in understudied regions. A high diversity virus subtypes 
from multiple bird species has been described, however, the amount of sequence data is 
still limited and does not reflect the number of reports. To date the geographical 
extension of the North American and the South American sub-lineages is unknown as 
well as the extent of exchange of genetic material between them.  
In this manuscript we conducted a review of AIV reports from Latin America. 
Available sequence data, virus and host species diversity per geographic location and 
time were analyzed. In addition, we performed phylogenetic analysis of AIV isolated in 
Latin America with two specific aims: 1) to provide an updated phylogeny of the viruses 
circulating in Latin America and 2) to detect reassortment events between sub-lineages 
within available data. As additional nucleotide sequence data is generated, these studies 
are necessary to better understand and assess the risk of AIV for the region, and define 
geographic areas, bird species and sampling times that could provide crucial information 





3.3. Materials and methods 
A literature review for AIV in Latin America was performed from indexed 
sources available online. Reported virus subtypes, accessible sequence data, and host 
species diversity were summarized per geographic location (country) and year of sample 
collection. The Influenza Research Database (IRD) was used to perform nucleotide 
searches (245). The data set included sequences from Mexico, Guatemala, El Salvador, 
Barbados, Peru, Brazil, Bolivia, Chile, and Argentina. Duplicate or identical sequences 
(100% identity) were removed from the dataset and one representative for each virus 
subtype, location, date and species was selected when multiple sequences were available 
from one single location and year. Sets of coding region sequences were downloaded and 
used for phylogenetic analysis. Sequences were aligned using MUSCLE with default 
parameters (246).  The best-fit nucleotide substitution models were selected individually 
for each gene by jModeltest (247, 248) GTR+Γ (PB2, PA, M genes) or GTR+Γ+I (PB1 
and NP genes) and TVM+I+G (NS gene). Phylogenetic trees were then constructed using 
the Bayesian inference method with MrBayes v.3.2 (249) run for 3.0 to 6.0 x 104 
generations, sampled every 50 generations.  
Two alternative methods for phylogenetic inference were tested to confirm tree 
topologies: Distance and Maximum Likelihood. Rooted phylogenetic trees were 
generated with the neighbor-joining method with Maximum Likelihood (ML) distance 
estimator, and 100 bootstrap replicates using PAUP 4.0b10 (Swofford, D. L. 2003, 
Sinauer Associates, Inc., Sunderland, MA) and Maximum Likelihood method and 100 
bootstrap replicates using RAxML v 7.3.0 (250) under  the GTR+Γ (PB2, PA, M) and 





In order to determine the extent of AIV surveillance in Latin America, we 
performed PubMed and Google searches using the words “avian influenza”, 
“surveillance”, “wild birds”, “Latin America”, “virus isolation”, “South America”, 
“Central America”. These searches resulted in 24 references, which are detailed below. 
Circulation of AIV has been found in poultry and wild birds (Figure 3.1). 14 reports 
contained information on specific virus subtypes, and only 8 were linked to nucleotide 
sequence data available on GenBank (and other related influenza virus databases) (Table 
3.1). The reported hemagglutinin (HA) subtypes included H1 to H11 and H13. The 
neuraminidase (NA) subtypes included N1 to N5, N8, and N9 (Table 3.2). Virus isolates 
have been recovered from multiple bird species mostly from waterfowl species from at 
the orders (Anseriformes, Charadriiformes, Pelecaniformes,) and poultry (Galliformes) 
(Table 3.3). In addition, virus isolation and/or virus genome detection by molecular 
techniques has been reported in terrestrial bird species from the orders Tinamiformes, 
Piciformes, Apodiformes and Passeriformes in Argentina, Guatemala and Peru (190, 242, 
251). 
Based on sequence data entries for “North America” (excluding USA and 
Canada) and “South America” on IRD, records for 196 virus strains were found (up to 
March 2012). Thirty-nine virus sequences were removed from further analysis because 
they represented duplicate sequences of the same viruses. The overall proportions of 
virus strains from domestic and wild birds were 80.9% and 19.1% respectively (n=157). 
From these, only 28 (22%) were complete genomes (sequences from all 8 gene segments 




Sequences from the surface genes (segments 4 and 6) were the most prevalent among the 
database followed by sequences from the matrix (M) gene (segment 7). Eighty-two 
percent of the strains were from Central and North America (Barbados, El Salvador, 
Guatemala, Mexico) and the remaining 18% from South America (Argentina, Bolivia, 
Brazil, Chile and Peru). The number and origin of the set of sequences selected for 
phylogenetic analysis is shown in Table 3.4. For the purpose of this manuscript, only 
sequences from the internal genes were analyzed. The high diversity of subtypes reported 
for the HA and NA genes makes it harder to analyze relationships among all available 
sequences together and data has been published regarding their phylogenetic relationships 
between the North and South American lineages (70, 125, 190, 242, 243). 
Maximum taxon representation (i.e. major number of strains and geographic 
locations) was obtained for the M and the nonstructural (NS) gene segments. The 
generated phylogenetic trees are shown in Figure 3.2. In all phylogenetic trees in this 
article, the North American lineage is represented by the viruses from Guatemala and 
Mexico as the phylogenetic relationships among these viruses within the North American 
lineage have been previously established (242, 252).  In the present study, all viruses 
derived from the H5N2 outbreak from Mexico, Guatemala and El Salvador clustered 
together, separated from the viruses found in wild birds in similar geographic locations. 
As reported, the virus from Barbados (253), and one sequence from Peru (251), clustered 
together with the North American Lineage. As expected, the viruses from South America 
clustered together in a separate sub-lineage. Interestingly, as it was previously reported 
(125), the M gene of A/Cinnamon teal/Bolivia/4537/2001(H7N3) clustered among the 




American sub-lineage. Likewise, sequence analysis from the same virus subtype linked to 
the outbreak in poultry from Chile, A/Chicken/Chile/184240-5/2002 revealed that the M 
and PB2 segments were derived from a North American-lineage virus whereas the rest of 
the genome belonged to the South American lineage. This argument, however, does not 
apply to sequences from the same year and location related to the same outbreak (Figure 
3.2 to 3.4). This analysis suggests that reassortment may have occurred at the time of the 
outbreak with another co-circulating virus. Further evidence for the circulation of viruses 
with mixed North and South American lineage genomes is depicted by A/semi-palmated 
sandpiper/Brazil/43/1990 (H2N1), whose PB2 and PA gene segments clearly belong to 
the North American lineage but its M gene segment is closely related to the South 
American lineage.  The phylogenetic analysis of the NS segment reflects well separated 
clades for both the North and South American lineages, as well as for type of birds (wild 
and domestic), with no apparent exchange of NS segments between viruses from 
different lineages. A similar argument can be made about other internal gene segments 
(PB1, NP) in which no evidence of exchange of these genes was observed between 
lineages. Overall, topologies for phylogenetic relationships among taxa were consistent 
when results were compared with those from Maximum likelihood and Neighbor Joining 










Figure 3.1. Countries of Latin America and the Caribbean from where Avian Influenza has been 
reported. 
Mexico, Guatemala, El Salvador, Barbados, Peru, Brazil, Bolivia, Chile and Argentina. In dark grey are 
shown the countries where AIV has been reported from both poultry and wild birds, and in light grey, 
countries where AIV has been reported only from wild birds.  The insert map of the western hemisphere 
shows a schematic representation of the migratory route of the Blue-Winged Teal, breeding areas are 




Table 3.1. Virus subtypes and published references for Avian Influenza in Latin America and the 
Caribbean per year of sample collection and country. 
 
Country Year Virus subtype 
nt sequences 
available Reference 
Argentina 2007 H13N9 Yes (70) 
 2009 H1N1 Yes (190) 
 2007-2010 H6N2, H6N8, H9N2 Yes (243, 254) 
Barbados 2004 H4N3 Yes (241) 
Brazil 1971 N/A  (234) 
 1977 N/A  (235) 
 1982 N/A  (236, 237) 
 1990 H2N1 Yes (218) 
 2005 N/A  (238) 
 2007 H3  (255) 
 2011 N/A  (239) 
Chile 2003 H7N3 Yes 
(55, 125, 
256) 
 2008 H5N9, H13N2  (233) 
 2009 H1N1 Yes (257) 
Colombia 2002-2005 H9N2  (192) 
El Salvador 2001 H5N2 Yes (240) 
Guatemala 2007-2010 
H7N9, H11N2, H8N4, H5N2, H5N3, H5N4, 
H3N8 Yes (240, 242) 
Mexico 2006 H7N3  (219) 
 1994-1998 H5N2 Yes (240) 
 2007-2009 H5  (258) 
Peru 2008 H3N8, H4N5, H10N9, H13N2  (198) 






Table 3.2. Hemmaglutinin (HA) and Neuraminidase (NA) subtypes reported from Latin America 
and the Caribbean. 
 
NA 
 HA Total 
NA ? 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
? 1     9 1 1  1        13 
1  2 1   1            4 
2     1 106 3   2  3  2    116 
3     2 2  18          20 
4      2   5         7 
5     5             5 
6                   
7                   
8    3   2           5 
9        2   3   1    6 
Total HA 1 2 1 3 6 120 6 21 5 2 3 3  3    176 
*Number estimates based on published reports (table 1) and nucleotide sequence data available 
on IRD. 
  South America (Argentina, Brazil, Chile, Peru) 
  Central America (El Salvador, Guatemala, Mexico) 
 Caribbean (Barbados) 






Table 3.3. Avian influenza detections and isolations in Latin America and the Caribbean.  
 
Order Species Common name Country Reference 
Anseriformes Anas bahamensis White-cheeked pintail Peru (198) 
 Anas clypeata Northern shoveler Mexico (258) 
 Anas cyanoptera Cinnamon teal Mexico, Peru (198, 219) 
 Anas discors Blue-Winged Teal Barbados, Guatemala (241, 242) 
 Aythya americana Redhead Mexico (258) 
 Dendrocygna viduata White-faced Whistling Duck Brazil (239) 
 Haematopus palliates American oystercatcher Peru (198) 
 Netta peposaca Rosy-billed Pochard Argentina (243, 254) 
 Unknown wild bird Brazil (233) 
 Unknown wild duck Peru (244) 
Charadriiformes Arenaria interpres Ruddy turnstone Peru (198) 
 Calidris pusilla Semipalmated sandpiper Brazil (218) 
 Larus dominicanus Kelp gull Argentina, Peru (70, 198) 
 Numenious phaeopus Whimbrel Peru (198) 
 Unknown Gull Chile (233) 
Pelecaniformes Pelicanus occidentalis thagus Peruvian pelican Peru (198) 







 Meleagris gallopavo Turkey Chile (257, 259) 
Tinamiformes Rhynchotus rufescens Red-winged tinamous Argentina (190) 
Passeriformes Campylorhamphus pucherani Greater Scythebill Peru (251) 
  Elaenia mesoleuca Olivaceous Elaenia Brazil (238) 
 Myiarchus tyrannulus Brown-Crested Flycatcher Guatemala (242) 
 Vireo olivaceous Red-eyed Vireo Brazil (238) 











PB2 PB1 PA NP M NS 
Argentina Wild birds 7 6 7 7 7 7 
Barbados Wild birds - - - - 1 1 
Bolivia Wild birds 1 1 1 1 1 1 
Brazil Wild birds 1 1 1 1 1 1 
Chile Poultry 4 4 5 5 8 9 
El Salvador Poultry 1 1 1 1 1 1 
Guatemala Wild birds and Poultry 17 17 14 14 14 15 
Mexico Poultry 22 31 23 21 24 25 
Peru Wild birds - - - - 1 - 







Figure 3.2. Bayesian phylogenetic trees for Matrix (M) and nonstructural (NS) gene segments of AIV sequences reported for Latin America and the 
Caribbean.  
Percentage posterior probabilities are shown. Viruses from South America appear in bold, and from domestic birds appear in italics. Viruses from one geographic 








Figure 3.3. Bayesian phylogenetic trees for PB2 and PB1 internal gene segments of AIV sequences reported for Latin America. 
Percentage posterior probabilities are shown. Viruses from South America appear in bold, and from domestic birds appear in italics. Viruses from one geographic 








Figure 3.4. Bayesian phylogenetic trees for PA and NP internal gene segments of AIV sequences reported for Latin America. 
Percentage posterior probabilities are shown. Viruses from South America appear in bold, and from domestic birds appear in italics. Viruses from one geographic 






The ecology and natural history of AIV in Latin America and the Caribbean is 
poorly understood (83, 91, 190). The emergence of the HPAI H5N1 in Asia led to a 
better recognition of the importance of AIV surveillance in the region. Plans have been 
put in place by animal diagnostic laboratories for the early detection of AIV in 
commercial poultry with an emphasis on the potential introduction of HPAI H5N1 in the 
region. However, efforts aimed at better defining AIV circulation in Latin America and 
the Caribbean continues to be limited. Lack of adequate resources, local infrastructure 
and more urgent animal health priorities, have somehow conspired against the 
establishment of long term AIV surveillance programs in the region. Under this context, 
it is perhaps important to note that countries that initiated long-term AIV surveillance 
programs have yield significant and valuable information; however, more is needed from 
these and other countries to better understand the ecology of AIV in this part of the 
world.  Here we reviewed the current knowledge of AIV in Latin America and the 
Caribbean, and summarized available data by geographic location, bird species, and virus 
subtypes. Figure 3.1 summarizes the distribution of AIV reports with a list of countries 
conducting surveillance studies that has been increasing over time. With limited available 
information on the precise geographic location of sampling collection from all countries 
we recognize that considering an entire country on Figure 3.1, may over represent the 
scale of existing studies. There are still major gaps in the tropical region between Central 





3.5.1. Avian influenza in poultry and wild birds.  
The H5N2 and the H7N3 outbreaks in Mexico and Chile represent two examples 
of virus introduction from migratory waterfowl into poultry. As described by Horimoto 
and collaborators, the Mexican H5N2 lineage evolved from a common ancestor: a virus 
from the North American lineage, introduced into poultry from migratory waterfowl 
(252). The subsequent spread and evolution of this virus into other areas of Mexico and 
Central America, as a result of a spill-over event, vaccination or other events facilitated 
the establishment of different sub-lineages in the region (240).  Besides the two poultry 
outbreaks in Mexico and Chile, the majority of virus isolates and virus subtypes reported 
for Latin America and the Caribbean, have been recovered from wild duck species, 
particularly Blue-Winged Teal, cinnamon teal, and other Anas species. The Blue-Winged 
Teal is likely as a potential key host for virus dispersal given its long distance migration 
between North and South America (83, 91). As evidenced by the studies from Central 
America, the viruses from Blue-Winged Teals from Guatemala comprise a wide array of 
genome constellations, suggesting multiple events of introduction or exchange between 
North and Central America from different bird migration pathways. Additional evidence 
from Barbados and Peru, suggest that bird migration seems to play a major role for virus 
spread across the American continent (198, 242, 253). Alternatively, differences in 
species diversity and distribution of bird populations have been suggested as possible 
determinants for the emergence of an independent genetic lineage in South America (70, 
190).  
In the context of AIV ecology in Latin America and the Caribbean, particular 




transmission of AIV in different locations around the world is still controversial. In Latin 
America, only one virus isolate has been recovered from a wild terrestrial bird species 
(190) and virus RNA has been detected in a few other specimens (238, 242, 251). In the 
US, terrestrial birds such from the order Passeriformes have been shown to harbor 
relatively high rates of AIV infection (114). Moreover, the introduction and spread of 
West Nile virus across Central America and the Caribbean has shown that small 
migratory terrestrial birds may play an important role on spread of infectious diseases 
into new populations in the region (199, 260, 261). Under this perspective, the role of 
terrestrial resident and migratory bird species in AIV dispersal needs further study.  
3.5.2. Phylogenetic relationships 
Evidence of reassortment between viruses from the North and South American 
lineages has been detected for both the surface and internal genes of isolated viruses 
(190, 243). Reassortment occurs at low frequencies between the Eurasian and the North 
American lineage viruses (65, 75, 191). In South America, more data is needed in order 
to estimate the frequencies of such reassortment events.  Based on the summarized data, 
subtype diversity seems to be as high as in other regions of the world. Both H7 and H5 
viruses have been detected in wild bird populations (197, 242, 258). It is well known that 
reassortment is a major mechanism for influenza viruses to maintain genetic diversity and 
the existence of a separate genetic lineage provides a larger genetic pool for potential 
reassortment and generation of novel subtypes in the wild.  
The overall topology and relationships among different viruses in the 
phylogenetic analysis is in agreement with results reported by the corresponding studies. 




which samples have been collected. This creates a scenario with unbalanced data from 
only a few locations and, most likely, poor taxon representation to perform a more 
complete analysis of the evolutionary relationships among these viruses at a continental 
scale. The extent of the interaction between bird species and the spread of virus lineages 
from both ends of the American continent is difficult to address with current available 
data. Underlined by the precedent of two LPAI and HPAI outbreaks in poultry, 
surveillance efforts in Latin America need to be expanded to include previously 
unstudied localities. Coordinated efforts with those countries with established capacity, 
would be of great benefit to better address which bird species, geographic locations as 
well as seasons for sampling collection could be more important to reveal the extent of 
reassortment between lineages and better understand the evolutionary history of AIV 




Chapter 4. Prevalence and diversity of low pathogenicity avian influenza 
viruses in wild ducks at the wintering grounds in Guatemala, 2010-2013 
 
Co-authors: M. L. Muller, A.L. Ramirez, L. Ortiz, M. Angel, C. Cordon-Rosales, 
D. R. Perez. (Manuscript in preparation) 
4.1. Abstract 
Waterfowl species are known to harbor the greatest diversity of low pathogenicity 
influenza A virus (LPAIV) subtypes, and are recognized as their main natural reservoir. 
In Guatemala there is evidence of circulation of LPAIV from the North American 
lineage; however the bird species contributing to viral diversity during the winter 
migration in Central America are unknown. In this study, samples from hunter-killed 
waterfowl were collected at the Pacific coast of Guatemala during three winter migration 
seasons between 2010 and 2013. A total of 1250 birds of 22 different species were 
sampled. LPAIV prevalence detected by rRT-PCR was 38.2%, 23.5% and 24.7% in the 
2010-11, 2011-12, and 2012-13 seasons respectively. Analysis of LPAIV prevalence over 
time indicated a decreasing trend in monthly prevalence during a migration season. Sixty-
eight viruses were isolated and 9 HA and 7 NA subtypes were identified in 19 subtype 
combinations. In 2012-13 the most prevalent subtype was H14, a subtype identified for 
the first time in the western hemisphere in 2010. The majority of positive samples and 
viral isolates were obtained from the blue-winged teal (Anas discors). Phylogenetic 
analysis revealed viruses from different genetic clades, including reassortant stains with 




comparison to other duck species, and the diversity of viruses found in these birds make 






Despite the increased awareness of the need to expand global efforts for 
surveillance of influenza A virus (IAV) in its natural reservoirs, there are still significant 
knowledge gaps. This is particularly the case with respect to the viruses that circulate in 
Central and South America [Chapter 3, (262)]. In 2012 an IAV outbreak caused by a 
HPAI H7N3 strain of wild bird origin in Mexico resulted in significant economic losses 
for one of the biggest egg and poultry producers of Latin America (127, 257, 263), 
raising concerns about further virus spreading across the region and serving as a reminder 
of the risk of IAV spillover from wild bird populations into domestic birds.  
In North America, mallards (Anas platyrhynchos) and northern shovelers (Anas 
clypeata) are two of the duck species with the highest prevalence of IAV (99, 103, 210, 
264). In addition, the blue-winged teals have been observed to harbor high diversity of 
virus subtypes at the wintering grounds, in particular in locations across the Mississippi 
and Central migration flyways (97, 98, 100, 210, 265). Studies at the wintering grounds 
in North America and Europe suggest that viral prevalence in waterfowl species tend to 
be low in comparison to the levels observed at the breeding grounds. The number of virus 
infections decreases over time in the population during an annual migration cycle that 
concludes with the northern migration, as birds return from the wintering grounds (94, 
95, 99). 
The evolution of IAV reflects geographical trends regarding the distribution and 
behavior of the reservoir species (53). The two more clearly defined phylogeographic 
lineages are the North American and Eurasian lineages (67, 83, 266). The co-circulation 




lineage demonstrates that IAV evolution is highly dynamic (218), illustrating the 
complexities of studying the genetic structure of virus populations from specific locations 
at any given time. 
Little information is available on the dynamics of influenza circulation in the 
southern subtropical regions of the Americas. In Guatemala, there is evidence of 
circulation of IAV from the North American lineage in wild waterfowl (Chapter 2 (242)); 
but the main bird species that contribute to viral diversity during and between migration 
seasons remains poorly characterized. Temporal variation of IAV in Central America has 
not been studied due to the limited number of samples obtained in the past. Convergence 
of multiple flyways into a reduced geographical area, distinguishes the wintering grounds 
of Central America from those in North America (267). In Europe, IAV surveillance in 
wild birds in a location where multiple flyways overlap, provided evidence of increased 
gene flow between host populations from different geographical regions, resulting in high 
diversity of locally circulating viruses (268). Similarly, congregation of bird populations 
from multiple migration flyways into a geographical bottleneck in Central America may 
provide unique niches for virus reassortment during the winter migration contributing to 
explain the patterns of extensive reassortments observed in viruses from the North (67, 
269, 270). 
To better understand the virus diversity at the wintering grounds in Central 
America, samples from hunter-killed waterfowl were collected at the Pacific coast of 
Guatemala during three consecutive winter migrations between 2010 and 2013. The 
patterns of IAV prevalence observed during the winter migration for blue-winged teal, 




diversity and the genetic structure of the virus population from Guatemala are provided. 
Phylogenetic analysis, genotype classification and analysis of genetic constellations were 
conducted in order to compare the viruses found to those from other geographical regions 





4.3. Materials and Methods 
4.3.1. Ethics statement 
Collection of samples from wild birds was approved by the Institutional Animal 
Use and Care Committee from Universidad del Valle de Guatemala. Permits for sampling 
different bird species at the different sampling sites were obtained from the Center for 
Conservation Studies (CECON) and the National Council of Protected Areas (CONAP). 
Sampling of hunter-killed birds was exempt from animal use and care regulations from 
the Institutional Animal Use and Care Committee of the University of Maryland. 
4.3.2. Sample collection 
Samples were collected from hunter-killed ducks during the winter migration 
season from 2010 to 2012 in the villages of el Pumpo in the department of Santa Rosa, 
Pasaco in the department of Jutiapa and in La Gomera in the department of Escuintla. 
Tracheal and cloacal swab samples were collected from birds as previously described 
(Chapter 2).  
4.3.3. Virus detection, isolation and molecular characterization 
All samples were tested for the presence of IAV RNA by rRT-PCR (Spackman, et 
al 2002 (203)). The details of the methods for RNA extraction, molecular testing and 
virus isolation are described in Chapter 2. Only IAV positive samples by rRT-PCR were 
tested for virus isolation. 
The subtype of all viral isolates was initially identified by partial sequencing of 




subtype (i.e. one of each different HA and NA combinations) from each sampling point 
was chosen for full-length genome sequencing. The full-genome sequence of the one 
virus isolate from 2010 was obtained by direct sequencing with the BigDye terminator kit 
on a ABI 3500 Genetic Analyzer also described in Chapter 2. For the viruses from 2011 
to 2013, complete genome sequences from 45 viruses were obtained by pyrosequencing 
in a 454 GS Junior system (272). For 30 of the 45 sequenced genomes, an initial multi-
segment amplification of IAV genes (M-RTPCR) (273) was performed in order to 
increase the number of virus specific reads. Sequencing reads were processed for shotgun 
run with the Junior Newbler software (v.2.7 and 3.0, Roche, Branford, CT). GS De Novo 
Assembler (v.3.0) was used to assemble initial contigs.  BLAST searches with the initial 
contigs were performed to identify closest matches. Reference genomes were then 
downloaded from NCBI Genbank database and IAV sequence reads were re-assembled 
using the GS Reference Mapper software (v.3.0). Contig assembly was refined with 
multiple rounds of reference mapping with default parameters to obtain final consensus 
sequences for each virus genome. 
4.3.4. Virus prevalence 
Prevalence of IAV was estimated for different bird species as the number of rRT-
PCR positives divided by the total number of individuals tested by rRT-PCR. Differences 
in prevalence between waterfowl species, sample collection sites, and seasons (2010-11, 
2011-12 and 2012-13) were analyzed with χ2 test at the 95% confidence level; only 
species with n>5 per sampling point were included in this analysis in GraphPad Prism 
v.6.0 (La Jolla, CA, www.graphpad.com). In addition, changes in prevalence over time 




least 10 observations of the least expected outcome (IAV positive) for the independent 
variable (collection date) (274). For all analyses, a two-sided alternative hypothesis was 
assumed with p-values <0.05 considered significant.  Logistic regression was done using 
the Real Statistics Resource Pack software (Release 3.2.1) for Excel (275). 
In order to estimate viral diversity, the Simpson diversity index was calculated 
based on the number of different subtype combinations (276). Confidence intervals were 
estimated according to Grundmann et al, 2001 (277). Viral diversity was compared 
between seasons (2011-12 vs 2012-13) using the Sørensen-Dice coefficient (278, 279), 
given by CC=n1,1/(n1,0+n0,1), where n1,1 is the number of subtypes present in both years, 
n1,0 and n0,1 are the number of unique subtypes observed in the first and the second season 
respectively . A CC = 1 describes identical communities, with an increased level of 
differences as CC approaches to zero.  
4.3.5. Phylogenetic analysis, gene constellations and genetic differentiation 
Phylogenetic analysis was conducted for all internal genes. Background virus 
strains with full-genome sequence data, collected between 2000 and 2013 from waterfowl 
species from different intercontinental genetic lineages available at the Influenza 
Research Database (245), were included in the analysis. Sequences were selected as 
follows: For the North American strains, one virus per month/year/state/country (Canada, 
Mexico, USA) was selected (n=250). For strains of Eurasian origin (Europe, Africa, Asia, 
Oceania) one virus per month/year/country was selected (n=81). Due to the limited 
number of sequences available for Central and South America, all virus isolates available 
for Guatemala (n=15) and South America (n=12) were included. Coding sequences were 




was determined for each gene by the Bayesian Information Criterion (BIC). Final 
phylogenetic trees were constructed using Maximum-Likelihood (ML) inference with the 
nucleotide substitution models, General Time reversible, with Gamma distribution and 
invariant sites GTR+Γ+I (PB2, PB1, PA, NP, NS), or only with gamma distribution and 
uniform rates GTR+Γ (NS). Robustness of tree topologies was assessed with 100 
neighbor-joining bootstrap replicates.  
For the surface genes, phylogenies were inferred for the H14 (one of the most 
abundant HA subtypes) and the N3 (the most abundant NA subtype). For the H14 
subtype, a phylogenetic tree was inferred using the minimum evolution method under the 
best-fit model of nucleotide substitution Tajima-Nei with Gamma distribution (TN93+G) 
determined by the BIC criterion. In addition to the viruses from Guatemala, all other 
available sequences of the H14 subtype from North America and Europe were included 
and a few background H4 viruses. For the N3 gene additional sequences from virus 
isolates between 2008 and 2013 from North America were included and a maximum 
likelihood tree was inferred with the best-fit model of nucleotide substitution Hasegawa-
Kishino-Yaho with Gamma distribution, HKY+G. Robustness of tree topology was 
assessed with 1000 neighbor-joining bootstrap replicates and tree topology was 
confirmed with a second inference with the distance method of Maximun Composite 
Likelihood and assessed with 1000 bootstrap replicates.   
In order to study virus diversity the genotype of the viruses from Guatemala was 
determined with the FluGenome tool (281). To study within lineage diversity, the 
lineages where the viruses from Guatemala were found were subdivided in clades. A 




values of >70% and that shared >96% identity with each other. Clades were defined for 
all internal genes; each clade was identified according to the segment lineage (determined 
by FluGenome tool) and numbered from 1 to n. For the surface genes (HA and NA) 
searches with full-length nucleotide sequences were performed in BLAST to identify the 
top 10 hits. In addition, pairwise distances were computed for each set of isolates of the 
same subtype in order to measure within subtype variability and identify potentially 
distinct variants. For this purpose, isolates with <95% identity between each other were 
identified as different variants. The information of variants for the surface genes was 
included in the analysis of gene constellations by digital genotyping (282). Gene 
constellations were defined as unique gene combinations at the level of clades; colors 
were assigned to different genes and used to build segment identity matrices.   
To compare similarity of the viruses from Guatemala with those from different 
migration flyways, the level of genetic differentiation among virus populations from 
different geographic locations was estimated. The FST values were calculated using 
DnaSP v.5 (283). For this analysis, the most abundant subtype of the surface genes was 
used. Nucleotide sequences of the N3 gene of viruses from the US and Canada between 
2010 and 2012, were downloaded from IRD.  The sequences were classified according to 
the migration flyways based on the geographical state or province of isolation 
(http://www.flyways.us/). Due to the number of sequences available of the N3 subtype 
between 2010 and 2012 from North America, only comparisons between the Pacific 
(n=49) and the Mississippi (n=50) flyways were possible. The level of genetic 







4.4.1. Influenza A prevalence 
Paired cloacal and tracheal swab samples were collected from 1250 birds at three 
localities between October 2010 and February 2011, and between November and January 
in 2011-12 and in 2012-13. Eight species were sampled in 2010-11, 16 in 2011-12, and 
10 in 2012-13 (Table 4.1). Most of the sampled birds were waterfowl species, in 
particular blue-winged teals, followed by northern shovelers and green-winged teals, all 
of which were sampled in all three seasons. A small number of samples were obtained 
from other bird families including doves, coots, and shorebirds (Table 4.2).  
 
Table 4.1 Study sites and distribution of sampled birds per season, Guatemala 2010-2013 
 
 
Season Department Location Latitude Longitude Sampled Birds 
2010-2011 Escuintla La Gomera 13° 56' 39.40"N 91° 6' 46.09"W 98 
 
Jutiapa Pasaco, Finca la Danta  13°53'8.60"N 90°11'45.30"W 4 
Total 
    
102 
      2011-2012 Escuintla La Gomera 13° 56' 39.40"N 91° 6' 46.09"W 359 
 
Jutiapa Pasaco, Finca la Danta  13°53'8.60"N 90°11'45.30"W 191 
Total 
    
550 
      2012-2013 Escuintla La Gomera 13° 56' 39.40"N 91° 6' 46.09"W 276 
  
La Gomera (Salinas) 13° 55' 47.28"N 91° 6' 56.808"W 246 
 
Santa Rosa El Pumpo 13°53'51.80"N 90°29'33.20"W 76 
Total 
    
598 
 






IAV was detected in 39 (38.2%) birds in 2010-11, in 129 (23.5%) birds in 2011-
12 and 148 (24.7%) birds in 2012-13. Prevalence estimates per species are shown in 
Table 4.2. Among duck species, the higher prevalence was observed in northern 
shovelers (35.2%), followed by blue-winged teals (24.7%) and green-winged teals 
(11.1%) (p=0.0168, χ2=8.173, df=2). Two white-winged doves tested positive for IAV. 
Analyses of prevalence for different bird species between migration seasons were 
performed only for ducks, as the majority of positive samples were from these species. 
Only those species with n>5 per sampling point were included, specifically the blue-
winged teal and the northern shoveler. 
For blue-winged teals, prevalence was significantly different between collection 
sites in 2011-12 (p=0.0324, χ2=4.577, df=1), but not in 2012-13. For the northern 
shoveler, the number of sampled birds was smaller, and IAV prevalence was not 
significantly different between sampling sites in 2011-12 or 2012-13 (Fisher test). 
Samples from hunted-waterfowl were consistently obtained from the department of 
Escuintla through all sampling seasons and in greater proportion than the other locations. 
In order to remove possible confounding factors due to variations between sampling sites, 
only data from Escuintla was used to analyze differences in prevalence between host 
species and sampling seasons; and to analyze temporal variations of IAV detection in 
blue-winged teals.  
In the 2011-12 season, the prevalence of IAV in northern shovelers (42%, n=64) 
was significantly higher than in blue-winged teals (19%, n=272). Similarly, in the 
subsequent season (2012-13) a higher prevalence in northern shovelers was observed 




prevalence was compared between seasons and a higher prevalence was observed in 
2010-11 (p=0.0117, χ2=8.901, df=2). Univariate logistic regression was used to analyze 
variation of IAV detection over time (by date and month) in blue-winged teals for 2011-
12 (n=272) and 2012-13 (n=484). In 2011-12, a decrease in IAV prevalence towards the 
end of the migration season was observed (Figure 4.1). This change in prevalence over 
time was significant when results were analyzed by collection date as continuous variable 
(p=1.94×10-5, χ2=18.2), or by month as categorical variable (p=1.95×10-6, χ2=22.6). 
Data from blue-winged teals in January 2013 was available only for one of the two 
sampling sites of Escuintla. Data from both collection sites was combined for the 
regression analysis; the changes in prevalence by collection date or month observed 










Table 4.2. Percentage prevalence for waterfowl species sampled during the wintering migration seasons in Guatemala, 2010-2013 
 
 
    2010-2011 2011-2012 2012-2013 Total 








Anatidae Anas acuta (Northern Pintail) 
  
0(0) 2 0(0) 3 0(0) 5 
 
Anas americana (American Wigeon) 
    
2(28.6) 7 2(28.6) 7 
 
Anas clypeata (Northern Shoveler) 1(25) 4 28(37.8) 74 8(29.6) 27 37(35.2) 105 
 
Anas crecca (Green-winged Teal) 0(0) 1 1(6.3) 16 1(100) 1 2(11.1) 18 
 
Anas discors (Blue-winged Teal) 29(35.4) 82 99(22.8) 434 135(24.5) 550 263(24.7) 1066 
 
Anas sp. (Dabbling duck) 4(57.1) 7 (0) 
   
4(57.1) 7 
 
Aythya affinis (Lesser Scaup) 
  
0(0) 1 0(0) 1 0(0) 2 
 






Dendrocygna autumnalis (Black-bellied Whistling-
Duck) 1(50) 2 (0) 
   
1(50) 2 
 
Dendrocygna bicolor (Fulvous Whistling-Duck) 2(100) 2 (0) 
   
2(100) 2 
 
Oxyura jamaicensis (Ruddy Duck) 
  
0(0) 1 0(0) 1 0(0) 2 











Streptopelia decaocta (Eurasian Collared-Dove) 
    
0(0) 2 0(0) 2 
 
Zenaida asiatica (White-winged Dove) 
  
0(0) 8 2(40) 5 2(15.4) 13 
 






















Scolopacidae Catoptrophorus semipalmatus (Willet) 1(50) 2 
    
1(50) 2 
 





Threskiornithidae Eudocimus albus (White Ibis) 1(50) 2 (0) 1 0(0) 1 1(25) 4 




4.4.2. Virus isolation and viral subtypes 
Sixty-eight viruses were isolated from 316 rRT-PCR positive samples with an 
isolation rate of 21.5%. The majority of isolates were obtained from blue-winged teals 
(n=61), and the remaining isolates were obtained from the northern shoveler (n=5), the 
green winged teal (n=1) and the American widgeon (n=1) (Table 4.3).  The percentage of 
IAV isolation per species was 5.7% for blue-winged teals, 4.7% for northern shovelers. A 
total of 19 subtype combinations were found, from 9 different HA subtypes and 7 
different NA subtypes. Only one virus isolate, of the H5N3 subtype was obtained in the 
2010-11 season. In the 2011-12 season, 34 isolates were obtained and the most prevalent 
subtype combinations were H3N2 (n=10, 29%) and H1N3 (7, 20%). In the season of 
2012-13, 33 isolates were obtained and the most prevalent subtype was H14N3 (9, 27%), 
followed by H4N2 (7, 21%) and H3N2 (5, 15%). From the HA subtypes found, in 2011-
12 the most prevalent were the H3 (n=14, 41%), the H1 (7, 20%) and the H4 (5, 15%), 
and in 2012-13, the H14 (12, 36%), H3 and H4 (8, 23% both). The most frequent NA 
subtypes were N3 (17, 50%) and N2 (12, 35%) in 2011-12; both subtypes were also the 
most frequently isolated during 2012-13 (nN3=13, 39%, and nN2=12, 36%). H5 virus 
isolates were obtained during all three seasons (one isolate per season) and two H7 
isolates were obtained in the second and third seasons respectively. All H5 and H7 
viruses were determined to be of low pathogenicity, by analysis of the monobasic amino 












Table 4.3. Subtypes of IAV isolated during the wintering season in Guatemala, 2010-2013 
 
 
Species November   December   January   Total 
2010 2011 2012   2010 2011 2012   2012 2013   
Anas americana (American wigeon) - - -   - - H4N2   - -   1 
             
Anas clypeata (Northern shoveler) - H1N3 - 
 





          
Anas crecca (Green-winged teal) - - - 
 





          















 - H14N6  


















Similar numbers of isolates were obtained during the 2011-12 and 2012-13 
seasons. H1 and H12 subtypes were only detected during 2011-12, and the H2 subtype 
was only detected in 2012-13, with the remaining six HA subtypes identified both 
seasons. The N9 and N4 subtypes were only found during the 2012-13 season; the 
remaining 5 NA subtypes  (N2, N3, N5, N6, N8) were found during both seasons. From 
the 19 subtype combinations found, only seven were observed during both seasons. The 
estimated indexes of diversity were 0.860(0.794,0.925) and 0.843(0.776,0.910) for 2011 
and 2012, respectively. The diversity index indicated high diversity of subtypes during 
both seasons; based on the subtype combinations, the composition of the virus 
populations between the two seasons was different as indicated by the Sørensen-Dice 
coefficient (CC = 0.269).  
Variation of subtype diversity over time is shown in Figure 4.2. The most 
prevalent subtypes H3 and H4, N3 and N2 were found in at least two months of each 
season. The N3 subtype was the only NA subtype detected in 2010 and observed during 
all months in the following seasons. The highest diversity of virus subtypes was detected 
in the months during peak prevalence as detected by rRT-PCR. All other subtypes, with 
the exception of the H14 (see below), were found sporadically or only during one month 
within a season. H5 viruses were isolated in November in 2010, December in 2012, and 
in January in 2013, whereas the H7 viruses were only detected in January, in the 2011-12 
and 2012-13 seasons. There is no evidence of circulation of H14 viruses in the western 
hemisphere prior to 2010. In Guatemala three H14 viruses were recovered during the 
2011-2012 season (100), and during the 2012-13 season the H14 was the most prevalent 














Mixed infections were detected on six occasions (i.e. virus isolation samples 
having more than one variant of an internal or surface gene segment detected by deep 
sequencing). In three samples, two variants of one or two internal gene segments were 
detected (with <95% shared identity at the nucleotide level), being PA (isolate identifier 
H105-15, subtype H14N3), NP and NS (H102-09, H3N2), and PB2 and NS (H109-03, 
H3N8), respectively. Two viruses with two NA subtypes were found (H102-23, 
H3N2/N8 and H110-14, H14N5/N3), and one sample with two variants of PB2, PA, HA 
and NA (H114-76, H7/H11, N3/N9).  
4.4.3. Phylogenetic analysis, gene constellations and gene flow 
Phylogenetic inference by the maximum likelihood method of the internal genes, 
including sequences from other geographic locations, revealed that for the most part the 
viruses are closely related to other contemporary viral strains from North America. For 
each of the internal genes it was observed that the virus isolates from Guatemala are from 
different clades within the North American lineage, including some of the same clades of 
the viruses previously isolated in Guatemala. For the PB2 gene (Figure 4.3), viruses from 
7 different clades were observed, for the PB1 gene 5 clades (Figure 4.4) and for the PA, 
gene variants from 9 different clades were found (Figure 4.5), where two viruses (H109-
14 and H114-76) clustered together within the Eurasian lineage with other viruses 
recently isolated in the US. For the NP gene, viruses from 5 clades within the North 
American lineage were observed (Figure 4.6); in addition, three isolates recovered in 
2012 (H112-31, H112-60 and H114-14) clustered with viruses isolated in or prior to 2007 




the M gene, 5 clades were found (Figure 4.7) including three viruses isolated in 2011 
(H102-46, H103-05, H104-39) closely related to viruses isolated mainly between 2000 
and 2007 in the US. For the NS, viruses from both alleles (A and B) were found (Figure 
4.8). Viruses from at least 4 clades were found for the allele A, including the same basal 
lineage (distinct to the other lineages) observed for NP. Viruses from 1 clade were found 
for NS allele B. For all the genes, no reassortants with viruses from the South American 
lineage were found.  
For the surface genes, the top matches on BLAST searches are contemporary 
viruses (from 2009 to 2013) from North America from different geographic locations; 
most of them from the Pacific and the Mississippi flyways, and some from locations 
across the Atlantic and Central flyways (Appendices section, Table 0.2). Some viruses 
were found to have more divergent surface genes, explained as follows: For two of the 
H3 viruses (H112-60 and H114-14), the top 10 matches included few isolates from 2010 
and 2009, 2007 and one from 1987 (Table 4.4). These two isolates shared 99.8% identity 
with each other, but only 80% with the other H3 genes from Guatemala. Similarly for the 
H4 subtype, the closest match for one isolate (H112-31) included a virus isolated the 
subsequent year in Louisiana and one quail H4N2 isolate from California in 2012. The 
rest of the matches included isolates from or prior to 2007, and two viruses from Canada 
from 1977 and 1990 respectively (Table 4.4). The H4 HA shared only 83% identity with 
the other H4 HAs from Guatemala. Definition of different gene alleles with <95 % 
identity resulted in two gene variants for the H3 subtype, three for the H4, and two for the 
H5; for the rest of the subtypes (H1, H2, H7, H11, H12 and H14) only one variant was 







Figure 4.3 Maximum Likelihood Phylogenetic inference for the Polymerase Basic 2 (PB2) gene of 
LPAIV from Guatemala and other LPAIV from the North American, Eurasian and South American 
lineages between 2000 and 2013. 
The Eurasian lineage is shown in green, the South American lineage is shown in red, and the North 
American lineage is shown in grey. The viruses from Guatemala isolated are shown in light blue (2008-
2010) and dark blue (2010-2013). Bootstrap support values >70% are shown for lineages and main clades. 












Figure 4.4. Maximum Likelihood Phylogenetic inference for the Polymerase Basic 1 (PB1) gene of 
LPAIV from Guatemala and other LPAIV from the North American, Eurasian and South American 
lineages between 2000 and 2013. 
The Eurasian lineage is shown in green, the South American lineage is shown in red, and the North 
American lineage is shown in grey. The viruses from Guatemala isolated are shown in light blue (2008-
2010) and dark blue (2010-2013). Bootstrap support values >70% are shown for lineages and main clades. 














Figure 4.5. Maximum Likelihood Phylogenetic inference for the Polymerase Acid (PA) gene of 
LPAIV from Guatemala and other LPAIV from the North American, Eurasian and South American 
lineages between 2000 and 2013. 
Polymerase acid (PA) gene. The Eurasian lineage is shown in green, the South American lineage is shown 
in Red, and the North American lineage is shown in grey. The viruses from Guatemala isolated are shown 
in light blue (2008-2010) and dark blue (2010-2013). Bootstrap support values >70% are shown for 











Figure 4.6. Maximum Likelihood Phylogenetic inference for the Nucleoprotein (NP) gene of LPAIV 
from Guatemala and other LPAIV from the North American, Eurasian and South American lineages 
between 2000 and 2013. 
The Eurasian lineage is shown in green, the South American lineage is shown in Red, and the North 
American lineage is shown in grey. The viruses from Guatemala isolated are shown in light blue (2008-
2010) and dark blue (2010-2013). Bootstrap support values >70% are shown for lineages and main clades. 











Figure 4.7. Maximum Likelihood Phylogenetic inference for the Matrix protein (M1) gene of LPAIV 
from Guatemala and other LPAIV from the North American, Eurasian and South American lineages 
between 2000 and 2013. 
The Eurasian lineage is shown in green, the South American lineage is shown in Red, and the North 
American lineage is shown in grey. The viruses from Guatemala isolated are shown in light blue (2008-
2010) and dark blue (2010-2013). Bootstrap support values >70% are shown for lineages and main clades. 















Figure 4.8. Maximum Likelihood Phylogenetic inference for the Non-structural 1 (NS1) gene of 
LPAIV from Guatemala and other LPAIV from the North American, Eurasian and South American 
lineages between 2000 and 2013. 
The Eurasian lineage is shown in green, the South American lineage is shown in Red, and the North 
American lineage is shown in grey. The viruses from Guatemala isolated are shown in light blue (2008-
2010) and dark blue (2010-2013). Bootstrap support values >70% are shown for lineages and main clades. 










Table 4.4. Top 10 BLAST hits of the most divergent HA genes of IAV isolated in Guatemala in 
wintering waterfowl between 2012 and 2013 
 
 









   JN864063.1|A/Anas strepera/Arizona/A00271503/2009(H3N8) 99.0 98.8 
 CY076165.1|A/American coot/Oregon/20589-007/2007(H3N8) 98.6 98.5 
 CY097718.1|A/mallard/Mississippi/386/2010(H3N8) 98.5 98.4 
 CY097726.1|A/mallard/Mississippi/390/2010(H3N8) 98.5 98.4 
 CY097702.1|A/mallard/Mississippi/354/2010(H3N8) 98.5 98.3 
 CY032720.1|A/northern pintail/California/HKWF792/2007(H3N8) 98.4 98.3 
 CY097710.1|A/mallard/Mississippi/360/2010(H3N8) 98.4 98.3 
 CY097678.1|A/American green-winged teal/Mississippi/285/2010(H3N8) 98.3 98.2 
 CY076013.1|A/cinnamon teal/California/44287-325/2007(H3N8) 98.1 98.0 
 EU871828.1|A/duck/LA/17G/1987(H3N8) 94.7 94.7 
 H4 































For the NA genes, the top 10 BLAST hits for most of the viruses included recent 
virus isolates from North America, from different locations in the US and Canada 
(Appendices section, Table 0.3).  Similarly to the HA genes, it was found that the top 10 
BLAST hits for the H4N2 of virus H112-31 included the same isolate from Louisiana, 
and another H4N2 isolate of a turkey from Minnesota from 2014, with the rest of the top 
hits including isolates from 1978 to 2010 with apparent low frequency of detection in the 
last decades in the US (Table 4.5). The N2 of virus H112-31 shared only 87% identity 




three isolates, from the 2010-2011 (H098-32), and from the 2011-2012 season (H104-69 
and H105-05), included viruses isolated during a poultry outbreak of HPAI H7N3 in 
Mexico in 2012. For the N6, the top BLAST hits were viruses from Canada isolated 
between 2006 and 2008. For the N8, the NA of the two viruses with the most divergent 
H3 genes (H112-60 and H114-14) had as top matches viruses from the US isolated 
between 2007 and 2010, but also included one isolate from Louisiana from 1987. The 
two N8 genes shared 98.7% identity with each other, but only 78% with the other N8 
viruses isolated in Guatemala, which were similar to more recent isolates from North 
America (Table 4.5). Based on pairwise distances, two gene variants of N2 sharing 87% 
identity where identified. For the N3, three gene variants were identified with 93 to 94% 
identity between groups, two variants for the N5 (94% identity between groups), and 
three for N8, with 78 and 93% shared identity between groups. For the rest of the NA 
subtypes (N4, N6, and N9) only one variant was detected with >97% identity within 
variant groups. 
From a total of 50 virus genomes (including mixed infections), 31 unique 
genotypes were identified (Table 4.6) and 49 gene constellations. Genes from 1 lineage 
were identified for the PB2 and PB2 genes, and from 3 lineages (H, E and D) for the PA. 
Most NP genes were H lineage, with the exception of three strains that couldn’t be 
assigned to any particular lineage and were therefore designated as “unknown” or U. For 
the M gene, all genes were from lineage E and for the NS, three lineages were identified 
including 1D, E and 2B. For the HA genes, the 9 lineages corresponding the 9 HA 
subtypes were assigned, but the two most divergent H3 and one H4 couldn’t be assigned 




were assigned to an “unknown” lineage and were named 3U and 4U accordingly. In 
addition, the HA of the H14 viruses from North America share <90% identity with the 
HA of the H14 viruses originally described in the eastern hemisphere (272, 284, 285). 
According to the FluGenome 90% identity as the cutoff value for lineage definition, the 
H14 genes were classified in an “unknown” lineage within this subtype and named 14U. 
For the NA, genes were assigned to 7 lineages, with the exception of the two most 
divergent N2 and one N8 genes that were assigned to “unknown” lineages designated as 
“U”.  Analysis of gene constellations by digital genotyping for each year is shown in 
Figure 4.9 and Figure 4.10 for the 2011-12 and 2012-13 seasons respectively. This 
analysis revealed great variability between gene constellations within and between 
migration seasons and allowed identification of common gene clades and gene 
combinations for each year. Even when the number of gene constellations, were almost 
as many as the number of individual viruses observed, some isolates were found to share 
partial gene combinations of specific lineages. For example, a common gene combination 
was PB1 (F-1), M (E-1) and NS (1D-1) during both seasons. In addition, in 2010-11 
viruses from the PB2 clade C-1 and PA clade H-2 were more prevalent whereas in 2012-
13 the PB2 C-2 clade and PA E-1 clade were more abundant; the PA E-1 clade was found 
almost exclusively in combination with the PB2 C-2 lineage. In fact for the PA gene, the 
H lineage was more prevalent in 2011-12 and the E lineage was more prevalent in 2012-
13 (Table 4.6).  For the M and NS genes, during both years the M (E-1) clade and the NS 
(1D-1) clade were most prevalent. Viruses from other clades were observed both years, 
but these clades were different each year, being the M clades E-3, E-4 and E-5 and NS 




13. For the NP gene only one clade was different between years: the H-5 clade was not 
observed in 2012-13 and instead NP genes from an unidentified lineage were observed. 
The gene constellation of the viruses with HA and NA from unassigned lineages were 
almost unique to these viruses and included the NP variant with unassigned lineage. 
The phylogenetic analysis of the H14 viruses indicates that the viruses from 
Guatemala from 2011 were closely related to viruses later isolated in North America in 
2012 (Mississippi and Arkansas) and were the closest ancestors of the viruses found in 
Guatemala during the winter in 2011-2012 and in Texas during the spring of 2013 
(Figure 4.11). Phylogenetic analysis of the N3 gene suggested a close relationship among 
three of the viruses from Guatemala [one from 2010 (H098-32) and two from 2011 
(H104-69 and H105-05)] and the NA genes of the HPAI H7N3 strain isolated from 
poultry in Mexico in 2012 (Figure 4.12).  Comparison of genetic differentiation between 
the N3 gene of the viruses from Guatemala and those from the Pacific and Mississippi 
flyways revealed that the virus populations from these localities are not significantly 
different from each other. The FST values were 0.163 between Guatemala and the 
Mississippi flyway, 0.214 between the Guatemala and the Pacific Flyway and 0.116 
between the Mississippi and the Pacific flyways. The FST between the virus populations 
from Guatemala from 2011-12 and 2012-13 was 0.292 (Table 4.7). Comparisons between 
migration flyways by year were not possible given the small number of sequences 





Table 4.5. Top 10 BLAST hits for the most divergent NA genes of LPAIV isolated in Guatemala between 2011 and 2013 
 
 
GenBank Accession|Virus name 
% identity 
H112-31 H098-32 H103-05 H104-69 H105-05 H110-27 H112-60 H114-14 
N2 
        KJ413567.1|A/blue-winged teal/LA/AI13-1334/2013(H4N2) 98.7 
       KM244116.1|A/turkey/Minnesota/16423-3/2014(H4N2) 98.4 
       CY097754.1|A/mallard/Mississippi/407/2010(mixed) 98.0 
       CY053823.1|A/pekin duck/California/P30/2006(H4N2) 97.5 
       CY004785.1|A/mallard duck/ALB/354/1978(H4N2) 91.7 
       CY014560.1|A/mallard duck/Alberta/205/1978(H6N2) 91.6 
       CY004045.1|A/pintail duck/ALB/367/1978(H6N2) 91.6 
       CY004001.1|A/mallard duck/ALB/250/1978(H6N2) 91.6 
       CY004050.1|A/blue-winged teal/ALB/651/1978(H6N2) 91.6 
       CY004041.1|A/pintail duck/ALB/133/1978(H6N2) 91.6 
       N3 






   CY097336.1|A/mallard/Wisconsin/2560/2009(H2N3) 
 
98.3 99.2 
     CY096996.1|A/blue-winged teal/Wisconsin/2572/2009(H2N3) 
 
98.2 99.1 
     CY097376.1|A/mallard/Wisconsin/2785/2009(H2N3) 
 
98.1 99.0 
     CY039598.1|A/northern shoveler/California/HKWF2031/2008(H7N3) 
 
97.9 98.2 97.4 97.5 
   CY097320.1|A/mallard/Wisconsin/4236/2009(mixed) 
 
97.8 98.5 97.3 97.3 
   CY039542.1|A/green winged teal/California/AKS1370/2008(H7N3) 
 
97.7 98.1 97.2 97.3 





   CY032730.1|A/northern shoveler/California/HKWF979/2007(H3N3) 
 
97.7 98.1 97.1 97.2 
   EU500862.1|A/chicken/SK/HR-00011/2007(H7N3) 
 
97.6 97.9 96.9 97.0 
   KJ413442.1|A/blue-winged teal/TX/AI12-614/2012(H10N3) 
   
99.4 98.2 
   CY166180.1|A/mallard/Mississippi/12OS445/2012(H10N3) 
   
99.3 98.1 
   JX317626.1|A/chicken/Jalisco/CPA1/2012(H7N3) 
   
99.2 98.0 




GenBank Accession|Virus name % identity 
N6 
        CY103120.1|A/mallard/Alberta/246/2006(H4N6) 
     
98.5 
  CY103128.1|A/mallard/Alberta/254/2006(H4N6) 
     
98.5 
  CY103213.1|A/mallard/Alberta/106/2007(mixed) 
     
98.5 
  CY103238.1|A/mallard/Alberta/114/2007(H4N6) 
     
98.5 
  CY103317.1|A/mallard/Alberta/156/2007(mixed) 
     
98.3 
  CY103326.1|A/mallard/Alberta/160/2007(H4N6) 
     
98.4 
  CY103342.1|A/northern pintail/Alberta/265/2007(H4N6) 
     
98.4 
  CY103469.1|A/mallard/Alberta/121/2008(H4N6) 
     
98.5 
  CY103477.1|A/mallard/Alberta/270/2008(H4N6) 
     
98.5 
  CY140477.1|A/mallard/Minnesota/Sg-00931/2008(H4N6) 
     
98.3 
  N8 
        CY076167.1|A/American coot/Oregon/20589-007/2007(H3N8) 
      
98.3 99.0 
CY097704.1|A/mallard/Mississippi/354/2010(H3N8) 
      
98.1 98.7 
CY032722.1|A/northern pintail/California/HKWF792/2007(H3N8) 
      
98.1 98.7 
CY097728.1|A/mallard/Mississippi/390/2010(H3N8) 
      
98.1 98.7 
CY097712.1|A/mallard/Mississippi/360/2010(H3N8) 
      
98.0 98.6 
CY097720.1|A/mallard/Mississippi/386/2010(H3N8) 
      
98.0 98.6 
CY097129.1|A/mallard/Ohio/2039/2009(mixed) 
      
97.9 98.6 
CY076015.1|A/cinnamon teal/California/44287-325/2007(H3N8) 
      
97.8 98.5 
CY097680.1|A/Am. green-winged teal/Mississippi/285/2010(H3N8) 
      
97.8 98.5 
EU871830.1|A/duck/LA/17G/1987(H3N8)             94.6 95.3 





Table 4.6. Genotypes and gene constellations of sequenced IAV from Guatemala isolated from 
wintering waterfowl (2010-2013) 
 
 
Virus ID Genotype 
Genetic clade 
PB2 PB1 PA HA NP NA M NS 
H098-32 CFH5CH3AE1D C-1 F-1 H-2 5C-1 H-3 3A-1 E-1 1D-1 
H101-25 CFE4AH2DE1D C-4 F-1 H-2 4A-1 H-1 8A-1 E-1 1D-1 
H101-29 CFH3CH8AE1D C-1 F-4 E-2 3C H-4 2D E-4 1D-1 
H102-05 CFH4AH2DE1D C-1 F-1 H-2 4A-1 H-3 2D E-1 1D-1 
H102-09a* CFH3CH2DE2B C-7 F-1 H-3 3C H-3 2D E-1 1D-1 
H102-09b* CFH3CH2DE1D C-7 F-1 H-3 3C H-3 2D E-1 2B 
H102-10 CFH4AH8AE1D C-1 F-1 H-2 4A-2 H-5 8A-1 E-1 1D-1 
H102-23 CFE3CH2DE1D C-7 F-1 E-4 3C H-5 2D E-4 1D-1 
H102-23 CFE3CH8AE1D C-7 F-1 E-4 3C H-5 8A-1 E-4 1D-1 
H102-32 CFE3CH2DE1D C-4 F-1 E-5 3C H-3 2D E-1 1D-1 
H102-46 CFE1DH3AE1D C-1 F-2 E-5 1D H-4 3A-3 E-3 1D-1 
H103-05 CFH1DH3AE1D C-6 F-1 H-3 1D H-1 3A-1 E-5 1D-1 
H103-20 CFH3CH2DE1D C-1 F-2 H-3 3C H-1 2D E-1 1D-1 
H103-37 CFH4AH3AE1D C-2 F-2 H-2 4A-2 H-3 3A-2 E-1 1D-1 
H104-38 CFH1DH3AE1D C-1 F-1 H-2 1D H-3 3A-3 E-3 1D-1 
H104-69 CFH11CH3AE1D C-2 F-2 H-2 3C H-1 3A-2 E-1 1D-1 
H104-93 CFE3CH3AE1D C-1 F-1 E-2 12A H-2 5D-1 E-1 1D-1 
H104-99 CFH12AH5DE1D C-1 F-1 H-2 11C H-1 3A-1 E-1 1D-1 
H105-01 CFH1DH3AE1D C-2 F-1 H-2 1D H-3 3A-2 E-1 1D-1 
H105-04 CFH11CH3AE1D C-4 F-5 H-1 11C H-1 3A-3 E-1 1D-1 
H105-05 CFH5CH3AE1D C-1 F-2 H-2 5C-2 H-1 3A-1 E-1 1D-1 
H105-08 CFH3CH3AE1D C-1 F-2 H-1 3C H-5 3A-3 E-1 1D-1 
H105-15a* CFE14UH3AE1D C-4 F-1 E-2 14U H-5 3A-2 E-1 1D-1 
H105-15b* CFE14UH3AE1D C-4 F-1 E-2 14U H-5 3A-3 E-1 1D-1 
H105-31 CFH14UH3AE1D C-4 F-1 H-2 14U H-2 3A-3 E-1 1D-1 
H106-62 CFH14UH6AE1D C-6 F-1 H-1 14U H-5 6A E-1 1D-1 
H107-88 CFE7FH3AE1D C-6 F-1 E-2 7F H-1 3A-2 E-1 1D-3 
H108-02 CFE14UH3AE1D C-2 F-1 E-1 14U H-1 3A-1 E-1 1D-1 
H108-39 CFE4AH2DE1D C-1 F-1 E-4 4A-2 H-3 2D E-1 1D-1 
H108-45 CFE3CH2DE1D C-1 F-1 E-2 3C H-1 2D E-1 1D-1 
H109-06 CFH4AH2DE1D C-5 F-3 H-1 4A-1 H-2 2D E-1 1D-2 
H109-14 CFD3CH3AE1D C-2 F-2 D 3C H-1 3A-2 E-1 1D-1 
H109-15 CFE3CH2DE2B C-1 F-1 E-2 3C H-1 2D E-1 2B 
H109-38a* CFE3CH8AE1D C-2 F-1 E-2 3C H-2 8A-2 E-2 1D-2 
H109-38b* CFE3CH8AE1D C-4 F-1 E-2 3C H-2 8A-2 E-2 1D-1 
H109-49 CFE14UH3AE1D C-2 F-1 E-1 14U H-1 3A-1 E-1 1D-2 
H110-04a* CFH14UH5DE1D C-1 F-1 H-2 14U H-1 3A-1 E-2 1D-1 
H110-04b* CFH14UH3AE1D C-1 F-1 H-2 14U H-1 5D-2 E-2 1D-2 
H110-27 CFE4AH6AE1D C-4 F-2 E-1 4A-1 H-1 6A E-1 1D-1 
H110-31 CFH14UH3AE1D C-2 F-1 H-1 14U H-3 3A-1 E-1 1D-1 
H110-37 CFH11CH3AE1D C-1 F-1 H-1 11C H-4 3A-1 E-1 1D-1 
H111-98 CFna2HH3AE1D C-4 F-1 na 2H H-1 3A-2 E-1 1D-1 
H112-31 CFE4UU2UEE C-2 F-3 E-1 4U U 2U E-2 E 
H112-60 CFE3UU2UEE C-2 F-3 E-1 3U U 8U E-2 E 
H113-07 CFE14UH3AE1D C-2 F-1 E-1 14U H-1 3A-1 E-1 1D-2 
H113-08 CFE14UH4AE1D C-2 F-1 E-1 14U H-1 4A E-1 1D-2 
H113-53 CFH5CH3AE1D C-2 F-1 H-1 5C-1 H-1 3A-1 E-1 1D-1 
H113-76 CFE14UH4AE1D C-2 F-1 E-1 14U H-1 1A E-1 1D-2 
H114-14 CFE3UU8UEE C-2 F-3 E-1 3U U 8U E-2 E 
H114-76a* CFE11CH3AE2B C-1 F-1 D 11C H-1 9A E-2 2B 
H114-76b* CFD7FH9AE2B C-1 F-1 E-3 7F H-1 3A-1 E-2 2B 
* Mixed infections; the gene constellations in mixed infections cannot be assigned individually to each of 
the co-infecting viruses, the order in which their genes appear listed in the table are only with the purpose 









Figure 4.9. Digital genotyping of AIV isolated from wintering waterfowl in Guatemala during the 2011-12 season. 
Virus genomes are represented in a segment identity matrix based on the genetic constellations derived from the clades (with >96% ID and >70% bootstrap clade 








Figure 4.10. Digital genotyping of AIV isolated from wintering waterfowl in Guatemala during the 2012-13 season. 
Virus genomes are represented in a segment identity matrix based on the genetic constellations derived from the clades (with >96% ID and >70% bootstrap clade 




















Figure 4.11. Evolutionary relationships inferred by the Minimum Evolution method of the HA genes 
of H14 IAV from Guatemala 
Viruses from Guatemala are shown in bold. Bootstrap support values >70% are shown. Scale-bar in the 



















Figure 4.12. Maximum Likelihood phylogenetic inference for the NA gene of the N3 viruses from 
Guatemala and North America isolated between 2008 and 2013. 
Viruses from Guatemala are indicated with green circles, the N3 of a chicken derived HPAI H7N3 virus 
from Mexico in 2012 is indicated with a red circle. Bootstrap support values >70% are shown. Scale-bar in 





















Table 4.7. Genetic differentiation index between the virus populations from Guatemala, and the 
locations across the Mississippi and Pacific flyways in North America. 
 
 
Population 1 Population 2 Genetic differentiation 
Fst χ2 P-value df 
Location      
Guatemala1 Mississippi flyway2 0.1633 73 0.348 69 
Guatemala1 Pacific flyway3 0.2140 72 0.4115 70 
Mississippi flyway2 Pacific flyway3 0.1167 99 0.3965 96 
      
Year      
Guatemala, 2011 Guatemala, 2012 0.2917 22 0.3405 20 
1 N3 neuraminidase nucleotide sequences of the virus isolates from Guatemala obtained during the winter 
migration between 2010 and 2013 
2 N3 neuraminidase nucleotide sequences available in the IRD of virus isolates obtained between 2010 and 
2012 in locations across the Mississippi flyway (United States: Arkansas, Illinois, Louisiana, Minnesota, 
Mississippi, Missouri, Ohio, Wisconsin; Canada: Saskatchewan) 
3 N3 neuraminidase nucleotide sequences available in the IRD of virus isolates obtained between 2010 and 







Sampling of hunter-harvested waterfowl in Guatemala revealed relatively a high 
detection rate of IAV at wintering grounds. Prevalence estimates based on rRT-PCR for 
northern shovelers and blue-winged teals are higher than reported in wintering 
populations in other geographical regions (97, 99). Overall prevalence estimates based on 
virus isolation for blue-winged teals (5.7%) and northern shovelers (4.7%) are 
comparable with studies from wintering ducks from California and Louisiana (99, 100, 
210). A higher prevalence based on rRT-PCR is not surprising, as quantitative rRT-PCR 
is known to be more sensitive than virus isolation techniques. Selection of the strains that 
are able to replicate in ECE during virus isolation may also explain the differences in 
prevalence estimates obtained with each method. It is important to note that virus 
prevalence estimates should be interpreted and compared to other studies in the context 
of the testing methodologies. An increase in rRT-PCR virus prevalence compared to 
previous years was observed previously in 2010 in Guatemala (Chapter 2). The reasons 
of the high prevalence observed in 2010 and during the present study are unknown; the 
high diversity of co-circulating subtypes and subtype combinations detected may help to 
explain this observation. A high diversity of AIV subtypes was observed in wintering 
grounds in California and Texas (97, 99, 265), with comparable virus isolation rates.  
During the 2010-11 and 2011-12 seasons a decreasing trend in prevalence was 
observed towards the end of the migration, supporting observations from previous years 
in Guatemala and similar to patterns of prevalence observed in wintering grounds in 
California and Texas (97, 99, 265). This decrease is likely explained by the accumulation 




reduced number of susceptible individuals, not only to circulating subtypes but to other 
viruses from related genetic clades (286). During 2012-13 the pattern of IAV detection 
over time was different and the prevalence of IAV in January two-times higher in 
comparison to previous years. A plausible explanation could be the introduction and a 
potential outbreak of H14, the most prevalent HA subtype detected during that season. As 
mentioned above, the H14 is presumably a novel LPAI subtype to the western 
hemisphere. In January 2013, 4 of the 5 virus isolates obtained from blue-winged teals 
that month were from the H14 subtype. Current reports indicate that isolation of H14 
viruses has been sporadic in North America (287, 288). It is not clear if the H14 virus 
persisted in wintering grounds in Guatemala after its first detection in 2011, or if it was 
re-introduced during the following season. Phylogenetic analysis confirmed the genetic 
relationships observed in previous studies, and the tree topology with additional H14 
sequences from 2012-2013 suggest that the viruses from Guatemala were similar to and 
closest ancestors of the viruses isolated in different locations across the Mississippi 
flyway in the following seasons (2012 and 2013) (272, 287). 
Whether outbreaks of H14 in waterfowl have occurred in other locations in North 
America is unknown. Competitive exclusion between different viruses in a population 
already infected with multiple subtypes during peak prevalence periods at the breeding 
grounds may impede a higher level of transmission of newly introduced subtype of 
distinct genetic lineages such as the H14 (65, 75). It has been hypothesized that the 
wintering grounds may serve as repositories to maintain subtype diversity as ducks may 
arrive susceptible to subtypes that they were not exposed in the breeding grounds (98, 




that after the first introduction of H14 in 2011, these viruses persisted in (yet unknown) 
local reservoirs between migration seasons, spreading upon the arrival of a new 
susceptible population in the subsequent season. Maintenance and contribution to virus 
diversity by resident duck populations have been demonstrated in studies in California 
(289, 290) and amplification of locally circulating subtypes upon arrival of migrants to a 
particular location may result in epizootic events (291). Either of these possibilities is 
supported by isolation of other rare subtypes and subtype combinations at the wintering 
grounds in Texas and Guatemala (98, 100). Experimental infections with North American 
strains of H14 (272) indicate that these viruses are very similar in their phenotype to 
other LPAIV subtypes already circulating in the region. In the long-term the H14 viruses 
will likely continue to circulate in the western hemisphere, providing a unique an 
opportunity to study virus movement and spread between host species and geographical 
across the American continent. In addition to the H14, other prevalent subtypes found in 
this study include the H3 and the H4, both of which are commonly isolated in North 
America (93). However, these subtypes were found in non-commonly isolated 
combinations such as H1N3 (the second most prevalent subtype in 2011-12), H3N3 and 
the H4N3. The H6 subtype, also prevalent in North America (65, 99), was not found in 
this study.  
Mixed infections included viruses from the H3, H14 and H7/H11 subtypes. 
Detection of mixed infections provides evidence of reassortment at the wintering 
grounds. Whether these subtypes are more likely than others to reassort is unknown, and 
the lack of detection of mixed infection involving other subtypes may be just a result of 




frequency of mixed infections has been usually measured by the percentage of virus 
isolates from a single sample containing more than one HA and NA subtype (99, 292, 
293). However the presence of more than one gene variant of any of the internal gene 
segments should equally be considered a mixed infection. Such argument implies that 
frequencies of co-infection in the natural host have perhaps been underestimated in the 
past. Deep sequencing data provides detailed information of all variants of specific genes 
present in a single sample, making possible to resolve mixed infections (294). 
Incorporation of next-generation sequencing technologies into wild bird surveillance 
would help to provide better estimates of co-infections and reassortment events in nature 
allowing comparisons between different geographical locations. It must be noted that 
virus isolation may have an impact in the detection of mixed infections (295). Despite 
evidence of mixed infections in this study, the real number of co-infections may still be 
underestimated. 
Phylogenetic analysis of the internal gene segments and the N3 NA surface gene 
segment, as well as BLAST searches of HA gene segments, indicates that birds from at 
least two migration flyways (Pacific and Mississippi) may be equally contributing to the 
diversity of viruses circulating in Guatemala. This observation is supported by similar 
levels of genetic differentiation estimated among the three populations (Pacific, 
Mississippi and Guatemala). The high mutation rates of the IAV RNA replication 
process, make it difficult to infer gene flow rates among populations from genetic 
differentiation estimates (296). Comparison of gene polymorphisms in other subtypes, 
and internal genes, between virus populations from multiple migration flyways and years, 




America is still limited in comparison to the large number of viral genomes from North 
America. More accurate estimates of gene flow at a large scale are only possible as data 
accumulates not only from Guatemala but also from other locations in Central America.   
The high diversity of viruses that circulate in ducks wintering in Guatemala, 
estimated by the diversity index, is also reflected in the number of different genotypes 
and gene constellations observed. At least 60% of the viruses differed from each other in 
at least one gene at the level of genotype and 96% of the viruses were unique at the level 
of gene constellations. The diversity of genotypes has been observed to be higher in areas 
where migrations flyways overlap and duck populations congregate (74, 78, 297, 298). 
Our results support the hypothesis that congregations of birds from different flyways at a 
natural geographical bottleneck in Central America, may increase opportunities for virus 
reassortment, contributing to the extensive gene flow between bird populations from 
different migration flyways observed in North America (67, 269, 270). Thus, Guatemala 
represents a "hotspot" for IAV surveillance, previously underappreciated until this study. 
In the literature, many approaches have been undertaken to study the diversity and 
genetic composition of viral populations at different geographic locations. However, 
there is a lack of standardized methodologies that not only describe the genetic diversity 
of the viruses circulating in specific populations, but also allow comparisons among 
geographic locations. Phylogenetic analysis provides information of the genetic 
relationships among virus populations from different geographic locations.  However, 
such analysis is based on individual gene sequences and makes it difficult to compare 
entire viral genomes. In this study, we combined the characterization of virus genotypes 




compare my findings to other studies using similar approaches (298, 299). This analysis 
showed that the genotypes that circulate in Guatemala are similar to those that circulate in 
other locations at the other end of the Atlantic and the Pacific flyways. Virus genotyping 
with FluGenome, however, does not provide information of genetic variant diversity 
within a single lineage. The assignment of genetic clades and the use of digital 
genotyping helped to visualize the genetic structure of the virus population, illustrating 
the contribution of genetic shift to the genetic diversity observed at the wintering grounds 
in Guatemala. The results from this analysis indicate that certain combinations of internal 
genes were more likely to be detected within a season, and that the main gene 
combinations varied between different years. In addition, digital genotyping allowed 
detection of potential reassortant strains that emerged during the period of sample 
collection. This was observed by changes in gene constellations in viruses from the same 
subtypes towards the end of the migration season, for example H14N4 viruses were only 
observed at the end of the migration season, with similar combination of internal genes 
harbored by the H14N3 viruses at the beginning of the season.   
One interesting finding was the detection of rarely observed variants of H4, H3 
and N2 and N8 genes. The viruses had similar genotypes and gene constellations from 
each other, but different from the majority of the other viruses. Two of their internal 
genes, NP and NS, belonged to the same lineage of a non-contemporary virus detected in 
Louisiana in 2013, A/blue-winged teal/Louisiana/AI12-1334/2013(H4N2) (300). For the 
other internal genes unique clades were observed. The lack of sequences of recent viruses 
with similar genetic makeup, and the relatively long branch lengths observed for the 




circulating without being detected. These viruses may have been present either in a lower 
proportion to those from other contemporary lineages, or in locations where no 
surveillance is currently taking place, making it difficult to assess their origin. 
Interestingly, those rare variants were not observed at the beginning of the migration 
season, but only from December 2012 and January 2013 in Guatemala, which were 
presumably the same viruses observed during the spring of 2013 in the US. 
In addition, to generate information of locally circulating viruses, avian influenza 
surveillance in Guatemala, as in many countries, was started to serve as a platform for the 
early detection of HPAI strains, including Eurasian-origin H5N1 viruses (Explained in 
Chapter 2). In this study PA genes from Eurasian lineage were detected in viruses from 
the H3N3 and H3N8 subtypes. The phylogenetic analysis indicates that this could be a 
separate introduction than of the H14 strain, as the PA genes are related to viruses 
detected recently in North America, distinct from the H14 strains. Detection of genes 
from the Eurasian lineage (in addition to the detection of the H14 subtype) provides 
evidence of long distance gene migration across the American Continent and that virus 
spread of Eurasian strains by migratory birds to Central America is plausible and could 
happen over the course of a few annual migration cycles. In the current study no 
reassortants strains with the South American lineage were detected. The frequency of this 
event and geographic locations where it is more likely to occur remains to be elucidated. 
Distribution of host species and the geographical barriers have been hypothesized to 
explain the limited reassortment between the North and South American lineages (300). 
However, as previously mentioned, the gap of surveillance in countries from Latin 




Another finding from this study is the detection of N3 genes closely related to the 
HPAI H7N3 strain that caused a poultry outbreak in Mexico in 2012; this was also 
observed for some of the internal genes of the viruses from Guatemala, when the viruses 
from chickens were included in the analysis (data not shown). In our study, the H7 
subtype was only found at the end of the migration season. A higher probability of 
detection of H7 subtype at the end of the wintering season and early during the spring is 
supported by observations in the blue-winged teal (100), suggesting that risk of spillover 
to poultry of viruses from this subtype could be subjected to seasonal patterns of LPAIV 
circulation in wild birds. The link between viruses from wild-bird origin and the HPAI 
H7N3 from Mexico highlights the importance of increasing surveillance at both ends of 
the migration flyways, to better understand virus migration patterns between geographic 
locations through out the year.  
Among other species that tested positive for IAV were two white-winged doves. 
The number of samples collected from Columbiformes in this study was limited and no 
isolates were obtained from the rRT-PCR positive samples. There is natural and 
experimental evidence that doves and pigeons are susceptible to infection with IAV, 
including the H7N9 subtype from Asia (115). Although, their role in IAV transmission 
remains unclear, association with habitats where waterfowl species are abundant, such as 
wetlands, may increase the probability of exposure to IAV in terrestrial birds (discussed 
in Chapter 2). Nonetheless, the number of natural infections observed has been limited, 
suggesting that these species may solely act as incidental hosts.  
In summary, we detected a wide diversity of virus subtypes and genomic 




diversity of circulating viruses seems to vary between years and overall virus prevalence 
seems to decrease at the end of the migration season at the studied locations. Detection of 
rare gene variants indicates silent circulation of viruses in unknown reservoirs or 
ecological niches; these observations underscore the importance of expanding 
surveillance to additional geographic locations to capture the diversity of circulating 
strains across the American Continent. Our findings are supported by previous 
observations at the wintering grounds in Guatemala and other locations. A potential 
epizootic of the H14 subtype in blue-winged teals, supported by high levels of its 
detection during the 2012-13 season, provides further evidence that the wintering grounds 
in Central America may serve as places where virus variants with limited circulation may 
be amplified upon arrival of yearly migrants.  Detection of reassortant strains with genes 
from the Eurasian lineage provides evidence of long distance movement of viruses from 
different genetic lineages and migration flyways between North and Central America. To 
our knowledge, the genomes reported in this study constitute the greatest collection of 
LPAIV from Central America. Surveillance in other species, and other locations in 
Central America, characterization of viruses that circulate in resident bird populations 
(during and after the winter migration), and incorporation of more systematic sampling 
methodologies, (including the use of geo-transmitters), are needed to better understand 
the ecology of IAV in this region. Although additional bird species need to be 
investigated, the high relative abundance of the blue-winged teals in comparison to other 
duck species in Central America, the particular behavior of this long-distance migrant 
(83, 300, 301), and the diversity of viruses found in these ducks makes them a candidate 
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Chapter 5. Swine influenza surveillance in Guatemala 
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5.1. Abstract 
In 2009 the emergence of the pandemic H1N1 (pH1N1) strain of influenza A 
virus (IAV) of swine origin highlighted the need of increasing surveillance of IAV in pigs 
on a global scale. In Central America, Guatemala is the country with the largest pork 
production and the circulation of IAV in the swine population has not been investigated 
in detail. The main objective of this study was to determine the presence of IAV in the 
swine population in Guatemala. Two nation-wide multistage random surveys for IAV 
were conducted during October in 2010 and from June to August in 2011. Nasal swabs 
and blood samples were collected from commercial farms and smallholder production 
systems. Samples were collected from 154 herds in 2010 (n=500) and 126 herds in 2011 
(n=489). Herd prevalence for IAV detected by rRT-PCR was 36.3 and 34.6% for 2010 
and 2011 respectively. Herd sero-prevalence based on ELISA was 19.5 and 5.6% for 
2010 and 2011 respectively. Antibodies against H1N1 and H3N2 subtypes to viruses 
from different genetic clusters of swine origin (including pH1N1) were detected by 
hemagglutination inhibition assay. Three fully pH1N1 and one fully H3N2 seasonal 
human-like viruses were isolated. Results from the present study suggest that different 
IAV circulate in pigs in Guatemala and that human-animal contact may play an important 





The emergence of pandemic H1N1 (pH1N1) influenza A virus (IAV) of swine 
origin in 2009, highlighted the need of increasing surveillance for influenza virus in pigs 
on a global scale (302). Introduction of swine IAV into humans as well as reverse 
zoonotic transmission has been observed on multiple occasions in different geographical 
regions. As a result, interspecies transmission events of IAV viruses between human and 
animal hosts are now being recognized to be important in the generation of novel 
reassortant strains with the potential to spread among humans and swine populations 
(130, 160, 303).  
In Latin America, very limited information is available on circulating strains of 
swine influenza and its epidemiology remains poorly understood (304). In general, 
animal raising and handling practices in many Latin-American countries resemble those 
from other regions (such as Asia) that are believed to be associated with an increased risk 
of exposure to zoonotic influenza viruses (305). In Central America, Guatemala is the 
country with the largest swine industry (estimated population size > 2.7 million (306)). 
Although large-scale commercial closed farming systems exist, the majority of pig 
production units (PPU) are peridomestic – in household backyards or open smallholdings 
– without specialized animal handling practices. A characteristic of these farming 
systems is that pigs are raised in open spaces or kept in contact with other domestic 
animals (307, 308). In Guatemala, there are no recommendations or regulations for 
vaccination against swine influenza, and little is known about the genetic and antigenic 
properties of circulating viruses. Circulation of swine H1N1 and H3N2 in the country has 




number of strains were used in this study which may have resulted in limited detection of 
the antigenic diversity. To our knowledge virus isolation from animal samples has not 
been attempted; consequently, the genetic makeup of circulating viruses remains 
unknown. In addition to the genetic diversity of virus strains, the distribution of IAV in 
the swine population and its year-to-year variations have not been investigated.  In this 
study, two multistage cross-sectional surveys were performed in pigs in Guatemala to 
determine circulation of swine influenza subtypes including the 2009 pandemic H1N1 
strain. Viral infection and exposure were investigated using molecular and serological 
testing. Information on the type of PPU, geographical location and animal characteristics 




5.3. Materials and methods 
5.3.1. Study design 
Two nation-wide cross-sectional surveys were done in 2010 (October) and 2011 
(June-August) to investigate the circulation of IAV in pigs, including the 2009 pandemic 
H1N1 strain. A sample size per year of n=500, was estimated using 5% prevalence at a 
95% confidence level (estimated population of ~650,000 individuals) (Winepiscope 2.0 
(310)). A multistage-random design was used. The number of pigs and pig production 
units (PPU) were chosen proportionally by department (administrative subdivisions in 
Guatemala) and type of farming system (farms and smallholdings), according to the 
country’s distribution of the pig population. A form was designed to collect different 
exposure variables at the farm level (type of farm, geographic location) and at the animal 
level (animal health status, age and sex).  
5.3.2. Sample collection  
Field veterinarian epidemiologists from the Guatemala Ministry of Agriculture 
conducted recruitment and identification of participating farms and smallholdings, data 
collection, and sampling. Samples were collected from pigs with preference given to 
animals with signs of respiratory disease or when a foci of respiratory disease (defined as 
≥ 10% of susceptible pigs in a PPU showing respiratory signs) was observed in the PPU 
at the time of sampling. For virus detection, nasal swabs were collected using sterile 
Dacron swabs and kept in tubes containing 3 mL of viral transport medium (VTM, 
Medium 199 with Hanks balanced salt solution, 2 mM L-glutamine, 0.5% bovine serum 




Penicillin, 200 mg/L Streptomycin, 2×106 IU/L Polimyxin B, 250 mg/L Gentamycin, 
0.5×106 IU/L Nistatin, 60 mg/L Ofloxacine, and 0.2 g/L Sulphamethoxazol).  
Additionally, for antibody detection, 2 mL of blood were collected from the orbital 
sinuous veins using 5 or 10 mL Vacutainer (Becton, Dickinson and Co., Franklin Lakes, 
NJ) collection tubes, and a 22 or 18 x 1 ½ gauge needle. Samples were preserved at 4°C 
and submitted between 1 to 4 days to the laboratory of Universidad del Valle de 
Guatemala for testing. 
5.3.3. Virus detection and isolation 
Viral RNA was extracted from 50 µL of nasal swab supernatant with the 
MagMAX-96 AI/ND Viral RNA Isolation Kit (Ambion, Austin, TX, USA) according to 
the manufacturer’s instructions and eluted in a final volume of 50 µL. Influenza virus A 
RNA was detected by rRT-PCR with Matrix specific primers according to published 
protocols (203).  Two rRT-PCR assays were validated at the UVG laboratory using the 
One-Step RT-PCR and the Quantitec QuantiTect Probe RT-PCR Kits (QIAGEN, Hilden, 
Germany) in the ABI 7300 Real-Time PCR System (Applied Biosystems, Foster City, 
CA). Influenza A Matrix rRT-PCR positive samples were tested for N1 subtype with 
recommended specific primers for pandemic H1N1 (311). Positive controls for Matrix 
and N1 RNA detection included RNA extracts from inactivated virus (provided by the 
National Veterinary Services Laboratories, USDA, Ames, Iowa) or in-vitro transcribed 
RNA from DNA plasmid coding for the corresponding gene segment. The positive 
control was calibrated to a Ct value between 25 and 35 for the diagnostic purposes of the 





All rRT-PCR positive samples were tested for virus isolation in MDCK cells. 
Briefly, 1 mL of a 1:2 dilution of clarified nasal swab supernatant was inoculated in 1-
well of a 6 well plate containing approximately 3×105 MDCK cells. Samples were 
incubated for adsorption for 1 hour at 35°C in a 5% CO2 atmosphere, after which the 
swab supernatant was removed and replaced with 3 mL of freshly prepared OptiMEM 
media (Life technologies, Grand Island, NY) with 1 μg/mL TPCK trypsin (SIGMA, St. 
Louis, MO) and antibiotics and antimycotics (SIGMA). Samples were kept at 35°C in a 
5% CO2 atmosphere, and supplemented with TPCK trypsin (1 μg/mL) and tested for 
virus presence every 3 days by HA assay. Samples were observed for presence of 
cytophatic effect (CPE) up to 10 days post inoculation. Presence of influenza A virus was 
confirmed in samples where CPE was observed and the samples tested positive by HA 
and by the rapid strip test Flu Detect (Synbiotics, San Diego, CA). For samples negative 
for CPE and HA assay blind passages were done at 5 dpi with 1 mL of clarified tissue 
culture supernatant, and treated as described above. Up to three blind passages were done 
per sample to test for viable virus in all samples. 
5.3.4. Genome sequencing and molecular characterization 
Virus isolates were identified by direct sequencing of HA and NA genes with 
Influenza A universal primers (205) and comparison with BLAST (312) as previously 
described (Chapter 2). Full genome sequences were obtained for all virus isolates 
(Genbank accessions KJ175112 to KJ175143). Full-length nucleotide sequences of all 
gene segments of all virus isolates were compared to other contemporary H1N1 and 
H3N2 strains by BLASTN (NCBI) to obtain the closest match for each segment. 




and the Caribbean were selected for sequence comparison. Protein alignments were 
performed against selected sequences in order to identify point mutations relative to the 
closest relative viruses of human origin. A second set of alignments was performed using 
HA and NA protein sequences of the representative swine isolates and reference strains 
of swine and human origin to identify sequence variation at the antigenic sites. In 
addition, the Sequence Feature Variant Types tool of the Influenza Research Database 
(313) was used to identify genetic markers present in the pig isolates associated with 
increased replication, virulence or pathogenicity in mammalian hosts.   
For the surface genes, nucleotide sequences of human H3N2 (from 2007 to 2013) 
and pandemic H1N1 viruses (from 2009 to 2013) from Central America and the 
Caribbean were downloaded from the EpiFlu database of the Global Initiative on Sharing 
All Influenza Data (GISAID, http://platform.gisaid.org). As a reference, vaccine strains 
of H3N2 (from 2007 to 2013) and pandemic H1N1 were included. Phylogenetic analyses 
were performed using MEGA software version 6.0 (280). Sequences were manually 
trimmed and final coding sequences were aligned with MUSCLE for codons. After 
alignment, identical sequences were removed and taxon datasets were subsampled in 
order to reduce sampling bias, by keeping 1 of every 5 sequences with equal genetic 
distance (as determined by the number of differences) when samples from the same 
location and year had a distance of d=0 between each other. Final phylogenetic trees were 
constructed using Maximum-Likelihood (ML) inference with the best-fit model of 
nucleotide substitution determined by the BIC criterion, Hasegawa-Kishino-Yano (HKY) 
+ Γ. Robustness of tree topologies was assessed with 100 neighbor-joining bootstrap 




geographical regions (Africa, Asia, Europe, North and South America, and Oceania) was 
inferred for the human H3 HA with viruses between 2010 and 2012. The tree was 
inferred by ML, under the GTR+GAMMA model of nucleotide substitution in RAxML 
(250). Tree topology was confirmed by Bayesian analysis using MrBayes v.3.2.2 (249) 
under the GTR+GAMMA model. Tree parameters are available upon request. 
Convergence was reached after 8×106 generations. Final sequences included in each tree 
are listed in appendices section (Table 0.4). 
5.3.5. Serological testing  
Serum samples were tested for antibodies against Influenza A with the 
commercially available kit, IDEXX ELISA Influenza A Ab (IDEXX, Westbrook, ME). 
According to manufacturer’s instructions, a 1:10 dilution of each pig sample was tested. 
The cut off value was validated and adjusted from 0.50 to 0.56 (314). ELISA positive 
samples were tested by Hemagglutination inhibition assay (HI) against a selected panel of 
swine and human H1 and H3 viruses from different genetic clusters. HI assay was 
performed with standard protocols (315). Briefly, one volume of pig sera was treated 
with 3 volumes of RDE by incubating at 37°C overnight. After inactivation of RDE at 
56°C for 30 minutes, 0.85% saline was added to obtain a 1:10 dilution of the original 
sample. 25 µl aliquots of 2-fold serially diluted serum samples were incubated for 30 min 
at RT with 25 µl of virus containing 8 HA units of the corresponding virus strains. The 
assay was read after adding 50 µl of 0.5% turkey red blood cells and incubating at RT for 
30-40 min. Seropositive and seronegative ferret sera were used as positive and negative 
controls respectively. A serum control for each sample (sample without virus) was also 




last dilution of antiserum that completely inhibited the hemagglutination of the virus 
dilution containing 8 HA units. Samples with an HI titer ≤ 1:40 were considered negative 
for antibodies against the tested viruses. Samples were considered positive to the antigen 
with the highest inhibition titer, and exposure to multiple viruses was considered positive 
when the inhibition titer was the same for more than one reference antigen and when 
positive to multiple subtypes. 
5.3.6. Epidemiological analysis 
Pig production units were considered positive when at least one animal tested 
positive by rRT-PCR. Herd prevalence values were estimated as the total of positive units 
(farms and villages) over the total of sampled units. For herd prevalence estimates, PPU 
were defined as follows: for commercial farms, each farm was considered an individual 
PPU, and the total number of sampled farms was used to estimate prevalence per state. 
Pigs in smallholdings are commonly kept in open spaces and in proximity or shared with 
other smallholdings within the same village. Therefore prevalence in smallholdings was 
calculated at the village level (1 village = 1 PPU), and the total number of sampled 
villages was used to obtain national prevalence estimates. Prevalence values were 
computed with 95% confidence.  
In addition, prevalence values were compared by χ2 test and Fisher’s test (α<0.05) 
when assumptions were met, to establish differences at the herd level among 
geographical regions (central, north, east, south, west) and types of farms (commercial 
farm or small holding). Prevalence at the animal level was estimated as the total number 
of influenza A positive rRT-PCR samples over the total of collected samples per year, 




status (in 2010 and 2011), age and sex (data available only in 2011) were analyzed. 
Serological prevalence values were estimated similarly based on ELISA results at the 
herd and animal level and analyzed by different statistical comparisons as explained 
above.  
To analyze the association of collected variables with virological and serological 
detection of IAV, prevalence risk ratios (PRR) were estimated at the herd level for type 
of farm and geographical region, and at the animal level for health status, age and sex. 
The use of PRR was chosen over prevalence odds ratio (POR), as POR is more sensitive 
to variations in disease prevalence, with stronger deviation from the null hypothesis and 





5.4.1. Sample collection 
Samples were collected from 154 herds in 2010 (500 pigs) and 129 herds in 2011 
(499 pigs).  In 2010, 54% sampled PPU were commercial farms (n=83, 330 pigs) and the 
rest were smallholdings (46%, n=71, 170 pigs).  In 2011, 53 commercial farms were 
sampled (41%, 231 pigs), and 73 smallholdings (56%, 258 pigs). In addition, samples 
were submitted from 1 abattoir (4 pigs), and from 2 farms that were not identified as 
commercial or smallholdings (5 and 1 pigs respectively). Samples from the abattoir and 
the unidentified farms were tested in the laboratory, but they were excluded from all 
statistical analyses. At the time of sampling in 2010, 92% (n=460) of pigs were reported 
with respiratory signs, 5.8% (n=29) with no signs, and 2.2% (n=11) as “unknown” for 
health status. In 2011, only a total of 14.1% (n=69) of pigs were reported with respiratory 
signs, 70.6% (n=345) with no signs, and 15.3% (n=75) as “unknown”. Information on 
animal sex and age was collected only in 2011. A summary of the sample distribution by 
collected exposure variables is shown in Table 5.1.  
5.4.2. Virus prevalence and seroprevalence 
Similar herd prevalences for IAV detected by rRT-PCR were obtained in both 
years. Herd prevalence was 36.4% in 2010 and 34.9% in 2011 (Table 5.2), with no 
significant difference between these years. Circulation of influenza A virus in pigs was 
detected all over the country in both years of the study, with the exception of two 




geographical regions, and the distribution of positive PPU varied between the two years 
of the study (Table 5.3). 




Year Total 2010 2011 
n (%) n (%) n (%) 
Sex 
      Female N/D - 192 (38) 192 (19)
Male N/D - 262 (53) 262 (26) 
Unknown 500 (100) 45 (9) 545 (55) 
Age 
      Pup N/D - 66 (13) 66 (7) 
Weanling N/D - 9 (2) 9 (1) 
Juvenile N/D - 337 (68) 337 (34) 
Adult N/D - 76 (15) 76 (8) 
Unknown 500 (100) 11 (2) 511 (51) 
Type of PPU 
      Farm 330 (66) 231 (47) 561 (57) 
Smallholding 170 (34) 258 (53) 428 (43) 
Health Status 
      Sick 460 (92) 69 (14) 529 (53) 
Healthy 29 (6) 345 (71) 374 (38) 
Unknown 11 (2) 75 (15) 86 (9) 
Geographical region 
     Central 51 (10) 51 (10) 102 (10) 
North 112 (22) 111 (22) 223 (22) 
East 101 (20) 101 (20) 202 (20) 
South 109 (22) 109 (22) 218 (22) 
West 127 (25) 127 (25) 254 (25) 
N/D: Not determined. 
 
Herds from different departments were grouped by relative geographic location 
(central, north, east, south and west); herd prevalence was not significantly different 
among regions in 2010, although borderline associations were observed with states from 
the east and west (Table 5.4). In contrast, in 2011 the distribution of positive herds varied 
significantly (p = 0.0012, χ2 = 17.99, df = 4), with significant associations with the north 




In 2010 a higher prevalence was observed in commercial farms (43.4% of herds positive) 
when compared to smallholdings (28.1%). This difference was not significant, but a 
borderline association [PRR95% = 1.5 (0.98, 2.4)] was observed. In 2011 a similar 
prevalence was observed in smallholdings (35.6%) and commercial farms (34.0%) with 
no significant difference.  
At the animal level no significant difference in virus prevalence was observed 
between sex or age (Table 5.5). However a borderline association with IAV detection 
was observed in juvenile pigs [PRR95% = 1.2 (0.7, 2.2)]. Data available for health status 
was analyzed independently for each year (data not shown), and combined for both years. 
A higher prevalence in sick animals (16.5%) was observed in 2010 in comparison to 
healthy individuals (10.3%). In 2011 similar prevalence was observed in healthy (11%) 
and sick animals (9%). When both years were combined, sick animals had a higher 
prevalence (16%) than healthy animals (11%), with no significant difference. The 
estimated PRR suggested an association between IAV detection and sick animals (Table 
5.5).  
 
















PPU (95% CI) 
2010 154 56 36.4(28.7, 44.0) 154 30 19.5(13.2, 25.7) 






Table 5.3. Prevalence of IAV detected by rRT-PCR and geographic distribution of PPU and pigs 

























North    
 
     
Alta Verapaz 7 24 3(42.9) 4(16.7)  7 24 1(14.3) 1(4.2) 
Peten 10 27 3(30.0) 3(11.1)  10 27 3(30.0) 3(11.1) 
Total 17 51 6(35.3) 7(13.7)  17 51 4(23.5) 4(7.8) 
Central          
Baja Verapaz 2 13 2(100) 4(30.8)  2 13 2(100) 2(15.4) 
Chimaltenango 7 32 1(14.3) 1(3.1)  4 27 1(25.0) 1(3.7) 
Guatemala 11 38 4(36.4) 4(10.5)  7 33 6(85.7) 6(18.2) 
Sacatepequez 9 29 0 - 0 -  6 29 3(50.0) 3(10.3) 
Total 29 112 7(24.1) 9(8.0)  19 102 12(63.2) 12(11.8) 
East          
Chiquimula 11 21 2(18.2) 2(9.5)  16 21 0 - 0 - 
El Progreso 4 13 2(50.0) 2(15.4)  3 13 0 - 0 - 
Izabal 5 10 2(40.0) 2(20.0)  3 10 2(66.7) 2(20.0) 
Jalapa 2 10 1(50.0) 1(10.0)  1 10 1(100) 3(30.0) 
Jutiapa 10 34 4(40.0) 4(11.8)  11 34 1(9.1) 1(2.9) 
Zacapa 7 13 6(85.7) 9(69.2)  7 13 3(42.9) 3(23.1) 
Total 39 101 17(43.6) 20(19.8)  41 101 7(17.1) 9(8.9) 
South          
Escuintla 8 36 2(25.0) 3(8.3)  5 36 3(60.0) 5(13.9) 
Retalhuleu 6 17 1(16.7) 1(5.9)  3 17 0 - 0 - 
Santa Rosa 4 27 1(25) 3(11.1)  4 27 4(100) 4(14.8) 
Suchitepequez 8 29 3(37.5) 4(13.8)  4 28 4(100) 
5 
(17.9) 
Total 26 109 7(26.9) 11(10.1)  16 108 11(68.8) 14(13.0) 
West          
Huehuetenango 10 53 3(30.0) 6(11.3)  8 53 5(62.5) 8(15.1) 
Quetzaltenango 7 16 2(28.6) 3(18.8)  7 16 1(14.3) 1(6.3) 
Quiche 8 17 5(62.5) 10(58.8)  3 17 1(33.3) 2(11.8) 
San Marcos 5 15 0 - 0 -  9 15 2(22.2) 4(26.7) 
Solola 4 12 4(100) 9(75.0)  3 12 1(33.3) 1(8.3) 
Totonicapán 9 14 5(55.6) 5(35.7)  3 14 3(100) 3(21.4) 
Total 43 127 19(44.2) 33(26.0)  33 127 13(39.4) 19(15.0) 
Total 154 500 56(36.4) 80(16.0) 
 





With respect to the detection of antibodies against IAV, herd seroprevalence 
values of 19.5 and 5.6% were observed for 2010 and 2011 respectively (Table 5.6). 
Prevalence was lower in 2011. However, the composition of the sample between years 
was different in terms of animal health status: in 2010 the majority of sampled pigs had 
respiratory signs (92%), whereas in 2011 only 15% had signs. Due to the potential 
differences in susceptibility and prior-exposure to IAV of these two groups, 
seroprevalences between years were not statistically compared. Distribution of 
seropositive PPU by department varied between different years ranging between 0% and 
100% seropositive PPU in both years (Table 5.6). When compared by geographical 
region, herd seroprevalence varied among different areas in 2010 (p = 0.0005, χ2 = 19.8, 
df = 4), with significant association with the east and south (Table 5.7). The number of 
seropositive herds in 2011 was too low to perform statistical comparisons, but the 
majority of positive herds were located in the west and central areas. 
At the animal level, comparisons of seropositive pigs were made by sex and age, 
but for this analysis only data from 2011 was available. No significant difference was 
observed between male and female animals. The number of seropositive pigs was too low 
for statistical comparisons; the higher proportion of positive samples was found in adult 
pigs (Table 5.8).   
5.4.3. Hemagglutination inhibition assay 
Antigenic responses against H1N1 and H3N2 subtypes from different genetic and 
antigenic clusters (Table 5.9) were detected in ELISA positive samples. In both years, 
antibodies against the pandemic H1N1 strain were found in the majority of samples. 




alpha, and gamma clusters) were detected; antibodies against the H1 beta cluster were 
only found in one sample with mixed exposures (positive to more than one virus). All 
samples were negative when tested against the H1 delta antigen. For the H3 subtype, the 
majority of samples tested positive against H3 (cluster III) followed by H3 (cluster IV). A 
number of mixed exposures between the pandemic H1N1 virus and other H1 or H3 
viruses of swine origin were detected. In 2011 only 7 samples tested positive by ELISA, 
three of which were positive to the pandemic strain and two that had mixed exposures 
with the pandemic H1N1 and the H3 (IV) subtype. All samples from both years tested 
negative against a human-like H3N2 isolate obtained in 2010 [A/Guatemala/CIP049-
IP040078/2010(H3N2)] (see below). The subtype specific response of 8 ELISA positive 
samples from 2010 and of 2 from 2011 could not be identified with tested antigens.  
Exposure to different subtypes varied between types of PPU: exposure to H1 
viruses of swine origin was detected in farms, whereas in smallholdings only exposure to 
pandemic H1 was found. With respect to the H3 subtype, exposure to antigens from 
clusters III and IV was detected in farms in 2010 as single or multiple exposures. In 
smallholdings exposure to H3 viruses was only found in samples with co-exposure to 



























(95% CI) p, χ2, df 
Type of PPU                   
Smallholding 20(35.7) 51(52) Reference 0.0506, 3.8, 1 
 
26(59.1) 47(57.3) Reference 0.8475, 0.04, 1 
Farm 36(64.3) 47(48) 1.5(1,2.4) 
  
18(40.9) 35(42.7) 1(0.6,1.6) 
 Geographical region 
        Central 6(10.7) 11(11.2) 1(0.5,1.9) 0.2977, 4.9, 4 
 
4(9.1) 13(15.9) 0.6(0.3,1.6) 0.0012, 18, 4 
North 7(12.5) 22(22.4) 0.6(0.3,1.2) 
  
10(22.7) 9(11) 1.7(1,2.8) 
 East 17(30.4) 22(22.4) 1.3(0.8,2) 
  
7(15.9) 34(41.5) 0.4(0.2,0.8) 
 South 7(12.5) 19(19.4) 0.7(0.4,1.4) 
  
10(22.7) 6(7.3) 2(1.3,3.2) 
 West 19(33.9) 24(24.5) 1.3(0.9,2)     13(29.5) 20(24.4) 1.2(0.7,2)   




Table 5.5. Prevalence risk ratios of animal exposure factors associated with IAV detection in sampled 
pigs in Guatemala, 2010-2011 
 
 
Variable IAV positive (%) IAV negative (%) PRR (95% CI)* p, χ2, df* 
Sex       
 Female 23(44.2) 167(42.5) Reference 0.8119, 0.06, 1 
Male 29(55.8) 226(57.5) 0.9(0.6,1.6) 
 Age 
    Pup 8(14.5) 58(13.7) 1.1(0.5,2.1) 0.7605, 1.2, 3 
Weanling 1(1.8) 8(1.9) 1(0.1,6.2) 
 Juvenile 40(72.7) 287(67.8) 1.2(0.7,2.2) 
 Adult 6(10.9) 70(16.5) 0.6(0.3,1.5) 
 Health status 
   Healthy 42(33.9) 332(42.6) Reference 0.0662, 3.4, 1 
Sick 82(66.1) 447(57.4) 1.4(1,2)   
*Significant associations (lower limit of 95% CI <1) and p values (p<0.05) are shown in bold 
 
5.4.1. Virus isolation and molecular characterization 
In 2010, 4 viruses were isolated from rRT-PCR positive samples. CT-values from 
rRT-PCR positive samples ranged between 17 and 41 (mean 36.5, median 37.7, stdev = 
4.5), 10 samples had CT-values <30 and 11 samples had CT-values between 30 and 35. 
The CT-values of the samples from which the viruses were isolated were between 27 and 
35. Full-length genome sequences were obtained and the viruses were identified as H1N1 
(3 isolates) and H3N2 (one isolate) subtypes based on >95% homology in BLAST 
searches. Viruses were identified as A/swine/Guatemala/CIP049-IP070165/2010 (H1N1), 
A/swine/Guatemala/CIP049-IP070166/2010 (H1N1), A/swine/Guatemala/CIP049-
IP070167/2010 (H1N1) and A/swine/Guatemala/CIP049-IP040078/2010 (H3N2). All 
gene segments of the three H1N1 viruses shared >98% sequence identity with each other, 
and clustered with the pandemic lineage. The H3N2 (here after 040078-H3N2) virus was 
identified as a fully human-like strain. No reassortant viruses were detected and in 2011 




Table 5.6. Seroprevalence of IAV detected by ELISA and geographic distribution of PPU and pigs 
























North          
Alta Verapaz 7 24 1(14.3) 1(4.2)  7 24 0- 0- 
Peten 10 27 3(30.0) 5(18.5)  10 27 2(20.0) 2(7.4) 
Total 17 51 4(23.5) 6(11.8)  17 51 2(11.8) 2(3.9) 
Central          
Baja Verapaz 2 13 0(-) 0(-)  2 13 
0(-) 0(-) 
Chimaltenango 7 32 0(-) 0(-)  4 27 
0(-) 0(-) 
Guatemala 10 38 0(-) 0(-)  7 33 
0(-) 0(-) 
Sacatepequez 9 29 1(11.1) 1(3.4)  6 29 
0(-) 0(-) 
Total 28 112 1(3.6) 1(0.9)  19 102 0(-) 0(-) 
East          
Chiquimula 11 21 3(27.3) 5(23.8)  16 21 1(6.3) 1(4.8) 
El Progreso 4 13 1(25.0) 1(7.7)  3 13 
0(-) 0(-) 
Izabal 5 10 0(-) 0(-)  3 10 
0(-) 0(-) 
Jalapa 2 10 0(-) 0(-)  1 10 
0(-) 0(-) 
Jutiapa 10 34 3(30.0) 13(38.2)  11 34 
0(-) 0(-) 
Zacapa 7 13 2(28.6) 3(23.1)  7 13 
0(-) 0(-) 
Total 39 101 9(23.1) 22(21.8)  41 101 1(2.4) 1(1.0) 
South          
Escuintla 8 36 4(50.0) 6(16.7)  5 36 
0(-) 0(-) 
Retalhuleu 6 17 1(16.7) 1(5.9)  3 17 
0(-) 0(-) 
Santa Rosa 4 27 4(100) 7(25.9)  4 27 
0(-) 0(-) 
Suchitepequez 8 29 3(37.5) 6(20.7)  4 28 
0(-) 0(-) 
Total 26 109 12(46.2) 20(18.3)  16 108 0(-) 0(-) 
West          
Huehuetenango 11 53 2(18.2) 2(3.8)  7 53 
0(-) 0(-) 
Quetzaltenango 7 16 0(-) 0(-)  7 16 
0(-) 0(-) 
Quiche 8 17 2(25.0) 2(11.8)  3 17 
0(-) 0(-) 
San Marcos 5 15 0(-) 0(-)  9 15 2(22.2) 3(20.0) 
Solola 4 12 0(-) 0(-)  3 12 1(33.3) 1(8.3) 
Totonicapán 9 14 0(-) 0(-)  3 14 
0(-) 0(-) 
Total 44 127 4(9.1) 4(3.1)  32 127 3(9.4) 4(3.1) 
Total 154 500 30(19.5) 53(10.6) 
 

















Table 5.7. Prevalence risk ratios of farm exposure factors associated with IAV seropositivity in sampled PPU in Guatemala, 2010-2011 
 
 
  2010         2011       











(95% CI) p* 
Geographical region                 
Central 4(13.3) 13(10.5) 1.2(0.5,3.1) 0.0005, 19.8, 4 
 
2(33.3) 15(12.3) 3.3(0.6,16.5) 
 North 1(3.3) 27(21.8) 0.2(0,1.1) 
  
0(0) 21(17.2) 0.4(0,6.5) 
 East 9(30) 30(24.2) 1.3(0.6,2.5) 
  
1(16.7) 40(32.8) 0.4(0.1,3.5) 
 South 12(40) 14(11.3) 3.3(1.8,6) 
  
0(0) 17(13.9) 0.5(0,8.1) 
 West 4(13.3) 40(32.3) 0.4(0.1,1) 
  
3(50) 29(23.8) 3(0.6,14.1) 
 Type of PPU 
         Smallholding 8(26.7) 63(50.8) Reference 0.0173, 5.7, 1 
 
4(66.7) 69(58) Reference 1.00 
Farm 22(73.3) 61(49.2) 2.4(1.1,5)     2(33.3) 50(42) 0.7(0.1,3.7)   
* P value for Fisher's exact test, comparisons by geographical region in 2011 were not done due to the low number of seropositive pigs  




Table 5.8. Prevalence risk ratios of animal exposure factors associated with IAV seropositivity in 
sampled pigs in Guatemala, 2011 
 
 





Sex       
 Female 4(57.1) 189(42.3) - 0.47 
Male 3(42.9) 258(57.7) 0.6(0.1,2.4) 
 Age 
    Pup 1(14.3) 65(13.5) 1.1(0.1,8.7) 
 Weanling 0(0) 9(1.9) 3.2(0.2,52.3) 
 Juvenile 3(42.9) 334(69.4) 0.3(0.1,1.5) 
 Adult 3(42.9) 73(15.2) 4.1(0.9,17.8)   
*p-value for Fisher's exact test. Significant associations (lower limit of 95% CI <1) and p values (p<0.05) 
are shown in bold 
 
Virus isolates were analyzed for the presence of mutations in the protein sequence 
in comparison to other viruses circulating in the region (Mexico, Central America and the 
Caribbean) between 2009 and 2011. A number of mutations in the pandemic-like isolates 
were identified in different genes, including PB2, PA, HA, NA, M2 and NS1 (Table 
5.10). Two synonymous mutations found in the HA (V251L and R222K) were to 
residues that are more frequent in swine-origin viruses of the H1 subtype. This was also 
the case for one of the mutations identified in PA (E688G) and two of the mutations 
identified in NA (G298A and a mixed base E462D). A specific role for these residues has 
not been described; the HA R222K mutation is present in the antigenic site Ca1, while 
the others are mapped to experimentally determined epitopes reported in the IRD. For the 
HA protein five glycosylation sites were predicted at positions 28, 40, 104, 294 and 304. 
In addition, protein alignments of the HA1 and NA sequence were performed against 
reference pandemic strains and swine viruses from different H1 genetic clusters (318). In 
comparison to reference pandemic strains and in contrast with the reference swine 




R222K mutation) (Figure 5.1 and Figure 5.2). The presence of phenotypic markers 
associated with transmissibility and pathogenesis in mammalian hosts showed that the 
pH1N1 isolates contain the prototypic motifs described for the pandemic viruses (Table 
5.11).  
For the human-like H3N2 virus three mutations were identified when compared to 
human H3N2 viruses circulating in the region between 2009 and 2011, one in PB1 and 
two in HA (Table 5.10). The PB1 mutation N213D is located in the nuclear localization 
signal. For the HA one mutation was observed in the signal peptide (A16T) and one in 
the HA1 extracellular domain. The mutations are contained between experimentally 
determined epitopes, but a specific role for the amino acids at the positions has not been 
described. The H3N2 virus codifies for a truncated PB1-F2 protein of 53 amino acids. A 
total of seven glycosylation sites were predicted for the H3 protein at positions 24, 38, 79, 
149, 181, 301, 499. Protein alignments of HA1 (H3) showed two mutations in the 
antigenic site C of 040078-H3N2 when compared to seasonal human vaccine strains 
(Figure 5.3A). Differences in the antigenic sites were observed in comparison to other 
swine viruses (Figure 5.3B). For the N2 no mutations were observed when compared to 
human strains (Figure 5.4) and only one mutation was found when compared to swine 
viruses (Figure 5.5). Analysis of phenotypic markers showed that the H3N2 isolate is a 
well-adapted human isolate that contains several of the described determinants of 
mammalian and human transmission, including markers for high transmissibility in 
humans (Table 5.12). No markers related to increased infectivity or replication that have 
been described for swine respiratory epithelial cells were found. The M2 protein of 





Table 5.9. Antigenic responses detected by hemagglutination inhibition assay detected in pig sera, Guatemala, 2010-2011 
 
 
Virus Reference strain 
2010   2011 
Farm(%) Smallholding(%) Total(%)   Farm(%) Smallholding(%) Total(%) 
H1 pandemic A/Mexico/4108/2009 9(20.5) 1(11.1) 10(18.9) 
 
2(66.7) 1(25) 3(42.9) 
H1N1 α only A/swine/Minnesota/02053/2008 (α) 5(11.4) 
 
5(9.4) 
    H1N1 β only A/swine/Nebraska/02013/2008 (β) 
       H1N1 γ only A/swine/Missouri/02060/2008 (γ) 2(4.5) 
 
2(3.8) 
    H1N2 δ only A/swine/Iowa/02039/2008 (δ) 
       swH3N2 (III) only A/swine/Wisconsin/14094/99 9(20.5) 
 
9(17) 




    huH3 only A/swine/Guatemala/IP-04-0078/2008 
       H1 pandemic, H1 α 
  
1(11.1) 1(1.9) 





    H1 pandemic, H1 γ 
 
1(2.3) 2(22.2) 3(5.7) 
    H1 pandemic, swH3 (III) 
  
1(11.1) 1(1.9) 












    swH1 
 
2(4.5) 1(11.1) 3(5.7) 





    U 
 
5(11.4) 3(33.3) 8(15.1) 
 
1(33.3) 1(25) 2(28.6) 
Total   44 9 53   3 4 7 




In the phylogenetic analysis the pH1N1 isolates the viruses cluster with other 
contemporary pandemic viruses that circulated in Guatemala and other neighboring 
countries (Belize, El Salvador and Mexico) during the same year. The topology of the 
HA tree contained multiple clusters. The HA of the three viruses from Guatemala was 
found in separate clusters from early pH1N1 isolates and other swine pH1N1 viruses 
from other countries, indicating an independent introduction event from humans (Figure 
5.6). In contrast, the NA clustered with early isolates and other pH1N1 viruses from pigs, 
indicating a less divergent NA in viruses circulating across the region (Figure 5.7). The 
relatively short branch lengths for the HA and the NA of the swine isolates indicate a 
recent introduction into pigs, without extensive adaptation.  
For the H3N2 virus, the HA and NA clustered with contemporary viruses that 
circulated in humans in Guatemala between 2010 and 2012. The HA clustered with other 
human viruses 2010 to 2012 that circulated in Central America, Mexico and the 
Caribbean but in a separate cluster from the most recent vaccine lineages (Figure 5.8).  
The same was not observed for the N2, which clustered within the lineage of the current 
vaccine (Figure 5.9). The existence of a separate HA clade was confirmed by generating 
a tree that included additional H3N2 viruses from previous vaccine lineages since 2000 
(data not shown). In addition, to confirm if the circulation of viruses from this clade was 
specific to Central America, background viruses from other geographical regions (North 
and South America, Africa, Asia, Europe and Oceania) between 2010 and 2012 were 
included to construct a global maximum likelihood phylogenetic inference. In this tree 
the swine isolate from Guatemala still clustered in a separate clade from the vaccine 




from other geographical regions, indicating that circulation of viruses from this clade was 
not exclusive to Central America. However, the majority of sequences reported between 
those years from Central America, and to a lesser extent the viruses from South America, 
were contained in the same clade with the swine virus from Guatemala. This observation 
suggests a more extensive circulation of viruses in the region during those years. Co-
circulation of a genetically distinct clade of H3N2 viruses has not been described in the 
literature, and the most recently published H3N2 phylogenies include viruses up to 2010. 
The topology of the global inference was further confirmed by Bayesian analysis, 








Figure 5.1. Protein alignment of the HA1 region of pH1N1 isolates, with human and swine viruses 
Antigenic sites are shown in colored boxes A (red), B (green), C (purple), D (orange), E (blue). The N 
residues of predicted glycosylation sites for 040078-H3N2 are marked in blue in the consensus sequence. 







          
                               20        30        40        50        60        70        80        90       
                             --+---------+---------+---------+---------+---------+---------+---------+------- 
A/Mexico/4108/2009           DTLCIGYHANNSTDTVDTVLEKNVTVTHSVNLLEDKHNGKLCKLRGVAPLHLGKCNIAGWILGNPECESLSTASSWSYIV         97 
A/Netherlands/602/2009       ................................................................................         97 
A/California/07/2009         ................................................................................         97 
A/swine/GT/070165/2010       ................................................................................         97 
A/swine/GT/070166/2010       ................................................................................         97 
A/swine/GT/070167/2010       ................................................................................         97 
A/swine/Minnesota/02053/2008 ..................I....................R....G.I.............L.........F.V.......         97 
A/swine/Nebraska/02013/2008  ..................................T..D......................L.........F.........         97 
A/swine/Missouri/02060/2008  ..................................TR........................L...................         97 
A/swine/Iowa/02039/2008      ..I.................K.KL...........S......L.K.I...Q..N.SV..........G..ISKE......         97 
 
                               100       110       120       130       140       150       160       170      
                             --+---------+---------+---------+---------+---------+---------+---------+------- 
A/Mexico/4108/2009           ETSSSDNGTCYPGDFIDYEELREQLSSVSSFERFEIFPKTSSWPNHDSNKGVTAACPHAGAKSFYKNLIWLVKKGNSYPK        177 
A/Netherlands/602/2009       ...........................................................................D....        177 
A/California/07/2009         ..P.............................................................................        177 
A/swine/GT/070165/2010       ................................................................................        177 
A/swine/GT/070166/2010       ................................................................................        177 
A/swine/GT/070167/2010       ................................................................................        177 
A/swine/Minnesota/02053/2008 ...N.Y..........N......................AN.....ET.R......S...TN...R........D.T...        177 
A/swine/Nebraska/02013/2008  ..PN............N......H...............AN......T.........Y...N...R........E.....        177 
A/swine/Missouri/02060/2008  ...N............N.............................ETDR..........TN...R..............        177 
A/swine/Iowa/02039/2008      ..PN....A....Q.A.......................E......-TVT..S.S.S.N.ER...R.....TV.NGL..N        176 
 
                               180       190       200       210       220       230       240       250      
                             --+---------+---------+---------+---------+---------+---------+---------+------- 
A/Mexico/4108/2009           LSKSYINDKGKEVLVLWGIHHPSTSADQQSLYQNADAYVFVGSSRYSKKFKPEIAIRPKVRDQEGRMNYYWTLVEPGDKI        257 
A/Netherlands/602/2009       ..............................................................R.................        257 
A/California/07/2009         ......................P.........................................................        257 
A/swine/GT/070165/2010       ..........................................T.K...................................        257 
A/swine/GT/070166/2010       ..........................................T.K............................L......        257 
A/swine/GT/070167/2010       ..........................................T.K...................................        257 
A/swine/Minnesota/02053/2008 I....V.N................NN................T.K.N........T.......A..I...........T.        257 
A/swine/Nebraska/02013/2008  .......N.K.....I......P..T...TI.............K...R......V.......A...D....II....T.        257 
A/swine/Missouri/02060/2008  IN.....N.E.......A.............................R..E....T.......A................        257 
A/swine/Iowa/02039/2008      .....E........I...V...PNIEN.RT..HTEN...S.V..H..GR.T...TK..........I......L....T.        256 
 
                               260       270       280       290       300       310       320       330      
                             --+---------+---------+---------+---------+---------+---------+---------+------- 
A/Mexico/4108/2009           TFEATGNLVVPRYAFAMERNAGSGIIISDTPVHDCNTTCQTPKGAINTSLPFQNIHPITIGKCPKYVKSTKLRLATGLRN        337 
A/Netherlands/602/2009       ................................................................................        337 
A/California/07/2009         ................................................................................        337 
A/swine/GT/070165/2010       ......................................................V.........................        337 
A/swine/GT/070166/2010       ......................................................V.........................        337 
A/swine/GT/070167/2010       ......................................................V.........................        337 
A/swine/Minnesota/02053/2008 .................NKGS.....V..I.A.....N................V..V...E........R..M......        337 
A/swine/Nebraska/02013/2008  .................K.GS.....V..A...........................V...E...........M......        337 
A/swine/Missouri/02060/2008  ................LK..S.........S....D......N..............V...E...........M......        337 
A/swine/Iowa/02039/2008      I...N...IA.W....LS.GL.....T.NA.MDE.DAK....Q....S......V..V...E.....R.....M......        336 
 
                               340  
                             --+--- 
A/Mexico/4108/2009           VPSIQS                                                                                  343 
A/Netherlands/602/2009       ......                                                                                  343 
A/California/07/2009         I.....                                                                                  343 
A/swine/GT/070165/2010       ......                                                                                  343 
A/swine/GT/070166/2010       ......                                                                                  343 
A/swine/GT/070167/2010       ......                                                                                  343 
A/swine/Minnesota/02053/2008 I.....                                                                                  343 
A/swine/Nebraska/02013/2008  I.....                                                                                  343 
A/swine/Missouri/02060/2008  I.....                                                                                  343 







Figure 5.2. Alignment of NA amino acid sequences of pH1N1 isolates, with human and swine viruses 
 Antigenic sites are shown in blue boxes. The N residues of predicted glycosylation sites for 




                             ---------+---------+---------+---------+---------+---------+---------+---------+ 
                                      10        20        30        40        50        60        70        80 
                             ---------+---------+---------+---------+---------+---------+---------+---------+ 
A/Mexico/4108/2009           MNPNQKIITIGSVCMTIGMANLILQIGNIISIWISHSIQLGNQNQIETCNQSVITYENNTWVNQTYVNISNTNFAAGQSV         80 
A/Mexico_City/WR1297N/2009   ................................................................................         80 
A/swine/GT/070165/2010       ................................................................................         80 
A/swine/GT/070166/2010       ................................................................................         80 
A/swine/GT/070167/2010       ................................................................................         80 
A/Wisconsin/04/2009          ............ISIA..IIS.M..........A.....T.S..NTGI...RI.....S....H.....N...VV..EDK         80 
A/swine/Minnesota/02053/2008 ..T..R.....T...IV.IISIL........L.......T.GK.YS.M...N....V................I.TV.D.         80 
A/swine/Nebraska/02013/2008  ..T..R.....T..LIV.IIS.L.....MV.L.......T.GK.HT.M..KN....V...............KIVKM.D.         80 
A/swine/Missouri/02060/2008  ..T..R.....T..LIV.IVS.L......V.L.......T.ER.HP...S.N.....................IVD..D.         80 
 
                             ---------+---------+---------+---------+---------+---------+---------+---------+ 
                                      90        100       110       120       130       140       150       160 
                             ---------+---------+---------+---------+---------+---------+---------+---------+ 
A/Mexico/4108/2009           VSVKLAGNSSLCPVSGWAIYSKDNSVRIGSKGDVFVIREPFISCSPLECRTFFLTQGALLNDKHSNGTIKDRSPYRTLMS        160 
A/Mexico_City/WR1297N/2009   .........................I......................................................        160 
A/swine/GT/070165/2010       .........................I......................................................        160 
A/swine/GT/070166/2010       .........................I......................................................        160 
A/swine/GT/070167/2010       .........................I......................................................        160 
A/Wisconsin/04/2009          T..T........SI......T....I...................H......................V.B.....A...        160 
A/swine/Minnesota/02053/2008 T.II.....................I.......I..M........H......................V...........        160 
A/swine/Nebraska/02013/2008  ...I.T.......I...........I.......I...........H......................V...........        160 
A/swine/Missouri/02060/2008  T..I.........I...........I.......I...........H................R.....V...........        160 
 
                             ---------+---------+---------+---------+---------+---------+---------+---------+ 
                                      170       180       190       200       210       220       230       240 
                             ---------+---------+---------+---------+---------+---------+---------+---------+ 
A/Mexico/4108/2009           CPIGEVPSPYNSRFESVAWSASACHDGINWLTIGISGPDNGAVAVLKYNGIITDTIKSWRNNILRTQESECACVNGSCFT        240 
A/Mexico_City/WR1297N/2009   ................................................................................        240 
A/swine/GT/070165/2010       ................................................................................        240 
A/swine/GT/070166/2010       ................................................................................        240 
A/swine/GT/070167/2010       ................................................................................        240 
A/Wisconsin/04/2009          ..L..A......K..............MG........................G.....KKQ.........V.M......        240 
A/swine/Minnesota/02053/2008 .....A.....................MG................................K.........V.M......        240 
A/swine/Nebraska/02013/2008  .....A.....................MG................................K.........V.M......        240 
A/swine/Missouri/02060/2008  .....A.....................MG................................K.........V.I......        240 
 
                             ---------+---------+---------+---------+---------+---------+---------+---------+ 
                                      250       260       270       280       290       300       310       320 
                             ---------+---------+---------+---------+---------+---------+---------+---------+ 
A/Mexico/4108/2009           VMTDGPSNGQASYKIFRIEKGKIVKSVEMNAPNYHYEECSCYPDSSEITCVCRDNWHGSNRPWVSFNQNLEYQIGYICSG        320 
A/Mexico_City/WR1297N/2009   .......D........................................................................        320 
A/swine/GT/070165/2010       .......D.................................................A......................        320 
A/swine/GT/070166/2010       .......D.................................................A......................        320 
A/swine/GT/070167/2010       .......D.................................................A......................        320 
A/Wisconsin/04/2009          I.......KA......K.....VT..I.L....FY.........TGIVM.....................D.........        320 
A/swine/Minnesota/02053/2008 .L..............KV.....I..I.LD..............AGKVV........A........D...D.........        320 
A/swine/Nebraska/02013/2008  .L..............KM....VI..I.LD..............AGKVM........A............D.........        320 
A/swine/Missouri/02060/2008  I...............KM.....I....LD..............TGKVV........A........D...N.........        320 
 
                             ---------+---------+---------+---------+---------+---------+---------+---------+ 
                                      330       340       350       360       370       380       390       400 
                             ---------+---------+---------+---------+---------+---------+---------+---------+ 
A/Mexico/4108/2009           IFGDNPRPNDKTGSCGPVSSNGANGVKGFSFKYGNGVWIGRTKSISSRNGFEMIWDPNGWTGTDNNFSIKQDIVGINEWS        400 
A/Mexico_City/WR1297N/2009   .............................................N..................................        400 
A/swine/GT/070165/2010       .............................................N..................................        400 
A/swine/GT/070166/2010       .............................................N..................................        400 
A/swine/GT/070167/2010       ...................X.........................N..................................        400 
A/Wisconsin/04/2009          V.......E.GE...N..TVD.........Y.............NRL.K............N..SD..V...V.A.TD..        400 
A/swine/Minnesota/02053/2008 V......S..GK.N....L............R.............N..................SS..K....IALTD..        400 
A/swine/Nebraska/02013/2008  V......S..GK.N....H...........YR.............N..S...........AE..SS..M....IALTD..        400 
A/swine/Missouri/02060/2008  V......S..GK.N....P............R................S............E..SS.......IALTD..        400 
 
                             ---------+---------+---------+---- -----+---------+---------+--------- 
                                      410       420       430        440       450       460        
                             ---------+---------+---------+---- -----+---------+---------+--------- 
A/Mexico/4108/2009           GYSGSFVQHPELTGLDCIRPCFWVELIRGRPKEN-TIWTSGSSISFCGVNSDTVGWSWPDGAELPFTIDK                  469 
A/Mexico_City/WR1297N/2009   ..................................-...................................                  469 
A/swine/GT/070165/2010       ..................................-...................................                  469 
A/swine/GT/070166/2010       ..................................-...................................                  469 
A/swine/GT/070167/2010       ..................................-...........................X.......                  469 
A/Wisconsin/04/2009          ..........................V..L.R..T..................AN...............                  470 
A/swine/Minnesota/02053/2008 ..............MN.............Q....-...A..........D.E..S.......D.......                  469 
A/swine/Nebraska/02013/2008  ..............MN.............Q....-...A...........GE.AS....                             458 





Table 5.10. Mutations in swine isolates from Guatemala in comparison to co-circulating viruses between 2009-2011 
 
Subtype Gene Mutation Type of mutation Isolate % in database (pandemic strains) 
% in database (swine 
strains) Location 
H1N1        
 PB2 Q288R non-synonymous (polar to basic) all 0.04 0.09  
  Xaa (S688F) non synonymous (polar to aromatic) 070167 0.04 N/D  
 PA Xaa (L589F) 
non-synonymous (nonpolar to 
aromatic) 070165 0.02 N/D PB1 binding region 
  Xaa (S600F) non synonymous (polar to aromatic) 070167 0.02 N/D PB1 binding region 
  E688G non-synonymous (acidic to polar) all 0.22 20.6 PB1 binding region 
  Xaa (A689P) synonymous 070167 N/D N/D PB1 binding region 
 HA V251L synonymous 070166 0.1 53.0 HA1 extracellular domain, beta strand 
  R222K synonymous all 3.7 73.0 
HA1 extracellular domain, beta strand. 
Antigenic site Ca1 
 NA G298A synonymous all 0.01 58.9 catalytic domain 
  Xaa (S340F) non synonymous (polar to aromatic) 070167 0.46 0.52 catalytic domain 
  Xaa (E462D) synonymous 070167 0.01 60.6 catalytic domain 
 M1  no     
 M2 T43I non synonymous (polar to nonpolar) all 0.2 0.55 transmembrane domain 
 NS1 V60F 
non-synonymous (nonpolar to 
aromatic) all N/D N/D NS1 alpha helix of RNA binding domain 
H3N2        
 PB1 N213D non synonymous (polar to acidic) 0400078 0.13 0.3 nuclear localization motif 
 PB1-F2 1 - 53 truncated peptide (53 aa) 0400078 13.39 0.0  
 HA A16T non synonymous (nonpolar to polar) 0400078 1.11 0.2 Signal peptide 
  
Xaa (G234R) 




Table 5.11. Phenotypic markers associated with transmission and pathogenicity found in all pH1N1 swine isolates from Guatemala 
 
 
Protein Amino Acid Reference* Comments 
PB2 271A PMID: 20181719 The residue 271 contributes to enhanced polymerase activity and viral growth in 
mammalian hosts. In this study the T271A mutation showed enhanced virus growth 
compared to that of the WT in mammalian cells in vitro.  
 360Y PMID: 18768983 The study was done on PR8/H5N1 6:2 reassortant wherein NS gene was derived from 
PR8(Cambridge) strain and remaining internal genes from PR8(UW) strain). The Tyr 
residue at position 360 of PR8(UW) PB2 confers high efficiency of vaccine seed virus 
growth in MDCK cells. Glu at position 55 of NS1 mediates growth enhancement of 
viruses in MDCK cells. 
 627E PMID: 19119420 The K627E mutation reduces transmission of human influenza viruses in the guinea pig, 
presumably because of reduced replicative ability in the upper respiratory tract. 
 590S, 591R PMID: 19995968 SR polymorphism enhances replication of virus in host cells. Adaptive mutation in 2009 
swine origin virus enhances polymerase activity in human hosts and compensates for 
E627.  
PA 85I, 186S, 336M PMID:21561908 These residues are responsible for the enhanced polymerase activity in mammalian cells. 
 57R, 62I, 65S, 85I, 86M, 
91V, 100V, 114E, 186S 
PMID:23283952 Multiple residues on PA of avian-origin pH1N1 influenza viruses suppress host cell 
protein synthesis during infection, allowing for preferential production of viral proteins. 
 409N PMID: 17073083 S409N enhances transmission in humans 
 245K PMID: 7966557 Mutations at these positions are capable of suppressing the temperature-sensitivity 
phenotype of the virus. 
NP 184K PMID: 19475480 A change from alanine to a lysine at residue 184 of NP results in increased replication and 
pathogenicity of the viruses in chickens. 
 16G PMID: 18058063 Wild-type A/PR/8 is highly pathogenic in mice, whereas the PR/8 with D16G is less lethal 
confirming that a single mutation in the N terminus of NP of the human PR/8 virus 
ignificantly decreases the pathogenicity of the virus in mice. Similarly, introduction the 
human-like G16D substitution into the NP of highly pathogenic A/Vietnam/1203/04 




 34G PMID: 12620793 Multiple loci confer ts phenotype to the vaccine strains from master donor virus (MDV) 
A/AA/6/60 used in FluMist: PB1 (K391E and E581G), PB2 (N265S), and NP (D34G). 
The PB1 (A661T) also contributes to the ts phenotype. 
 214R, 217R, 253I PMID:24335312 Residues 214, 217, and 253 of Aichi NP play a critical role in influenza virus morphology, 
possibly through interaction with the M1 layer during virus budding 
    
NA R226G PMID: 20522774 Introducing mutation R194G can compensate for the effects of H274Y mutation in NA 
(H274Y decreases surface expression of NA as well as reduces viral fitness) and thereby 
restore its activity. Therefore oseltamivir resistance is enabled by these permissive 
compensatory mutations that allow for subsequent H274Y mutations in the virus. 
 469C PMID:  11533192 The C-terminal Lys at this position is critical for virulence and its ability to replicate in the 
mouse. It supports plasminogen-binding activity which is critical for WSN virus 
neurotropism.  
 146, 469K PMID:  11533192 The presence of a C-terminal Lys 453 and the lack of glycosylation at position 130 (146 in 
N2 numbering) are required for binding of the NA to plasminogen.  
M1 30N, 142A, 207N, 209T PMID:23209789 Determinants of virus morphology (pH1N1 spherical). Single replacement of either one of 
the residue in M1 protein reduces overall viral production as well as growth kinetics. 
M2 31N PMID: 22132146 31N confers resistance to Adamantane 
NS1 149A PMID: 16971424 Residue 149 is crucial for the difference in virulence between GS/GD/1/96 and 
GS/GD/2/96 strains in chickens. Recombinant virus with Ala149 can antagonize the 
induction of interferon levels in chicken embryo fibroblasts (CEFs), but a recombinants 
with Val149  are not capable of the same effect.  
 92D PMID: 12195436, 
23042343 
This residue of NS1 is responsible for H5N1 viruses' resistance to the interferons and 
TNF-alpha and depends on the substitution of glutamic acid for aspartic acid at position 92 
of the NS1 molecule. This has been disputed by subsequent research 
 42S PMID: 18032512 This residue (P42S) is critical for the pathogenicity of H5N1 influenza viruses in 
mammalian hosts and plays an important role in decreasing the antiviral immune response 
of the host cell. 
 103F, 106M PMID: 17522219 Changing any one of the two residues, either L103 to F or I106 to M, in the HK97 NS1A 
protein caused increase in the rate of virus replication. HK97 NS1A protein is intrinsically 
defective in binding CPSF30. 
 227..230 (PEQK) PMID:  18334632 The avian and equine strains always have ESEV at the C-terminal region and human 
almost never have that. In contrast, majority of the human signatures have RSKV 
sequence; the remaining have avian signatures and are known to be of avian origin. 








Figure 5.3. Alignment of the HA1 region for 040078-H3N2 with A) human and B) swine IAV viruses 
Antigenic sites are shown in colored boxes A (red), B (green), C (purple), D (orange), E (blue). The N 
residues of predicted glycosylation sites for A/swine/Guatemala/CIP049-040078/2010 (H3N2) are marked 









Figure 5.4. Alignment of the NA a minoacid sequences of 040078-H3N2 and contemporary human seasonal IAV viruses 
Antigenic sites are shown in red boxes.  The N residues of predicted glycosylation sites for A/sw/GT/CIP049-040078/2010 are marked in blue 
 
                                    10        20        30        40        50        60        70        80 
                           ---------+---------+---------+---------+---------+---------+---------+---------+ 
A/Brisbane/10/2007         MNPNQKIITIGSVSLTISTICFFMQIAILITTVTLHFKQYEFNSPPNNQVMLCEPTIIERNITEIVYLTNTTIEKEICPK         80 
A/Perth/16/2009            ................................................................................         80 
A/Victoria/361/2011        ................................................................................         80 
A/sw/GT/CIP049-040078/2010 ................................................................................         80 
 
                                    90        100       110       120       130       140       150       160 
                           ---------+---------+---------+---------+---------+---------+---------+---------+ 
A/Brisbane/10/2007         LAEYRNWSKPQCDITGFAPFSKDNSIRLSAGGDIWVTREPYVSCDPDKCYQFALGQGTTLNNVHSNDTVRDRTPYRTLLM        160 
A/Perth/16/2009            ..................................................................N.............        160 
A/Victoria/361/2011        P...........G.....................................................N.............        160 
A/sw/GT/CIP049-040078/2010 ..................................................................N.............        160 
 
                                    170       180       190       200       210       220       230       240 
                           ---------+---------+---------+---------+---------+---------+---------+---------+ 
A/Brisbane/10/2007         NELGVPFHLGTKQVCIAWSSSSCHDGKAWLHVCITGDDKNATASFIYNGRLVDSIVSWSKEILRTQESECVCINGTCTVV        240 
A/Perth/16/2009            ......................................................V.........................        240 
A/Victoria/361/2011        ......................................................V.........................        240 
A/sw/GT/CIP049-040078/2010 ......................................................V.........................        240 
 
                                    250       260       270       280       290       300       310       320 
                           ---------+---------+---------+---------+---------+---------+---------+---------+ 
A/Brisbane/10/2007         MTDGSASGKADTKILFIEEGKIVHTSTLSGSAQHVEECSCYPRYPGVRCVCRDNWKGSNRPIVDINIKDHSTVSSYVCSG        320 
A/Perth/16/2009            .......................................................................I........        320 
A/Victoria/361/2011        .................K.....................................................I........        320 
A/sw/GT/CIP049-040078/2010 .......................................................................I........        320 
 
                                    330       340       350       360       370       380       390       400 
                           ---------+---------+---------+---------+---------+---------+---------+---------+ 
A/Brisbane/10/2007         LVGDTPRKNDSSSSSHCLDPNNEEGGHGVKGWAFDDGNDVWMGRTISEKSRLGYETFKVIEGWSNPKSKLQINRQVIVDR        400 
A/Perth/16/2009            ................................................................................        400 
A/Victoria/361/2011        ........T.....................................N.T...............................        400 
A/sw/GT/CIP049-040078/2010 ..............................................N.T...............................        400 
 
                                    410       420       430       440       450       460        
                           ---------+---------+---------+---------+---------+---------+--------- 
A/Brisbane/10/2007         GNRSGYSGIFSVEGKSCINRCFYVELIRGRKEETEVLWTSNSIVVFCGTSGTYGTGSWPDGADINLMPI                   469 
A/Perth/16/2009            .....................................................................                   469 
A/Victoria/361/2011        .D.............................................................L.....                   469 












Figure 5.5. Alignment of the NA amino acid sequences of 040078-H3N2 and swine IAV viruses 
Antigenic sites are shown in red boxes. The N residues of predicted glycosylation sites for 





Table 5.12. Phenotypic markers associated with transmission and pathogenicity found in A/swine/Guatemala/CIP049-040078/2010(H3N2) 
 
 
Protein Amino Acid Reference Comments 
PB2 199S PMID: 17073083, 
PMID: 10769072 
The presence of an A199S substitution enhances viral transmission to humans 
 271A PMID: 20181719 The mutation T271A contributes to enhanced polymerase activity and viral growth in mammalian 
cells in vitro.  
 360Y PMID: 18768983 The Tyr residue at position 360 of PR8(UW) PB2 confers high efficiency of vaccine seed virus 
growth in MDCK cells. 
 627K PMID: 11546875 The E627K substitution in avian isolates enhances replication and pathogenicity in mammals at a 
lower temperature in the upper respiratory tract. 
 627K PMID: 17073083, 
PMID: 10769072 
The presence of an E627K substitution enhances virulence 
 661T PMID: 18315849, 
PMID: 10769072 
The presence of an A661T substitution enhances viral transmission to humans 
 667I PMID: 10769072 The presence of an V667I substitution enhances viral transmission to humans 
 702R PMID: 18315849, 
PMID: 11546875, 
PMID: 19211790 
The presence of an K702R substitution enhances viral transmission to humans 
    
PB1 - - No markers of virulence or pathogenicity associated with PB1 found in 040078 
    
PB1-F2 66N PMID: 21084483 The S66N substitution results in reduced virulence thought reduced inhibition of the early 
interferon response. 
    
PA 409N PMID: 17073083 S409N enhances transmission in humans 
 245K PMID: 7966557 Mutations at these positions are capable of suppressing the temperature-sensitivity phenotype of 
the virus. 
    
HA 138A PMID: 22353399, 
18329747 
A serine at amino acid 138 is essential but not solely sufficient for a high infectivity phenotype in 
primary swine respiratory epithelial cells (SRECs). 
 124S PMID: 22353399 G124D exhibits high infectivity phenotype in swine respiratory epithelial cells (SRECs); 
preferentially binds polylactosamine glycans. 




 218G/R PMID: 20702632 The G218W (HA1) as well as the T156N(HA2) mutation enhance replication and virulence in vivo 
in mouse model. 
 218G/R PMID: 18983930 The single mutation Gly218Glu causes high pathogenicity in mice at late passage 10 and also 
causes enhanced binding abilities to ?2,3 and ?2,6 sialic acid-linked receptors. 
    
NP 184K PMID: 19475480 A change from alanine to a lysine at residue 184 of NP results in increased replication and 
pathogenicity of the viruses in chickens. 
 214K, 217S, 
253I 
PMID:24335312 Residues 214, 217, and 253 of Aichi NP play a critical role in influenza virus morphology, 
possibly through interaction with the M1 layer during virus budding. A/Aichi/2/68 214K, 217S, 
253I (filamentous) 
    
NA - - No markers of virulence, pathogenicity or neuraminidase inhibitors resistance were observed in 
NA of 040078 
    
M1 - - No markers determinants of virulence associated with M1 found in 040078 
    
M2 16G PMID: 22132146 A16G substitution leads to enhanced transmission in humans 
 31N PMID: 22132146 31N confers resistance to Adamantane 
 55F PMID: 22132146 C55F substitution leads to enhanced transmission in humans 
 11I, 14E, 
16G, 18R, 
20N 
PMID: 15777646 WSN strain possesses Ile, Glu, Gly, Arg and Asn, determinant of host range specificity. 
 31N PMID: 15673732 It is shown that single-amino-acid substitution at this position within the transmembrane domain of 
M2 produces amantadine resistance in Influenza viruses 
    
NS1 149A PMID: 16971424 Recombinant GS/GD/1/96 virus with Ala149 can antagonize the induction of interferon levels in 
chicken embryo fibroblasts (CEFs), recombinants with Val149  are not capable of the same effect.  
 
106M PMID: 17522219 Changing any one of the two residues, either L103 to F or I106 to M, in the HK97 NS1A protein 





PMID:  18334632 Majority of the human strains have the signature RSKV sequence; the remaining have avian 
signatures ESEV and are known to be of avian origin. 






Figure 5.6 Phylogenetic inference for the Hemagglutinin gene of pH1N1 viruses from Central America and the Caribbean (2009-2013).  
Maximum Likelihood phylogenetic inference using the best-fit model Hasegawa-Kishino-Yano (HKY) + Γ model of nucleotide substitution. Neighbor-Joining 
bootstrap support values ≥70% are shown. Reference strains, A/California/04/2009 (CA/04) and A/Netherlands/602/2009 (Nd/602) were included and are 
marked with black squares. The swine isolate from Guatemala is marked with a red circle.  Swine isolates from other countries (Cuba, Mexico and Costa Rica) 
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Figure 5.7 Phylogenetic inference for the N1 Neuraminidase gene of pH1N1 viruses from Central 
America and the Caribbean (2009-2013)  
Maximum Likelihood phylogenetic inference using the best-fit model Hasegawa-Kishino-Yano (HKY) + Γ 
model of nucleotide substitution. Neighbor-Joining bootstrap support values ≥70% are shown. Reference 
strains, A/California/04/2009 (CA/04) and A/Netherlands/602/2009 (Nd/602) were included and are 
marked with black squares. The swine isolate from Guatemala is marked with a red circle.  Swine isolates 
from other countries (Cuba, Mexico and Costa Rica) are marked with blue triangles. The cluster delineated 
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Figure 5.8 Phylogenetic inference for the Hemagglutinin gene of H3N2 viruses from Central America and the Caribbean (2007-2013) 
Maximum Likelihood phylogenetic inference using the best-fit model Hasegawa-Kishino-Yano (HKY) + Γ model of nucleotide substitution. Neighbor-Joining 
bootstrap support values ≥70% are shown. Reference vaccine strains were included to define lineages, and are marked with black squares. The swine isolate from 
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Figure 5.9 Phylogenetic inference for the Neuraminidase gene of H3N2 viruses from Central America and the Caribbean (2007-2013) 
Maximum Likelihood phylogenetic inference using the best-fit model Hasegawa-Kishino-Yano (HKY) + Γ model of nucleotide substitution. Neighbor-Joining 
bootstrap support values ≥70% are shown. Reference vaccine strains were included to define lineages, and are marked with black squares. The swine isolate from 
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The results of this study confirm that IAV circulated widely in PPU in Guatemala 
between 2010 and 2011. Detection by rRT-PCR yielded 14% of positive samples over the 
two-year period, with more than 30% positive herds each year. Reports from other 
regions about herd prevalence based on virus detection from cross-sectional studies are 
limited. In 2010 a similar study from Cuba reported 31.3% of farms positive to pH1N1, 
and 32.8% of tested pigs, positive to influenza A detected by rRT-PCR (319). In Costa 
Rica 2 out of 25 sampled PPU (8%) were positive for IAV by the same method during 
the same year (320). In a study from Mexico, the herd prevalence was not described but a 
positivity rate of 16.6% of tested samples was reported (321). From studies in other 
geographical regions, the percentage of positive herds or positive samples ranges between 
4% to more than 90% (165, 322-324). This variability suggests differences in the 
dynamics of IAV infection in different pig populations and geographical regions, 
although differences in study designs, sampled populations and laboratory-testing 
methods (rRT-PCR, virus isolation) have to be considered when making these 
comparisons. 
Cross-sectional studies to estimate seroprevalence have been conducted more 
broadly, usually targeting sows or adult animals; the percentage of seropositive herds on 
these studies are also variable, but herd prevalences of >50% are commonly reported 
(166, 325-329). In Guatemala the percentage of seropositive herds (19.5% and 5.6%) 
were estimated from data on all the sampled population, without making distinction by 




found in 2011 compared to 2010, may indicate variations of IAV infection in pigs 
throughout the year. Samples from 2010 were taken in October and samples from 2011 
were taken from June to August. The environmental factors that influence IAV 
transmission in the tropical countries like Guatemala are not well defined; in humans the 
proportion of IAV cases usually reaches a peak during the rainy season (at the middle of 
the year) and IAV transmission seem to be associated with specific humidity (330-333). 
Whether IAV prevalence in pigs is also influenced by environmental conditions, or is just 
a result of the nature of the annual pig production cycle (a greater proportion of pigs 
would have been exposed in later months of the year) is unclear; longitudinal studies are 
necessary to further address these questions.   
With respect to the geographical distribution of positive herds, the borderline 
association between detection of influenza infection and herds located in the east and the 
west observed in 2010 is further supported by the identification of two clusters of positive 
farms detected by spatial analysis using geographical coordinates from the sampled farms 
(334). In 2010, these clusters were found in the west and east of the country.  Similarly, 
the association observed in 2011 between positive PPU and their location in the southeast 
departments of the country, was also supported by a major cluster identified in this region 
by spatial analysis. The Ministry of Agriculture operates within five defined work zones 
based on these geographical regions (central, north, east, south, west), and our results 
indicate that prevalence risk ratio may help to predict the areas that are at greater risk of 
influenza infection when integrated as part of national IAV surveillance plan.  
Differences in IAV prevalence between types of PPU also varied between years. 




farms and smallholdings may be driven by different exposure factors, such as differences 
in infrastructure and animal handling practices associated with each type of system.   
In 2010 the majority of samples were collected from pigs reported with signs of 
respiratory disease, whereas in 2011 the majority of sampled pigs were reported as 
“healthy”. The heterogeneity between samples from both years may be a confounding 
factor and comparisons at the animal level between years were not done. Data from both 
years were combined, and an association between IAV virus detection and sick pigs was 
found. However, this association was weak, and the difference between groups (sick or 
healthy) was not significant. Considering that the percentage of positive samples found in 
2011 (mostly from healthy animals) was not different from 2010, observation of 
respiratory signs of disease pigs may not be a good indicator of IAV circulation in PPU 
from Guatemala. In addition, the occurrence of subclinical infections may explain the 
relatively high number of positive “healthy” animals observed in 2011.    
Borderline associations were found between detection of IAV and juvenile pigs, 
and between detection of seropositive animals IAV and adult pigs. The results of these 
analyses are limited as only data from 2011 was available (when only 7 samples tested 
positive for IAV antibodies). However, a higher risk of IAV infection in juvenile pigs, 
and a higher seroprevalence in adult animals (in particular sows) are in agreement with 
other studies (166, 329). In order to confirm these observations, additional studies 
designed to study particular associations in targeted populations will have to be 
performed.  
Evidence of exposure to IAV viruses of swine origin was found by HI assay. 




farms and in 2010, including viruses from the H1 alpha cluster and viruses from the H3 
subtype. Exposure to different type of viruses found in farms and smallholdings may 
reflect differences in the epidemiology of IAV in these populations. Our results indicate 
that smallholdings may be at higher risk of exposure to viruses of human origin, whereas 
commercial farms may be at higher risk of exposure to swine derived strains associated 
with animal movement.  
Exposure to the pH1N1 virus was found in the majority of positive animals, 
regardless of the type of PPU. Since the emergence of the pH1N1 in humans, 
introduction of pH1N1 viruses into pigs has been documented in many countries in Latin 
America, including Argentina, Brazil, Colombia, Costa Rica, Cuba and Mexico (319, 
320, 328, 335-338). In Guatemala, there is no information about the viruses that 
circulated in pigs prior to the emergence of the pandemic in 2009. Although reverse 
zoonotic transmission from humans is the most likely explanation, with the available 
information, it remains unknown whether other swine viruses with similar antigenic 
properties to the pH1N1 were already circulating in the region. 
Exposures to more than one virus were detected in a number of samples 
suggesting co-circulation of different viruses at the same time in positive PPU. In general 
the HI titers against the tested antigens were relatively low (geometric mean titers, GMT, 
ranged between 80 and 269, data not shown), which may indicate cross-reactive rather 
than strain specific responses. Summed to this, the subtype specific response of 10 
ELISA positive samples could not be identified by HI assay with the panel of tested 
antigens, indicating that other viruses with different antigenicity may be circulating in 




continued characterization of local strains is needed to improve current diagnostics 
methods.  
In 2010, from all samples positive for IAV matrix rRT-PCR, only 10 tested 
positive for the presence of pH1N1 with a second rRT-PCR targeting the N1 gene. In 
2011 all samples tested negative for N1 by the same test, but serological exposure to 
pH1N1 was detected in both years. The samples from which the pH1N1 viruses were 
isolated were negative when they were initially tested by the N1 specific rRT-PCR. 
Comparison of viral sequences revealed a mismatch with the sequences of the N1-R330 
3’ primer (5’-ggaaccgattcttaTactgttgtc-3’), which may have prevented primer extension 
during the amplification reaction. Results based on subtype specific assays need to be 
interpreted cautiously when there is little information on the viruses circulating in a 
specific region (e.g. Guatemala), as they may provide an underestimated prevalence of 
different subtypes. The surface genes are subjected to stronger evolutionary pressures, 
making difficult the design of primers and probes that are specific enough to distinguish 
between genetic lineages of one virus subtype but that still capture all variants within the 
same genetic lineage, such as the pH1N1 lineage. Therefore, to better capture the virus 
diversity of circulating viruses in future studies in Guatemala, we recommend the use of a 
IAV specific assay directed to a higher conserved gene (such as the matrix gene-based 
assay) followed by direct sequencing with next generation sequencing (when available) 
and molecular characterization of virus isolates. Until sufficient information of locally 
circulating viruses is generated, the application of subtype specific assays developed for 




In this study 4 virus isolates were obtained from 139 samples tested (rRT-PCR 
positive). For avian influenza, low rates of viral isolation from samples with CT-values 
>30 have been reported (268). In our study the majority of rRT-PCR positive samples 
(115/139) had CT-values above 35, which may explain the limited recovery of viral 
isolates from nasal swabs. The H3N2 virus was isolated from a sample with CT-value of 
27.5 and the three pH1N1 viruses were isolated from second and third cell passages of 
samples with 32<CT-value>35. Pandemic viruses are known to replicate well in tissue 
culture systems. Their high replication efficiency above other mammalian viruses (339, 
340) may explain the fact that these viruses could be recovered from samples with a low 
cDNA copy number. In future studies, virus isolation may be improved by follow up of 
identified foci of respiratory disease over time with laboratory confirmation and 
collection of different types of samples (e.g. lung biopsies collected from pigs at 
slaughter houses, or death sick animals).  
With respect to the molecular characterization of viral isolates, in-silico analysis 
of genetic markers for adaptation of influenza viruses to human and swine hosts suggest 
that the H3N2 and the pH1N1 viruses were recent introductions in pigs at the time of 
sampling. Alignments of the HA amino acid sequence of isolate 040078-H3N2 with other 
seasonal human H3N2 viruses revealed little differences in the antigenic sites between 
these viruses. Comparison of 040078-H3N2 isolate with other contemporary H3 viruses 
of swine origin suggest that although pigs in Guatemala were found to be exposed to H3 
viruses of swine origin (in particular from clusters III and IV), they could have little cross 
protection to a virus like the 040078-H3N2. All pigs from the same farm and department 




seropositive pigs for the H3 subtype were found. Evidence of circulation of a similar 
virus in 2011 was not detected, suggesting that spread of the human-like H3N2 in pigs 
may have been limited. Experimental evaluation of the transmissibility of the 040078-
H3N2 virus in pigs could help to better assess the risk of establishment and spread of 
seasonal human-like H3N2 viruses in pigs in Guatemala.  
Phylogenetic analysis of the 040078-H3N2 HA revealed that a distinct lineage of 
seasonal H3N2 viruses co-circulated with those from current human vaccine-lineage in 
Central America and other countries between 2010 and 2012. When sequences of more 
recent viruses (from 2013 and 2014) from Central America were incorporated into the 
phylogenetic analysis the majority of viruses isolated after 2012 clustered within the 
vaccine lineage suggesting lineage displacement of the other lineage in the region. 
However, it should be noted that the amount of sequences available of seasonal human 
IAV for Central America is very limited, making it difficult to interpret the significance 
of our results. Our findings underscore the importance of generating local information 
from animal and human viruses to guide local vaccine recommendations more accurately. 
The analysis of phenotypic markers and protein alignments of surface genes of the 
pH1N1 isolates demonstrates little variation from other pH1N1 strains from humans. In 
comparison to other pH1N1-like viruses recovered from pigs in other countries in Latin 
America, the viruses from Guatemala were more similar to the viruses of human origin. 
This indicates that the pH1N1 isolates found in pigs in Guatemala were a recent 
introduction from humans; however, the presence of amino acid residues that are more 
prevalent in pigs revealed undergoing adaptation of these viruses in the swine hosts. In 




demonstrate extensive circulation of the pandemic H1N1 lineage in pigs from different 
farms (commercial and smallholdings) in different departments since 2010. Although no 
reassortant viruses were found as part of our study, introduction of the pH1N1 pigs in 
Guatemala may represent the establishment of a novel genetic lineage with the potential 
to reassort with co-circulating viruses in this population.  Only long-term surveillance 
will help to characterize the pool of genetic and antigenic different viruses that are 
contributing to the epidemiology of IAV in pigs in Guatemala. 
In summary, our results provide evidence that different influenza A viruses 
(H1N1 and H3N2) circulate in the swine population of Guatemala in different types of 
PPU. Circulation of “human-like” strains in pigs suggests that human-animal contact may 
play an important role in the introduction of novel strains into the swine population in 
Guatemala.  Differences in prevalence and seroprevalence, and distribution of positive 
PPU between different years, suggest seasonal variation in the circulation influenza along 
the year that warrants further investigation with longitudinal studies in affected PPU. 
This study is the first in Guatemala analyzing IAV prevalence and its distribution in 
swine farms. Further studies are needed that address the risk factors associated with IAV 
infection in different types of PPU in Guatemala. Continued sampling is needed to 
increase the number of locally isolated strains. Surveillance for IAV in different species 
in Guatemala, and other countries in Central America, is important to improve our 
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Chapter 6. Conclusions and future prospects 
6.1. Conclusions 
6.1.1. Surveillance of Influenza A virus in wild birds in Guatemala 
The study of influenza A viruses in wild birds in Guatemala since 2007, has 
resulted in the most abundant data related to this subject available for Central America to 
date. Despite this fact, given the limitations in our study (which includes only a small 
number of sampled birds), our results are biased towards hunter-targeted species that are 
present during the winter migration at the sampled locations. Phylogenetic analysis of the 
viruses obtained during the initial years of the study demonstrated a close relationship 
with virus strains from North American wild waterfowl, and revealed high frequency of 
detection of viruses that are rarely found at the breeding grounds in North America. 
Continued surveillance from 2010 to 2013 provided additional data that allowed 
preliminary analysis of temporal variations in virus prevalence during the periods when 
reservoirs are highly abundant. The results of this analysis support a model of low virus 
prevalence towards the end of the migration cycle observed in other geographical 
locations. However, with the current amount of data derived from only a limited period of 
time, no definitive conclusions of the patterns of IAV transmission can be made. To this 
end, only intense systematic year round surveillance focused on specific bird populations 
would provide a better understanding of the seasonality of influenza transmission at the 
wintering grounds in Central America. 
The detection of high levels of the H14 subtype during the migration season of 




at wintering locations upon the arrival of migrants. Isolation of other subtypes and 
subtype combinations rarely seen at the breeding grounds during our study and in studies 
conducted in other geographical locations support this conclusion. In addition, the 
diversity of viruses found in blue-winged teals and their high relative abundance at the 
sampled locations make this a candidate species for targeted LPAIV surveillance in the 
Neotropics. However the contribution of resident bird populations and species remains 
unknown. The relative abundance of different species in Guatemala may be an 
influencing factor for the role of individual bird species to serve as IAV reservoirs. 
Implementation of additional methodologies to study multiple bird populations (including 
migrant and resident species) could help to address these questions.   
The literature revision and phylogenetic analysis of all sequence data on avian 
influenza available for Latin America and the Caribbean highlighted a significant gap in 
surveillance in the region, and a lack of understanding of the ecology of the viruses 
circulating in the southern hemisphere. Detection of distantly related gene variants in 
Guatemala provide evidence that current surveillance efforts across the region may not be 
adequately capturing the total diversity of viruses that circulate in natural hosts. Detection 
of reassortant viruses with genes from Eurasian origin in Guatemala confirms that long-
distance migration of viruses is plausible between two remote geographical locations. 
The diverse virus subtypes and genome constellations observed for the internal 
and surface genes suggest that birds from multiple migration routes are sourcing the 
viruses that circulate during winter in Guatemala. These observations provide additional 
evidence for the hypothesis that stopover habitats with overlapping flyways may serve as 




flyways through genetic reassortment and contributing to shape the evolution of the 
viruses at a continental scale. We propose that the existence of a natural geographical 
bottleneck in Central America provides such a unique niche for the birds migrating from 
North America, but we recognize that only continued surveillance over prolonged periods 
of time and in additional adjacent locations would help to confirm this hypothesis.  
6.1.2. Surveillance of Influenza A virus in swine in Guatemala 
The findings from IAV surveillance in swine populations in Guatemala between 
2010 and 2011 provide evidence of circulation of different IAV in the two main types of 
animal production systems. Sample collection was conducted during different seasons in 
2010 and 2011 (dry and rainy season, respectively). Differences in prevalence and 
seroprevalence, and distribution of positive PPU between different years, may suggest 
seasonal variation in the circulation of IAV in pigs throughout the year. Nevertheless our 
results may be influenced by the confounding factors related to the limitations in our 
study, such as the variability in the demographics of sampled populations between both 
years, and the quality of the information recovered from the sampled farms. We 
recognize such factors should be taken into account to interpret the similarities and 
discrepancies in levels of viral exposure observed between the two years. However, the 
variations observed warrant further investigation with longitudinal studies to define swine 
IAV seasonality in Guatemala. 
Circulation of “human-like” strains in pigs suggests that human-animal contact 
may play an important role in the introduction of novel strains into the swine population 
in Guatemala. Although no reassortant viruses were found as part of our study, 




mean the establishment of novel genetic lineages with the potential to reassort with co-
circulating viruses in this population, as observed in other geographic locations.  Only 
long-term surveillance will help to characterize the pool of genetic and antigenic variants 
that are contributing to the epidemiology of IAV in pigs in Guatemala. 
6.2. Future prospects and general recommendations 
6.2.1. Surveillance of Influenza A virus in wild birds in Guatemala 
Sampling of hunted birds is a cost effective strategy that allows capturing 
information about circulating IAV subtypes on an annual basis. Such a strategy could be 
applied in other countries from the region that, like Guatemala, have limited resources to 
investigate the ecology of zoonotic diseases. This does not mean that other sampling 
methodologies cannot be applied as sampling of hunted-killed birds doubtfully guaranties 
capturing the total diversity of viruses circulating in a particular region.  
Detection of viruses genetically related to HPAI strains detected in recent poultry 
outbreaks in intermediary locations between North and Central America, justifies 
continued surveillance at both ends of the migration flyways. We anticipate that our 
results will help to increase awareness at the regional level for the need to characterize 
strains from the southern hemisphere. 
In Guatemala, work still needs to be done to define the 1) patterns of viral 
circulation, 2) important host species and in particular, 3) how virus diversity is 
maintained between migration seasons. Systematic methodologies that integrate live bird 
captures and environmental sampling in other habitats and bird species, coupled with 




addition, collaboration with other groups working in other locations across the same 
migration flyways, would allow better comparisons of virus diversity among different 
bird species, locations and seasons. Finally, increased laboratory capability for diagnosis 
in Guatemala could help to speed up the process of virus characterization.  
With the use of deep sequencing data, detection of low-frequency variants in 
isolates of wild bird origin may help to provide critical information to better understand 
which genetic determinants are required for transmission of IAV to poultry. In addition, 
deep-sequencing data from field isolates could be used to assess the contribution of 
genetic drift and selection of gene variants to the evolution of IAV in its natural host. 
Sequencing of additional viruses isolates could help to identify more events of 
interlineage reassortment (including the South American lineage), and would contribute 
to characterizing the patterns of virus reassortment during one migration season. In this 
context, standardization of the methods to characterize the genetic structure of the virus 
population and gene constellations could simplify the way to visualize virus diversity at a 
given location and time. At the same time, this would facilitate direct comparison 
between virus populations from different locations. 
6.2.2. Surveillance of Influenza A virus in swine in Guatemala 
In order to better understand the epidemiology of influenza in swine populations 
in Guatemala, further studies are needed to analyze the risk factors associated with IAV 
infection in different types of PPU. In 2012 a pilot study was conducted to investigate in 
greater detail influenza circulation in two geographic locations within Guatemala, 
distinguished by differences in their climate and ecosystems. The results from this study 




for influenza infection in pigs (341). The implementation of longitudinal studies is 
needed in order to define the seasonal patterns of IAV infection in swine farms. Current 
efforts from our group in Guatemala are focused on the development of longitudinal 
studies at the human-animal interface. 
Continued surveillance for IAV in different species in Guatemala is important to 
improve our understanding of the ecology of animal influenza in tropical regions. The 
ultimate goal of influenza surveillance in animal and human hosts is to characterize local 
virus populations and their antigenic properties, in order to guide local vaccine 
recommendations. The establishment of sustainable long-term active IAV surveillance in 
pigs in Guatemala is hampered by limited resources, which are usually directed to the 
study of other pathogens of higher priority in the swine production sector. Our experience 
in IAV surveillance in pigs in Guatemala demonstrates that cooperation between 
governmental and academic institutions, supported by local and external funding, can 
help to optimize resources to study locally circulating pathogens in developing countries. 
Participation of the governmental sector is critical to increase awareness of swine 
producers, and increasing accessibility to farms for sample collections, whereas 
participation of the academic sector helps to provide technical advice and training for 
adequate sample collection and scientifically sound interpretation of the results. We 
advocate for such collaborations to continue, as this could increase the capability of the 







Table 0.1. Viruses isolated from wintering waterfowl in Guatemala between 2010 and 2013 
 
Sample 
identifier Strain Name 
Collection 
Date 
H006-02 A/blue-winged teal/Guatemala/CIP049-01/2008(H7N9) 7-Feb-08 
H008-41 A/blue-winged teal/Guatemala/CIP049-02/2008(H7N9) 5-Mar-08 
H094-10 A/blue-winged teal/Guatemala/CIP049-10/2009(H11N2) 11-Nov-09 
H094-11 A/blue-winged teal/Guatemala/CIP049-11/2009(H11N2) 11-Nov-09 
H094-15 A/blue-winged teal/Guatemala/CIP049-03/2009(H11N2) 11-Nov-09 
H096-04 A/blue-winged teal/Guatemala/CIP049-04/2010(H8N4) 31-Jan-10 
H096-05 A/blue-winged teal/Guatemala/CIP049-05/2010(H3N8) 31-Jan-10 
H096-07 A/blue-winged teal/Guatemala/CIP049-06/2010(H8N4) 31-Jan-10 
H096-14 A/blue-winged teal/Guatemala/CIP049-12/2010(H5N4) 31-Jan-10 
H096-20 A/blue-winged teal/Guatemala/CIP049-13/2010(H5N4) 31-Jan-10 
H096-31 A/blue-winged teal/Guatemala/CIP049-14/2010(H8N4) 31-Jan-10 
H096-34 A/blue-winged teal/Guatemala/CIP049-07/2010(H8N4) 31-Jan-10 
H096-39 A/blue-winged teal/Guatemala/CIP049-08/2010(H5N3) 31-Jan-10 
H096-41 A/blue-winged teal/Guatemala/CIP049-15/2010(H8N4) 31-Jan-10 
H096-48 A/blue-winged teal/Guatemala/CIP049-09/2010(H5N3) 31-Jan-10 
H098-32 A/blue-winged teal/Guatemala/CIP049H098-32/2010 (H5N3) 19-Nov-10 
H101-24 A/blue-winged teal/Guatemala/CIP049H101-24/2011 (H3N8) 5-Nov-11 
H101-29 A/blue-winged teal/Guatemala/CIP049H101-29/2011 (H4N2) 5-Nov-11 
H101-36 A/blue-winged teal/Guatemala/CIP049H101-36/2011 (H4N8) 5-Nov-11 
H102-05 A/blue-winged teal/Guatemala/CIP049H102-05/2011 (H4N2) 11-Nov-11 
H102-08 A/blue-winged teal/Guatemala/CIP049H102-08/2011 (H1N3) 11-Nov-11 
H102-09 A/blue-winged teal/Guatemala/CIP049H102-09/2011 (H3N2) 11-Nov-11 
H102-10 A/blue-winged teal/Guatemala/CIP049H102-10/2011 (H4N8) 11-Nov-11 
H102-11 A/blue-winged teal/Guatemala/CIP049H102-11/2011 (H3N2) 11-Nov-11 
H102-18 A/blue-winged teal/Guatemala/CIP049H102-18/2011 (H1N3) 11-Nov-11 
H102-19 A/blue-winged teal/Guatemala/CIP049H102-19/2011 (H3N2) 11-Nov-11 
H102-23 A/blue-winged teal/Guatemala/CIP049H102-23/2011 (H3N2) 11-Nov-11 
H102-25 A/blue-winged teal/Guatemala/CIP049H102-25/2011 (H3N2) 11-Nov-11 
H102-29 A/blue-winged teal/Guatemala/CIP049H102-29/2011 (H3N2) 11-Nov-11 
H102-32 A/blue-winged teal/Guatemala/CIP049H102-32/2011 (H3N8) 11-Nov-11 
H102-46 A/blue-winged teal/Guatemala/CIP049H102-46/2011 (H1N3) 11-Nov-11 
H103-05 A/northern shoveler/Guatemala/CIP049H103-05/2011 (H1N3) 25-Nov-11 
H103-13 A/blue-winged teal/Guatemala/CIP049H103-13/2011 (H3N2) 25-Nov-11 
H103-20 A/blue-winged teal/Guatemala/CIP049H103-20/2011 (H3N2) 25-Nov-11 
H103-27 A/blue-winged teal/Guatemala/CIP049H103-27/2011 (H3N2) 25-Nov-11 
H103-30 A/blue-winged teal/Guatemala/CIP049H103-30/2011 (H4N3) 25-Nov-11 
H103-37 A/blue-winged teal/Guatemala/CIP049H103-37/2011 (H4N3) 25-Nov-11 
H104-38 A/blue-winged teal/Guatemala/CIP049H104-38/2011 (H1N3) 1-Dec-11 
H104-69 A/northern shoveler/Guatemala/CIP049H104-69/2011 (H11N3) 1-Dec-11 
H104-93 A/blue-winged teal/Guatemala/CIP049H104-93/2011 (H3N3) 1-Dec-11 
H104-99 A/blue-winged teal/Guatemala/CIP049H104-99/2011 (H12N5) 1-Dec-11 
H105-01 A/blue-winged teal/Guatemala/CIP049H105-01/2011 (H1N3) 8-Dec-11 
H105-04 A/blue-winged teal/Guatemala/CIP049H105-04/2011 (H11N3) 8-Dec-11 
H105-05 A/blue-winged teal/Guatemala/CIP049H105-05/2011 (H5N3) 8-Dec-11 
H105-08 A/blue-winged teal/Guatemala/CIP049H105-08/2011 (H3N3) 8-Dec-11 
H105-15 A/blue-winged teal/Guatemala/CIP049H105-15/2011 (H14N3) 8-Dec-11 





identifier Strain Name 
Collection 
Date 
H105-32 A/blue-winged teal/Guatemala/CIP049H105-32/2011 (H1N3) 8-Dec-11 
H106-62 A/blue-winged teal/Guatemala/CIP049H106-62/2011 (H14N6) 15-Dec-11 
H107-88 A/northern shoveler/Guatemala/CIP049H107-88/2012 (H7N3) 22-Jan-12 
H108-02 A/blue-winged teal/Guatemala/CIP049H108-02/2012 (H14N3) 9-Nov-12 
H108-04 A/blue-winged teal/Guatemala/CIP049H108-04/2012 (H14N3) 9-Nov-12 
H108-11 A/blue-winged teal/Guatemala/CIP049H108-11/2012 (H14N3) 9-Nov-12 
H108-39 A/blue-winged teal/Guatemala/CIP049HT108-39/2012 (H4N2) 9-Nov-12 
H108-45 A/blue-winged teal/Guatemala/CIP049H108-45/2012 (H3N2) 9-Nov-12 
H108-53 A/blue-winged teal/Guatemala/CIP049H108-53/2012 (H4N2) 9-Nov-12 
H108-67 A/blue-winged teal/Guatemala/CIP049H108-67/2012 (H3N2) 9-Nov-12 
H109-06 A/blue-winged teal/Guatemala/CIP049H109-06/2012 (H4N2) 16-Nov-12 
H109-14 A/blue-winged teal/Guatemala/CIP049H109-14/2012 (H3N3) 16-Nov-12 
H109-15 A/blue-winged teal/Guatemala/CIP049H109-15/2012 (H3N2) 16-Nov-12 
H109-28 A/blue-winged teal/Guatemala/CIP049H109-28/2012 (H3N2) 16-Nov-12 
H109-38 A/blue-winged teal/Guatemala/CIP049H109-38/2012 (H3N8) 16-Nov-12 
H109-49 A/blue-winged teal/Guatemala/CIP049H109-49/2012 (H14N3) 16-Nov-12 
H109-67 A/blue-winged teal/Guatemala/CIP049H109-67/2012 (H14N3) 16-Nov-12 
H109-76 A/blue-winged teal/Guatemala/CIP049H109-76/2012 (H14N3) 16-Nov-12 
H109-86 A/blue-winged teal/Guatemala/CIP049H109-86/2012 (H4N2) 16-Nov-12 
H110-04 A/blue-winged teal/Guatemala/CIP049H110-04/2012 (H14N5) 29-Nov-12 
H110-27 A/blue-winged teal/Guatemala/CIP049H110-27/2012 (H4N6) 29-Nov-12 
H110-31 A/blue-winged teal/Guatemala/CIP049H110-31/2012 (H14N3) 29-Nov-12 
H110-36 A/blue-winged teal/Guatemala/CIP049H110-36/2012 (H11N9) 29-Nov-12 
H110-37 A/blue-winged teal/Guatemala/CIP049H110-37/2012 (H11N3) 29-Nov-12 
H111-98 A/blue-winged teal/Guatemala/CIP049H111-98/2012 (H2N3) 7-Dec-12 
H112-03 A/American wigeon/Guatemala/CIP049H112-03/2012 (H4N2) 21-Dec-12 
H112-31 A/blue-winged teal/Guatemala/CIP049H112-31/2012 (H4N2) 21-Dec-12 
H112-60 A/blue-winged teal/Guatemala/CIP049H112-60/2012 (H3N2) 21-Dec-12 
H112-79 A/northern shoveler/Guatemala/CIP049HT112-79/2012 (H4N2) 21-Dec-12 
H113-07 A/blue-winged teal/Guatemala/CIP049H113-07/2013 (H14N3) 11-Jan-13 
H113-08 A/blue-winged teal/Guatemala/CIP049H113-08/2013 (H14N4) 11-Jan-13 
H113-53 A/blue-winged teal/Guatemala/CIP049H113-53/2013 (H5N3) 11-Jan-13 
H113-74 A/blue-winged teal/Guatemala/CIP049H113-74/2013 (H14N3) 11-Jan-13 
H113-76 A/blue-winged teal/Guatemala/CIP049H113-76/2013 (H14N4) 11-Jan-13 
H114-14 A/northern shoveler/Guatemala/CIP049HT114-14/2013 (H3N8) 19-Jan-13 


















Table 0.2. Top ten BLAST hits for the HA genes of the viruses isolated from wintering waterfowl in 

























CY167159.1|A/mallard/Arkansas/12OS179/2012(H1N1)  99.2 99.3 99.1 99.0 
CY177037.1|A/mallard/California/3937/2012(H1N1)  99.2 99.2 99.0 99.0 
CY133290.1|A/mallard/Mississippi/10OS4593/2010(H1N2)  99.1 99.1 99.0 99.0 
CY133713.1|A/mallard/Mississippi/11OS34/2011(H1N3)  99.1 99.1 99.0 99.0 
CY133801.1|A/mallard/Missouri/10MO0253/2010(H1N2)  99.1 99.1 99.0 99.0 
CY120651.1|A/northern pintail/California/3452/2010(H1N1)  99.1 99.1 99.0 98.9 
CY132338.1|A/mallard/Ohio/11OS2203/2011(mixed)  99.1 99.1 99.0 
 CY133480.1|A/northern shoveler/Illinois/10OS4360/2010(mixed)  99.0 99.1 98.9 99.0 
CY166306.1|A/mallard/Illinois/11OS5582/2011(H1N1)  99.0 99.1 98.9 98.9 
CY166282.1|A/mallard/Illinois/11OS5564/2011(H1N8)  99.0 99.0 98.9 98.8 












CY186989.1|A/northern shoveler/Ohio/12OS5647/2012(H2N3)  99.4 
CY157278.1|A/mallard/California/3046/2012(H2N3)  98.4 
CY157318.1|A/mallard/California/3118/2012(H2N3)  98.3 
KJ568185.1|A/blue-winged teal/Ohio/13OS2104/2013(H2N3)   97.9 
CY039707.1|A/env/California/7313/2008(H2N3)   97.0 
CY039692.1|A/env/California/7286/2008(H2N3)   97.0 
CY039684.1|A/env/California/7279/2008(H2N3)   97.0 
CY039715.1|A/env/California/7335/2008(H2N3)   96.9 
CY039700.1|A/env/California/7303/2008(H2N3)   96.9 








































































CY186879.1|A/blue-winged teal/Ohio/12OS2229/2012(H3N6) 98.9 99.1 99.0 98.8 98.6 99.4 99.1 98.8 98.9 99.4 99.1 
  CY166234.1|A/mallard/Wisconsin/11OS4081/2011(H3N8) 98.8 99.0 99.0 98.7 98.6 99.0 99.2 99.0 98.8 99.1 98.9 
  CY187119.1|A/mallard/Wisconsin/12OS4331/2012(H3N8) 98.8 99.0 98.7 99.7 98.5 99.1 99.0 98.7 98.8 99.1 98.8 
  CY141025.1|A/mallard/Arkansas/AI09-5900/2009(H3N8) 98.7 98.8 98.6 98.7 98.3 98.9 98.8 98.6 98.7 99.0 98.7 
  CY142626.1|A/American green-winged teal/Interior 
Alaska/9BM6410R0/2009(H3N8) 98.3 98.5 98.3 98.4 98.1 98.6 98.5 98.3 98.3 98.7 98.4 
  CY142938.1|A/northern pintail/Interior 
Alaska/9BM7836R0/2009(H3N8) 98.3 98.5 98.3 98.4 98.1 98.6 98.5 98.3 98.3 98.7 98.4 
  CY143322.1|A/northern pintail/Interior 
Alaska/9BM12647R0/2009(H3N8) 98.3 98.5 98.3 98.4 98.1 98.6 98.5 98.3 98.3 98.7 98.4 
  CY143331.1|A/mallard/Interior Alaska/9BM12694R1/2009(mixed) 98.3 98.5 98.3 98.4 98.1 98.6 98.5 98.3 98.3 98.7 98.4 
  CY140860.1|A/blue-winged Teal/North Dakota/AI09-
3642/2009(H3N1) 98.3 98.5 98.3 98.4 
         CY096656.1|A/blue-winged teal/Guatemala/CIP049-05/2010(H3N8) 97.6 97.7 97.5 97.7 97.4 97.9 
       CY143146.1|A/mallard/Interior Alaska/9BM12285R0/2009(H3N8) 
    
98.0 98.5 98.4 98.2 98.3 98.7 98.4 
  CY142810.1|A/northern pintail/Interior 
Alaska/9BM11487R0/2009(H3N8) 
      
98.5 98.3 
     CY143066.1|A/northern pintail/Interior 
Alaska/9BM10819R0/2009(H3N8) 
        
98.3 98.7 98.4 
  JN864063.1|A/Anas strepera/Arizona/A00271503/2009(H3N8) 
           
99.0 98.8 
CY076165.1|A/American coot/Oregon/20589-007/2007(H3N8) 
           
98.6 98.5 
CY097718.1|A/mallard/Mississippi/386/2010(H3N8) 
           
98.5 98.4 
CY097726.1|A/mallard/Mississippi/390/2010(H3N8) 
           
98.5 98.4 
CY097702.1|A/mallard/Mississippi/354/2010(H3N8) 
           
98.5 98.3 
CY032720.1|A/northern pintail/California/HKWF792/2007(H3N8) 
           
98.4 98.3 
CY097710.1|A/mallard/Mississippi/360/2010(H3N8) 




           
98.3 98.2 
CY076013.1|A/cinnamon teal/California/44287-325/2007(H3N8) 
           
98.1 98.0 














































CY166979.1|A/blue-winged teal/Missouri/11OS2641/2011(H4N8) 99.5 
       CY133769.1|A/blue-winged teal/Missouri/10MO030/2010(H4N6) 99.4 
       CY166477.1|A/blue-winged teal/Wisconsin/11OS2657/2011(H4N6) 99.4 
       CY128966.1|A/American black duck/New Brunswick/03553/2009(H4N6) 99.4 
       CY128974.1|A/American black duck/New Brunswick/03511/2009(H4N6) 99.4 
       CY128990.1|A/American black duck/New Brunswick/03552/2009(H4N6) 99.4 
       CY166485.1|A/northern pintail/Wisconsin/11OS3295/2011(H4N2) 99.4 
       CY166557.1|A/northern shoveler/Wisconsin/11OS3013/2011(H4N8) 99.4 
       CY166971.1|A/blue-winged teal/Missouri/11OS2640/2011(H4N8) 99.4 
       CY128540.1|A/American black duck/New Brunswick/03559/2009(H4N6) 99.3 
       CY166768.1|A/American green-winged teal/Mississippi/11OS5869/2011(H4N6) 
 
99.4 99.1 
     CY186496.1|A/mallard/Ohio/12OS1418/2012(mixed) 
 
99.4 99.5 
     CY132133.1|A/mallard/Ohio/10OS1319/2010(H4N6) 
 
99.3 98.8 
     CY166696.1|A/mallard/Wisconsin/11OS4309/2011(H4N6) 
 
99.2 98.9 
     CY166704.1|A/mallard/Wisconsin/11OS4310/2011(H4N6) 
 
99.2 98.9 
     CY186716.1|A/mallard/Illinois/12OS4808/2012(H4N8) 
 
99.1 98.8 
     CY139539.1|A/mallard/New Brunswick/00992/2010(mixed) 
 
99.1 98.7 
     CY139522.1|A/American black duck/New Brunswick/00988/2010(mixed) 
 
99.1 
      CY139531.1|A/American black duck/New Brunswick/00991/2010(H4N6) 
 
99.1 
      KF534792.1|A/Anas discors/New Mexico/A00327695/2007(H4N6) 
 
98.8 
      CY132393.1|A/mallard/Ohio/11OS2083/2011(H4N8) 
  
98.8 
     CY132384.1|A/mallard/Ohio/11OS2072/2011(mixed) 
  
98.8 
     CY132517.1|A/mallard/Ohio/11OS2085/2011(H4N6) 
  
98.8 
     CY097026.1|A/blue-winged teal/Wisconsin/2741/2009(H4N6) 
   
99.4 99.2 99.1 
  CY096970.1|A/bufflehead/Illinois/4016/2009(H4N8) 
   
99.3 99.2 
   CY132901.1|A/blue-winged teal/Illinois/10OS1561/2010(H4N6) 
   
99.3 99.2 
   CY132909.1|A/blue-winged teal/Illinois/10OS1563/2010(H4N6) 
   
99.3 99.2 
   KJ567929.1|A/American green-winged teal/Ohio/13OS1864/2013(H4N8) 
   
99.3 99.1 
   KJ568169.1|A/mallard/Ohio/13OS1989/2013(H4N8) 
   
99.3 99.1 




H4 % Identity 
CY141001.1|A/blue-winged teal/Louisiana/AI09-5291/2009(H4N6) 
   
99.2 99.1 
   CY140769.1|A/mallard/Minnesota/AI09-3047/2009(mixed) 
   
99.2 99.1 
   KJ567977.1|A/blue-winged teal/Ohio/13OS2016/2013(H4N6) 
   
99.2 99.0 
   KJ568241.1|A/blue-winged teal/Iowa/13OS2367/2013(H4N8) 
   
99.2 99.0 
   CY166378.1|A/mallard/Illinois/11OS4311/2011(H4N2) 
     
99.6 
  CY167028.1|A/northern pintail/Illinois/11OS4756/2011(mixed) 
     
99.4 
  CY166832.1|A/American green-winged teal/Mississippi/11OS5903/2011(H4N6) 
     
99.2 
  CY132917.1|A/American green-winged teal/Illinois/10OS1598/2010(H4N8) 
     
99.2 
  CY133577.1|A/mallard/Iowa/10OS2420/2010(H4N6) 
     
99.2 
  CY138006.1|A/blue-winged teal/Nova Scotia/00296/2010(mixed) 
     
99.2 
  CY132790.1|A/American green-winged teal/Iowa/10OS2467/2010(mixed) 
     
99.1 
  CY138504.1|A/blue-winged teal/Nova Scotia/01008/2010(H4N6) 
     
99.1 
  CY138512.1|A/blue-winged teal/Nova Scotia/01009/2010(H4N6) 
     
99.1 
  CY139319.1|A/mallard/New Brunswick/00854/2010(H4N6) 
      
99.2 
 CY133069.1|A/mallard/Wisconsin/10OS2659/2010(H4N2) 
      
98.7 
 CY186951.1|A/blue-winged teal/Ohio/12OS3128/2012(H4N6) 
      
98.6 
 CY133432.1|A/mallard/Iowa/10OS2685/2010(H4N2) 
      
98.5 
 CY157486.1|A/mallard/California/3471/2012(H4N6) 
      
98.5 
 CY167020.1|A/northern shoveler/Illinois/11OS4707/2011(H4N6) 
      
98.5 
 CY177255.1|A/mallard/California/1398/2013(H4N6) 
      
98.5 
 CY177175.1|A/mallard/California/1369/2013(H4N6) 
      
98.4 
 CY187168.1|A/blue winged-teal/Wisconsin/12OS4224/2012(H4N8) 
      
98.4 
 CY103135.1|A/mallard/Alberta/256/2006(mixed) 
      
98.1 
 KJ413565.1|A/blue-winged teal/LA/AI13-1334/2013(H4N2) 
       
98.2 
CY122499.1|A/environment/California/NWRC183970-18/2006(H4N2) 
       
98.1 
CY122503.1|A/environment/New Mexico/NWRC184137-06/2006(H4N2) 
       
98.0 
CY053821.1|A/pekin duck/California/P30/2006(H4N2) 
       
97.5 
CY122536.1|A/environment/Utah/NWRC186341-12/2007(H4N2) 
       
97.4 
KM244114.1|A/turkey/Minnesota/16423-3/2014(H4N2) 
       
97.4 
CY122546.1|A/environment/Colorado/NWRC186600-24/2007(H4N2) 
       
97.4 
KF986862.1|A/quail/California/D113023808/2012(H4N2) 
       
96.4 
CY005968.1|A/mallard duck/ALB/291/1977(H4N1) 
       
86.9 





















CY033444.1|A/American green-winged teal/California/HKWF609/2007(H5N2)   98.6 97.1 
 CY096704.1|A/blue-winged teal/Guatemala/CIP049-08/2010(H5N3)  98.3 96.8 
 CY094181.1|A/mallard/California/8834/2008(H5N9)  98.3 96.7 
 GQ923253.1|A/avian/Missouri/466554-6/2006(H5N2)   98.3 96.7 
 CY096720.1|A/blue-winged teal/Guatemala/CIP049-09/2010(H5N3)  98.3 96.7 
 CY167175.1|A/American green-winged teal/Mississippi/12OS191/2012(H5N3)  98.2 96.7 
 CY133153.1|A/American green-winged teal/Wisconsin/10OS3127/2010(H5N2)  98.2 96.6 
 CY133785.1|A/mallard/Missouri/10MO084/2010(H5N9)  98.1 
  CY096680.1|A/blue-winged teal/Guatemala/CIP049-13/2010(H5N4)  98.0 96.5 
 CY096672.1|A/blue-winged teal/Guatemala/CIP049-12/2010(H5N4)  97.9 96.4 
 CY133909.1|A/northern shoveler/California/2815/2011(H5N2)  
 
96.6 















CY166637.1|A/American green-winged teal/Wisconsin/11OS3431/2011(H5N2)  
  
99.5 
























CY097317.1|A/mallard/Wisconsin/4236/2009(mixed)  98.5 
 CY132821.1|A/American green-winged teal/Mississippi/11OS98/2011(mixed)  98.3 
 CY133177.1|A/northern shoveler/Wisconsin/10OS3226/2010(H7N3)  98.2 
 CY133323.1|A/mallard/Wisconsin/10OS3232/2010(mixed)  98.2 
 CY133777.1|A/mallard/Missouri/10MO053/2010(H7N4)  98.2 
 CY097622.1|A/mallard/Missouri/220/2009(H7N3)  98.1 
 CY079412.1|A/northern shoveler/Mississippi/09OS643/2009(H7N7)  98.0 
 CY079308.1|A/American green-winged teal/Mississippi/09OS046/2009(H7N7)  98.0 
 CY132501.1|A/mallard/Ohio/11OS2033/2011(H7N8)  98.0 
 CY132509.1|A/mallard/Ohio/11OS2010/2011(H7N8)  98.0 
 KJ527614.1|A/blue-winged teal/Ohio/13OS1770/2013(H7N3)   
 
98.8 






CY133669.1|A/American green-winged teal/Mississippi/11OS250/2011(H7N3)  
 
98.3 
CY167232.1|A/American green-winged teal/Mississippi/12OS397/2012(H7N7)  
 
98.2 
CY167248.1|A/northern pintail/Mississippi/12OS420/2012(mixed)  
 
98.2 
CY167208.1|A/northern shoveler/Mississippi/12OS347/2012(H7N7)  
 
98.2 
CY167224.1|A/northern shoveler/Mississippi/12OS362/2012(H7N7)  
 
98.2 
CY167143.1|A/northern shoveler/Arkansas/12OS158/2012(H7N1)  
 
98.1 



























CY134407.1|A/cinnamon teal/California/225/2011(H11N9)  99.0 99.2 98.7 98.4 
CY186903.1|A/blue-winged teal/Ohio/12OS2152/2012(H11N9)  98.7 
 
98.0 97.7 
CY078050.1|A/mallard/Minnesota/Sg-00118/2007(H11N9)  98.6 98.8 98.1 97.8 
CY078130.1|A/mallard/Minnesota/Sg-00177/2007(H11N9)  98.6 98.8 98.1 97.8 
CY097566.1|A/mallard/Illinois/4179/2009(H11N9)  98.5 98.6 
  CY097066.1|A/common goldeneye/Iowa/3192/2009(H11N9)  98.5 98.8 98.2 98.0 
CY078154.1|A/mallard/Minnesota/Sg-00198/2007(H11N9)  98.5 98.7 
  CY133505.1|A/mallard/Illinois/10OS4130/2010(H11N2)  98.4 98.6 
  CY132859.1|A/mallard/Illinois/10OS3249/2010(H11N2)  98.4 
   KF542875.1|A/Anas acuta/New Mexico/A00629381/2008(H11N9)   98.2 98.5 97.8 97.6 
CY141009.1|A/mallard/Arkansas/AI09-5663/2009(H11N9)  
 
98.7 98.1 98.0 
CY133117.1|A/bufflehead/Wisconsin/10OS3214/2010(mixed)  
 














CY033700.|A/mallard duck/Minnesota/Sg-00055/2007(H12N5)   98.3 
CY064065.2|A/mallard/Minnesota/Sg-00055/2007(H12N5)  98.3 
CY097646.1|A/mallard/Ohio/1688/2009(H12N5)  98.1 
CY122508.1|A/environment/Nebraska/NWRC184928-24/2007(H12N5)  98.6 
CY130372.1|A/mallard/Interior Alaska/10BM02111R0/2010(H12N5)  99.4 
CY132850.1|A/mallard/Illinois/10OS3248/2010(mixed)  98.8 
CY134279.1|A/mallard/California/2595P/2011(H12N5)  98.6 
CY134287.1|A/mallard/California/2595V/2011(H12N5)  98.6 
CY186871.1|A/blue-winged teal/Ohio/12OS2140/2012(H12N5)  98.8 















































CY167267.1|A/northern shoveler/Mississippi/12OS456/2012(H14N2)  99.4 98.0 98.1 98.0 98.3 98.3 98.3 98.1 
KJ195668.1|A/blue-winged teal/Guatemala/CIP049H106-62/2011(H14N6)   99.3 98.1 98.3 98.1 98.3 98.3 98.4 98.3 
CY146897.1|A/northern shoveler/California/2696/2011(H14N2)  99.3 98.0 98.1 98.0 98.3 98.3 98.3 98.1 
CY167126.1|A/northern shoveler/Arkansas/12OS112/2012(mixed)  99.2 97.9 98.0 97.9 98.1 98.1 98.2 98.0 
KJ195676.1|A/blue-winged teal/Guatemala/CIP049H105-15/2011(H14N3)   99.2 98.1 98.1 98.0 98.2 98.2 98.3 98.1 
KF986854.1|A/blue-winged teal/TX/AI13-1028/2013(H14N5)   98.4 98.2 98.3 98.2 98.3 98.3 98.5 98.3 
CY133381.1|A/northern shoveler/Missouri/10OS4673/2010(H14N6)  97.8 96.6 96.7 96.6 96.9 96.9 96.9 96.7 
JN696316.2|A/long-tailed duck/Wisconsin/10OS4225/2010(H14N6)   97.1 96.0 96.1 95.9 96.2 96.2 96.2 96.1 
JN696315.2|A/white-winged scoter/Wisconsin/10OS3922/2010(mixed)   97.1 95.9 96.0 95.9 96.1 96.1 96.2 96.0 
JN696314.2|A/long-tailed duck/Wisconsin/10OS3912/2010(H14N6)   97.1 95.9 96.0 95.9 96.1 96.1 96.2 




Table 0.3. Top ten BLAST hits for the NA genes of the viruses isolated from wintering waterfowl in Guatemala, 2010-2013. 
 
 
























































CY167251.1|A/northern pintail/Mississippi/12OS420/2012(mixed) 99.4 99.5 99.4 99.1 99.0 99.1 99.3   99.3 98.8   





 CY133155.1|A/American green-winged teal/Wisconsin/10OS3127/2010(H5N2) 99.3 99.4 99.4 99.0 99.1 99.2 
   
98.7 
 CY140995.1|A/blue-winged teal/Louisiana/AI09-5234/2009(H11N2) 99.2 99.4 99.3 99.0 98.9 99.0 99.5 99.4 99.4 99.0 
 CY132824.1|A/American green-winged teal/Mississippi/11OS98/2011(mixed) 99.2 99.4 99.3 99.0 98.9 99.0 
     CY167269.1|A/northern shoveler/Mississippi/12OS456/2012(H14N2) 99.2 99.3 99.2 98.9 98.8 
   
99.2 
  CY096626.1|A/blue-winged teal/Guatemala/CIP049-10/2009(H11N2) 99.1 99.3 99.2 98.8 98.8 98.7 99.3 99.1 99.2 98.8 
 CY096642.1|A/blue-winged teal/Guatemala/CIP049-03/2009(H11N2) 99.1 99.3 99.2 98.8 
 
98.7 99.3 99.1 99.2 98.8 
 CY096634.1|A/blue-winged teal/Guatemala/CIP049-11/2009(H11N2) 98.9 99.1 99.1 98.8 
 
98.7 99.2 99.1 99.2 98.8 
 CY033446.1|A/American green-winged teal/California/HKWF609/2007(H5N2) 98.8 99.0 
   
98.4 98.8 98.7 98.8 98.4 
 CY120589.1|A/mallard/California/2396/2010(H5N2) 
  
99.2 98.9 98.8 
    
98.8 
 CY177031.1|A/northern shoveler/California/3769/2012(H6N2) 
    
99.4 99.5 
     CY177055.1|A/bufflehead/California/4935/2012(H11N2) 
    
99.2 99.2 
     CY166260.1|A/northern pintail/Wisconsin/11OS4111/2011(H6N2) 
      
99.5 99.4 99.4 
  CY133803.1|A/mallard/Missouri/10MO0253/2010(H1N2) 
      
99.5 99.4 99.4 
  CY133458.1|A/American wigeon/Iowa/10OS2748/2010(H2N2) 
      
99.2 99.2 99.2 98.8 
 CY132183.1|A/mallard/Ohio/11OS2213/2011(H11N2) 
       
99.2 
   KJ413567.1|A/blue-winged teal/LA/AI13-1334/2013(H4N2) 
          
98.7 
KM244116.1|A/turkey/Minnesota/16423-3/2014(H4N2) 
          
98.4 
CY097754.1|A/mallard/Mississippi/407/2010(mixed) 
          
98.0 
CY053823.1|A/pekin duck/California/P30/2006(H4N2) 
          
97.5 
CY004785.1|A/mallard duck/ALB/354/1978(H4N2) 
          
91.7 
CY014560.1|A/mallard duck/Alberta/205/1978(H6N2) 
          
91.6 
CY004045.1|A/pintail duck/ALB/367/1978(H6N2) 
          
91.6 
CY004001.1|A/mallard duck/ALB/250/1978(H6N2) 
          
91.6 
CY004050.1|A/blue-winged teal/ALB/651/1978(H6N2) 
          
91.6 



































































CY132991.1|A/American green-winged teal/Illinois/10OS3343/2010(H2N3) 98.5 
 
97.8 97.9 
        CY097336.1|A/mallard/Wisconsin/2560/2009(H2N3) 98.3 99.2 
  
98.9 98.7 99.0 98.7 98.7 98.7 98.8 98.7 
CY096996.1|A/blue-winged teal/Wisconsin/2572/2009(H2N3) 98.2 99.1 
         
98.7 
CY097376.1|A/mallard/Wisconsin/2785/2009(H2N3) 98.1 99.0 
          CY039598.1|A/northern shoveler/California/HKWF2031/2008(H7N3) 97.9 98.2 97.4 97.5 98.2 98.1 98.3 98.1 98.1 98.1 98.1 
 CY097320.1|A/mallard/Wisconsin/4236/2009(mixed) 97.8 98.5 97.3 97.3 99.2 99.0 99.2 99.0 99.0 98.8 99.0 99.0 
CY039542.1|A/green winged teal/California/AKS1370/2008(H7N3) 97.7 98.1 97.2 97.3 
        CY125730.1|A/Mexico/InDRE7218/2012(H7N3) 97.7 
 
99.0 97.9 
        CY032730.1|A/northern shoveler/California/HKWF979/2007(H3N3) 97.7 98.1 97.1 97.2 
        EU500862.1|A/chicken/SK/HR-00011/2007(H7N3) 97.6 97.9 96.9 97.0 
        KJ413442.1|A/blue-winged teal/TX/AI12-614/2012(H10N3) 
  
99.4 98.2 
        CY166180.1|A/mallard/Mississippi/12OS445/2012(H10N3) 
  
99.3 98.1 
        JX317626.1|A/chicken/Jalisco/CPA1/2012(H7N3) 
  
99.2 98.0 
        CY141019.1|A/mallard/Arkansas/AI09-5761/2009(H2N3) 
 
98.8 




99.2 99.1 99.3 99.1 99.1 98.9 99.0 99.0 
KJ413543.1|A/blue-winged teal/TX/AI13-1009/2013(H11N3) 
    
99.7 99.5 99.4 99.5 99.5 99.4 99.3 99.5 
CY167194.1|A/American green-winged teal/Mississippi/12OS311/2012(H5N3) 
    
99.6 99.4 99.7 99.4 99.4 99.2 99.4 99.4 
KJ527616.1|A/blue-winged teal/Ohio/13OS1770/2013(H7N3) 
    
99.5 99.4 99.6 99.4 99.4 99.2 99.3 99.3 
CY177047.1|A/mallard/California/3956/2012(H7N3) 
    
99.4 99.3 99.5 99.3 99.3 99.1 99.2 99.2 
CY097624.1|A/mallard/Missouri/220/2009(H7N3) 
    
99.0 98.9 99.1 98.9 98.9 98.7 98.8 98.9 
KJ568347.1|A/blue-winged teal/Iowa/13OS2316/2013(H7N3) 
    





































































CY167177.1|A/American green-winged teal/Mississippi/12OS191/2012(H5N3) 99.7 99.8 99.7 99.6 
       CY157019.1|A/mallard/California/3435/2012(H2N3) 99.6 99.7 99.6 99.4 
       CY157152.1|A/mallard/California/2837/2012(H2N3) 99.6 99.7 99.6 99.4 
       CY157248.1|A/mallard/California/2997/2012(H2N3) 99.6 99.7 99.6 99.4 
       CY157424.1|A/mallard/California/3310/2012(H2N3) 99.6 99.7 99.6 99.4 
       CY157176.1|A/mallard/California/2840/2012(H2N3) 99.5 99.6 99.5 99.4 
       CY157408.1|A/mallard/California/3223/2012(H2N3) 99.5 99.6 99.5 99.4 
       CY157448.1|A/mallard/California/3381/2012(H2N3) 99.5 99.6 99.5 99.4 
       CY157472.1|A/mallard/California/3430/2012(H2N3) 99.5 99.6 99.5 99.4 
       CY157577.1|A/mallard/California/3078/2012(H2N3) 99.5 99.6 99.5 99.4 
       KJ195678.1|A/blue-winged teal/Guatemala/CIP049H105-15/2011(H14N3) 
    
99.8 99.9 99.8 98.8 99.3 98.4 
 CY167186.1|A/northern shoveler/Mississippi/12OS231/2012(mixed) 
    
99.5 99.6 99.6 98.8 99.2 
  CY133418.1|A/northern shoveler/Missouri/10OS4750/2010(H7N3) 
    
99.4 99.4 99.4 98.5 99.2 98.5 
 CY185947.1|A/blue-winged teal/Louisiana/AI11-2911/2011(H7N3) 
    
99.4 99.4 99.4 98.5 99.0 
  CY186742.1|A/blue-winged teal/Illinois/12OS2951/2012(H11N3) 
    
99.4 99.4 99.4 98.4 
   CY097736.1|A/northern shoveler/Mississippi/397/2010(H1N3) 
    
99.3 99.4 99.4 98.5 99.1 98.6 
 CY133391.1|A/northern shoveler/Missouri/10OS4700/2010(mixed) 
    
99.3 99.4 99.4 98.5 99.1 98.6 
 CY133410.1|A/gadwall/Missouri/10OS4731/2010(H7N3) 
    
99.3 99.4 99.4 98.5 99.1 98.6 
 CY186991.1|A/northern shoveler/Ohio/12OS5647/2012(H2N3) 
    
99.2 99.2 99.2 98.3 99.8 
  CY133039|A/American green-winged teal/Illinois/10OS4014/2010(H7N3) 
    
99.2 
      CY133039.1|A/American green-winged teal/Illinois/10OS4014/2010(H7N3) 
     
99.2 99.2 98.5 99.0 
  CY133731.1|A/northern shoveler/Mississippi/11OS289/2011(H7N3) 
        
98.8 
  CY130390.1|A/northern pintail/Interior Alaska/10BM02539R0/2010(H7N3) 
         
99.1 
 CY094575.1|A/green-winged teal/California/1841/2009(H7N3) 
         
99.0 
 CY120565.1|A/mallard/California/1438/2010(H2N3) 
         
98.9 
 CY094463.1|A/green-winged teal/California/11275/2008(H7N3) 
         
98.8 
 CY039582.1|A/northern shoveler/California/HKWF1026/2007(H7N3) 






N3 (cont) % Identity 
CY134329.1|A/mallard/California/2961/2011(H2N3) 
          
99.4 
CY135723.1|A/mallard/Interior Alaska/10BM05347R0/2010(H7N3) 
          
99.4 
CY141533.1|A/mallard/Interior Alaska/10BM07066R0/2010(H7N3) 
          
99.4 
CY141688.1|A/northern pintail/Interior Alaska/10BM08586R0/2010(H7N3) 
          
99.4 
CY141776.1|A/mallard/Interior Alaska/10BM09563R0/2010(H7N3) 
          
99.4 
CY141800.1|A/mallard/Interior Alaska/10BM09818R0/2010(H7N3) 
          
99.4 
CY141808.1|A/northern pintail/Interior Alaska/10BM09832R0/2010(H7N3) 
          
99.4 
CY141816.1|A/northern pintail/Interior Alaska/10BM10166R0/2010(H7N3) 
          
99.4 
CY141824.1|A/mallard/Interior Alaska/10BM10324R0/2010(H7N3) 
          
99.4 

















CY132783.1|A/northern shoveler/Illinois/10OS3632/2010(mixed) 99.0 99.0 
CY166164.1|A/mallard/Wisconsin/11OS4489/2011(H8N4) 98.6 98.6 
CY166941.1|A/blue-winged teal/Missouri/11OS2563/2011(H12N4) 98.6 98.6 
CY166128.1|A/northern shoveler/Wisconsin/11OS4631/2011(mixed) 98.5 98.5 
CY167014.1|A/mallard/Illinois/11OS4421/2011(mixed) 98.3 98.3 
CY096666.1|A/blue-winged teal/Guatemala/CIP049-06/2010(H8N4) 97.9 97.9 
CY096682.1|A/blue-winged teal/Guatemala/CIP049-13/2010(H5N4) 97.9 97.9 
CY096674.1|A/blue-winged teal/Guatemala/CIP049-12/2010(H5N4) 97.8 97.8 
CY096714.1|A/blue-winged teal/Guatemala/CIP049-15/2010(H8N4) 97.8 97.8 






















CY130226.1|A/northern pintail/Interior Alaska/10BM02561R0/2010(H12N5) 99.5 
 CY143847.1|A/northern pintail/Interior Alaska/10BM10556R0/2010(mixed) 99.5 
 CY130374.1|A/mallard/Interior Alaska/10BM02111R0/2010(H12N5) 99.4 
 KM244062.1|A/guinea fowl/Massachusetts/14075-3/2013(H12N5) 99.0 
 CY096952.1|A/northern shoveler/Illinois/3767/2009(mixed) 98.8 
 CY097640.1|A/northern pintail/Missouri/319/2009(H12N5) 98.8 
 CY120557.1|A/mallard/California/1390/2010(H7N5) 98.5 
 CY064067.2|A/mallard/Minnesota/Sg-00055/2007(H12N5) 98.3 
 CY134281.1|A/mallard/California/2595P/2011(H12N5) 98.3 




CY166631.1|A/American green-winged teal/Wisconsin/11OS3425/2011(H12N5) 
 
99.0 
CY186849.1|A/American green-winged teal/Ohio/12OS2128/2012(H6N5) 
 
98.6 










































N8 % Identity 
Accession|Virus name H101-24 H102-10 H102-23 H109-38 H112-60 H114-14 
CY133571.1|A/blue-winged teal/Iowa/10OS2411/2010(H3N8) 99.3 
     CY133763.1|A/blue-winged teal/Missouri/10MO021/2010(H3N8) 99.2 
     CY166559.1|A/northern shoveler/Wisconsin/11OS3013/2011(H4N8) 98.9 
     CY166957.1|A/blue-winged teal/Missouri/11OS2585/2011(H4N8) 98.9 
     CY132919.1|A/American green-winged teal/Illinois/10OS1598/2010(H4N8) 98.9 
     CY140838.1|A/blue-winged Teal/Texas/AI09-3464/2009(H4N8) 98.8 
     CY140593.1|A/mallard/Minnesota/Sg-01042/2008(H6N8) 98.3 
     CY132412.1|A/mallard/Ohio/11OS1982/2011(mixed) 98.1 
     CY128477.1|A/mallard/Nova Scotia/02445/2007(mixed) 98.1 
     CY128760.1|A/American black duck/New Brunswick/02375/2007(H4N8) 98.1 
     CY132951.1|A/mallard/Wisconsin/10OS2773/2010(H3N8) 
 
99.5 
    CY132959.1|A/wood duck/Wisconsin/10OS2778/2010(H3N8) 
 
99.5 
    CY166284.1|A/mallard/Illinois/11OS5564/2011(H1N8) 
 
99.5 
    CY133325.1|A/mallard/Wisconsin/10OS3232/2010(mixed) 
 
99.3 
    CY187015.1|A/gadwall/Ohio/12OS2222/2012(H3N8) 
 
99.3 
    CY187023.1|A/American black duck/Ohio/12OS5510/2012(H3N8) 
 
99.3 
    KJ567907.1|A/blue-winged teal/Iowa/13OS2346/2013(H3N8) 
 
99.1 
    KJ568275.1|A/blue-winged teal/Iowa/13OS2345/2013(H3N8) 
 
99.1 
    CY139405.1|A/mallard/New Brunswick/00913/2010(mixed) 
 
99.0 
    KJ568123.1|A/American green-winged teal/Wisconsin/13OS3465/2013(H6N8) 
 
99.0 
    CY132029.1|A/mallard/Ohio/11OS2201/2011(mixed) 
  
99.1 
   CY132041.1|A/mallard/Ohio/11OS2208/2011(mixed) 
  
99.1 
   CY132332.1|A/mallard/Ohio/11OS2153/2011(H3N8) 
  
99.0 
   CY140771.1|A/mallard/Minnesota/AI09-3047/2009(mixed) 
  
99.0 
   CY166973.1|A/blue-winged teal/Missouri/11OS2640/2011(H4N8) 
  
98.9 
   CY132015.1|A/mallard/Ohio/11OS2138/2011(mixed) 
  
98.9 
   CY186758.1|A/blue-winged teal/Missouri/12OS2519/2012(H4N8) 
  
98.7 
   KJ527632.1|A/blue-winged teal/Ohio/13OS1759/2013(H4N8) 
  
98.4 
   KJ568115.1|A/American green-winged teal/Ohio/13OS2084/2013(H6N8) 
  
98.0 
   KJ568307.1|A/American green-winged teal/Ohio/13OS2086/2013(H6N8) 
  
98.0 
   CY073722.1|A/surface water/Minnesota/W07-2241/2007(H3N8) 
   
98.9 
  KJ568179.1|A/blue-winged teal/Ohio/13OS2018/2013(H3N8) 
   
98.6 
  KJ568267.1|A/blue-winged teal/Ohio/13OS3827/2013(H3N8) 






N8 % Identity 
KJ568363.1|A/American green-winged teal/Ohio/13OS2108/2013(H3N8) 
   
98.6 
  KJ568403.1|A/wood duck/Ohio/13OS3300/2013(H3N8) 
   
98.6 
  KJ568099.1|A/American green-winged teal/Ohio/13OS2106/2013(H3N8) 
   
98.6 
  KJ567899.1|A/blue-winged teal/Iowa/13OS2368/2013(H4N8) 
   
98.4 
  KJ568027.1|A/blue-winged teal/Ohio/13OS1783/2013(H4N8) 
   
98.4 
  KJ568155.1|A/blue-winged teal/Iowa/13OS2349/2013(H4N8) 
   
98.4 
  KJ568195.1|A/American green-winged teal/Ohio/13OS1775/2013(H4N8) 
   
98.4 
  CY076167.1|A/American coot/Oregon/20589-007/2007(H3N8) 
    
98.3 99.0 
CY097704.1|A/mallard/Mississippi/354/2010(H3N8) 
    
98.1 98.7 
CY032722.1|A/northern pintail/California/HKWF792/2007(H3N8) 
    
98.1 98.7 
CY097728.1|A/mallard/Mississippi/390/2010(H3N8) 
    
98.1 98.7 
CY097712.1|A/mallard/Mississippi/360/2010(H3N8) 
    
98.0 98.6 
CY097720.1|A/mallard/Mississippi/386/2010(H3N8) 
    
98.0 98.6 
CY097129.1|A/mallard/Ohio/2039/2009(mixed) 
    
97.9 98.6 
CY076015.1|A/cinnamon teal/California/44287-325/2007(H3N8) 
    
97.8 98.5 
CY097680.1|A/American green-winged teal/Mississippi/285/2010(H3N8) 
    
97.8 98.5 










CY133483.1|A/northern shoveler/Illinois/10OS4360/2010(mixed) 98.9 
CY133643.1|A/American green-winged teal/Mississippi/11OS90/2011(H11N9) 98.9 
CY133651.1|A/northern shoverl/Mississippi/11OS145/2011(H7N9) 98.8 
CY167013.1|A/mallard/Illinois/11OS4421/2011(mixed) 98.8 
CY167120.1|A/mallard/Arkansas/12OS061/2012(H1N9) 98.8 
CY133695.1|A/American green-winged teal/Mississippi/11OS257/2011(H11N9) 98.7 
CY133063.1|A/mallard/Wisconsin/10OS2667/2010(H11N9) 98.7 
CY133787.1|A/mallard/Missouri/10MO084/2010(H5N9) 98.7 
CY166372.1|A/blue-winged teal/Illinois/11OS4176/2011(H11N9) 98.7 




Table 0.4 Sequences used for phylogenetic analysis of the H3N2 swine influenza A viruses retrieved from GISAID  
 
We acknowledge the authors, originating and submitting laboratories of the sequences from GISAID’s EpiFlu™ Database that were used as background data for 
generating the phylogenetic trees of the virus isolated from Guatemala. The list is detailed below. 
 
 
Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
       H3       
       
EPI325849 HA Dominican Republic 2010-Jun-29 A/Santo Domingo/WRAIR3514T/2010 
 
Other Database Import 
EPI325801 HA Mexico 2010-Jan-26 A/Mexico City/WRAIR1752T/2010 
 
Other Database Import 
EPI315772 HA Nicaragua 2010-Jun-07 A/Managua/3209.01/2010 
 
Other Database Import 
EPI315224 HA Nicaragua 2010-Jun-01 A/Managua/1155.01/2010 
 
Other Database Import 
EPI463954 HA Mexico 2008-Dec-01 A/Mexico/24014/2008 
 
Other Database Import 
EPI463946 HA Mexico 2008-Dec-01 A/Mexico/24013/2008 
 
Other Database Import 
EPI463938 HA Mexico 2008-Dec-02 A/Mexico/24012/2008 
 
Other Database Import 
EPI463917 HA Mexico 2008-Nov-01 A/Mexico/24011/2008 
 
Other Database Import 
EPI463901 HA Mexico 2008-Nov-01 A/Mexico/24009/2008 
 
Other Database Import 
EPI463887 HA Mexico 2009-Apr-01 A/Mexico/24008/2009 
 
Other Database Import 
EPI463833 HA Mexico 2008-Nov-01 A/Mexico/24003/2008 
 
Other Database Import 
EPI277421 HA Nicaragua 2010-Jun-10 A/Managua/2867.01/2010 
 
Other Database Import 
EPI178230 HA Nicaragua 2007-Jun-05 A/Managua/4348.01/2007 
 
Other Database Import 
EPI176959 HA Australia 2007-Jan-01 A/Brisbane/10/2007 
 
Other Database Import 
EPI173816 HA Nicaragua 2007-Aug-03 A/Managua/4902.01/2007 
 
Other Database Import 
EPI154444 HA Nicaragua 2007-Jun-27 A/Managua/25/2007 
 
Other Database Import 
EPI154122 HA Nicaragua 2007-Jun-12 A/Managua/33/2007 
 
Other Database Import 
EPI154098 HA Nicaragua 2007-Jun-23 A/Managua/34/2007 
 
Other Database Import 
EPI154074 HA Nicaragua 2007-Jun-22 A/Managua/29/2007 
 
Other Database Import 
EPI154034 HA Nicaragua 2007-Jun-22 A/Managua/20/2007 
 
Other Database Import 
EPI309767 HA Guadeloupe 2010-Nov-30 A/GUADELOUPE/202/2010 
Centers for Disease Control and 
Prevention 
WHO Collaborating 
Centre for Reference 
and Research on 
Influenza 
EPI309389 HA Mexico 2010-Nov-04 A/Mexico/6998/2010 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI301119 HA Mexico 2010-Aug-13 A/Mexico/4268/2010 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI295227 HA Mexico 2010-Aug-31 A/Mexico/4674/2010 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI295208 HA Mexico 2010-Aug-27 A/Mexico/4391/2010 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI243572 HA Mexico 2009-Aug-07 A/Mexico/5216/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI459841 HA El Salvador 2013-Mar-18 A/El Salvador/433/2013 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI347486 HA El Salvador 2011-Sep-21 A/El Salvador/1513/2011 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI295104 HA El Salvador 2010-Aug-31 A/El Salvador/1103/2010 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI279985 HA El Salvador 2010-Aug-06 A/El Salvador/1060/2010 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI278812 HA El Salvador 2010-Jun-08 A/El Salvador/636/2010 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI484551 HA Costa Rica 2013-Jul-23 A/Costa Rica/4009/2013 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI397057 HA Costa Rica 2012-Jul-17 A/Costa Rica/9093/2012 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI349761 HA Costa Rica 2011-Nov-11 A/Costa Rica/8211/2011 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI211317 HA Costa Rica 2009-Jun-05 A/Costa Rica/5179/2009 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI395233 HA Dominican Republic 2012-Jun-04 A/Dominican Republic/6524/2012 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI279996 HA Dominican Republic 2010-Aug-03 A/Dominican Republic/4389/2010 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI254592 HA Dominican Republic 2009-Dec-04 A/Dominican Republic/3743/2009 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI211266 HA Dominican Republic 2009-May-25 A/Dominican Republic/988/2009 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI378216 HA Puerto Rico 2011-Dec-07 A/Puerto Rico/38/2011 
Centers for Disease Control and 
Prevention 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI377477 HA Puerto Rico 2011-Nov-20 A/Puerto Rico/36/2011 
Centers for Disease Control and 
Prevention 
Centers for Disease 
Control and Prevention 
EPI513286 HA Australia 2011-Oct-24 A/Victoria/361/2011 
WHO Collaborating Centre for 
Reference and Research on 
Influenza 
Centers for Disease 
Control and Prevention 
EPI211334 HA Australia 2009-Jan-01 A/Perth/16/2009 
WHO Collaborating Centre for 
Reference and Research on 
Influenza 
Centers for Disease 
Control and Prevention 
EPI468141 HA Guatemala 2013-Jul-09 A/Guatemala/287/2013 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI301071 HA Guatemala 2010-Oct-05 A/Guatemala/754/2010 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI295095 HA Guatemala 2010-Sep-02 A/Guatemala/690/2010 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI211337 HA Guatemala 2009-Jun-15 A/Guatemala/1913/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI193980 HA Guatemala 2009-Jul-09 A/Guatemala/29/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI193924 HA Guatemala 2009-Jun-03 A/Guatemala/1066/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI232463 HA Haiti 2009-Jul-01 A/Haiti/66/2009 
Laboratoire National de Sante 
Publique 
Centers for Disease 
Control and Prevention 
EPI193974 HA Honduras 2009-Jun-30 A/Honduras/2243/2009 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI185779 HA Honduras 2009-May-05 A/Honduras/56/2009 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI465947 HA Nicaragua 2013-May-07 A/Esteli/816/2013 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI396164 HA Nicaragua 2012-Jul-10 A/Managua/726.03/2012 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI497653 HA Trinidad and Tobago 2013-Oct-27 A/Trinidad/3558/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI459823 HA Trinidad and Tobago 2013-Mar-19 A/Trinidad/1117/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI459805 HA Dominica 2013-Jan-21 A/Dominica/653/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI459802 HA Anguilla 2013-Jan-10 A/Anguilla/104/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI394812 HA Bermuda 2012-Jun-13 A/Bermuda/1915/2012 Caribbean Epidemiology Center 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI326251 HA Anguilla 2011-Jan-24 A/Anguilla/273/2011 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI232523 HA Cayman Islands 2009-Oct-22 A/Cayman Islands/9266/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI185785 HA Jamaica 2009-Apr-28 A/Jamaica/2970/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI537015 HA United States 2012-Apr-15 A/Texas/50/2012 
Texas Department of State 
Health Services-Laboratory 
Services 
Centers for Disease 
Control and Prevention 
EPI397054 HA Puerto Rico 2012-Jun-27 A/Puerto Rico/36/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI394790 HA Puerto Rico 2012-Jun-26 A/Puerto Rico/34/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI394787 HA Puerto Rico 2012-Jun-14 A/Puerto Rico/23/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI391271 HA Puerto Rico 2012-Jun-11 A/Puerto Rico/08/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI387763 HA Puerto Rico 2012-Jun-03 A/Puerto Rico/04/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI371957 HA Puerto Rico 2012-Mar-02 A/Puerto Rico/02/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI371811 HA Puerto Rico 2012-Feb-12 A/Puerto Rico/03/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI353489 HA Puerto Rico 2011-Nov-26 A/Puerto Rico/30/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI347536 HA Puerto Rico 2011-Oct-20 A/Puerto Rico/23/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI295256 HA Puerto Rico 2010-Sep-24 A/Puerto Rico/01/2010 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI193918 HA Puerto Rico 2009-Jun-02 A/Puerto Rico/46/2009 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI193906 HA Puerto Rico 2009-May-26 A/Puerto Rico/25/2009 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI185802 HA Puerto Rico 2009-Feb-09 A/Puerto Rico/18/2009 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI185949 HA Trinidad and Tobago 2009-Jan-01 A/Trinidad/2940/2009 
 
Centers for Disease 
Control and Prevention 
EPI172432 HA Costa Rica 2008-Jun-19 A/Costa Rica/7172/2008 
 
Centers for Disease 
Control and Prevention 
EPI163130 HA Guatemala 2008-May-19 A/Guatemala/494/2008 
 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI162156 HA Nicaragua 2007-Jan-01 A/Managua/2760.01/2007 
 
Centers for Disease 
Control and Prevention 
EPI162130 HA Mexico 2008-Jan-17 A/Mexico/499/2008 
 
Centers for Disease 
Control and Prevention 
EPI157966 HA Mexico 2007-Oct-18 A/Mexico/3701/2007 
 
Centers for Disease 
Control and Prevention 
EPI162124 HA Mexico 2007-Oct-18 A/Mexico/3701/2007 
 
Centers for Disease 
Control and Prevention 
EPI157956 HA Martinique 2007-Feb-09 A/Martinique/12/2007 
 
Centers for Disease 
Control and Prevention 
EPI162123 HA Martinique 2007-Feb-09 A/Martinique/12/2007 
 
Centers for Disease 
Control and Prevention 
EPI157670 HA Honduras 2007-Oct-11 A/Honduras/6453/2007 
 
Centers for Disease 
Control and Prevention 
EPI162072 HA Honduras 2007-Oct-11 A/Honduras/6453/2007 
 
Centers for Disease 
Control and Prevention 
EPI157664 HA Honduras 2007-Oct-05 A/Honduras/6374/2007 
 
Centers for Disease 
Control and Prevention 
EPI162066 HA Honduras 2007-Oct-05 A/Honduras/6374/2007 
 
Centers for Disease 
Control and Prevention 
EPI157579 HA El Salvador 2007-Sep-03 A/El Salvador/579/2007 
 
Centers for Disease 
Control and Prevention 
EPI161999 HA El Salvador 2007-Sep-03 A/El Salvador/579/2007 
 
Centers for Disease 
Control and Prevention 
EPI157551 HA Costa Rica 2007-May-25 A/Costa Rica/4082/2007 
 
Centers for Disease 
Control and Prevention 
EPI161990 HA Costa Rica 2007-May-25 A/Costa Rica/4082/2007 
 
Centers for Disease 
Control and Prevention 
EPI155856 HA Dominica 2007-Feb-25 A/Dominican Republic/2896/2007 
 
Centers for Disease 
Control and Prevention 
EPI155503 HA Costa Rica 2007-Jan-05 A/Costa Rica/176/2007 
 
Centers for Disease 
Control and Prevention 
EPI155501 HA Costa Rica 2006-Nov-09 A/Costa Rica/7322/2006 
 
Centers for Disease 
Control and Prevention 
EPI155203 HA Honduras 2006-Oct-01 A/Honduras/1922/2006 
 
Centers for Disease 
Control and Prevention 
EPI342275 HA Guadeloupe 2010-Nov-30 A/Guadeloupe/201/2010 
National Influenza Center 
French Guiana and French Indies 
Centers for Disease 
Control and Prevention 
EPI326288 HA Guatemala 2011-May-25 A/Guatemala/199/2011 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI326291 HA Guatemala 2011-Mar-02 A/Guatemala/51/2011 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI340921 HA Guatemala 2011-Sep-02 A/Guatemala/453/2011 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI342193 HA Guatemala 2010-Jul-13 A/Guatemala/591/2010 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI346446 HA El Salvador 2011-Oct-03 A/El Salvador/1571/2011 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI331240 HA Mexico 2011-Apr-08 A/Mexico/2554/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI325913 HA Mexico 2010-Dec-22 A/Mexico City/WRAIR3570T/2010 
 
Other Database Import 
EPI325921 HA Mexico 2010-Dec-22 A/Mexico City/WRAIR3570T/2010 
 
Other Database Import 
EPI336107 HA Mexico 2008-Jan-14 A/Mexico/UASLP-012/2008 
 
Other Database Import 
EPI336112 HA Mexico 2008-Jan-10 A/Mexico/UASLP-011/2008 
 
Other Database Import 
       
N2       
 
EPI154036 NA Nicaragua 2007-Jun-22 A/Managua/20/2007 
 
Other Database Import 
EPI154068 NA Nicaragua 2007-Jun-21 A/Managua/16/2007 
 
Other Database Import 
EPI154100 NA Nicaragua 2007-Jun-23 A/Managua/34/2007 
 
Other Database Import 
EPI154140 NA Nicaragua 2007-Jun-11 A/Managua/28/2007 
 
Other Database Import 
EPI154446 NA Nicaragua 2007-Jun-27 A/Managua/25/2007 
 
Other Database Import 
EPI155502 NA Costa Rica 2007-Jan-05 A/Costa Rica/176/2007 
 
Centers for Disease 
Control and Prevention 
EPI155855 NA Dominica 2007-Feb-25 A/Dominican Republic/2896/2007 
 
Centers for Disease 
Control and Prevention 
EPI155857 NA Dominica 2007-Feb-25 A/Dominica/2898/2007 
 
Centers for Disease 
Control and Prevention 
EPI155990 NA Mexico 2007-May-03 A/Mexico/2222/2007 
 
Centers for Disease 
Control and Prevention 
EPI156038 NA Panama 2007-May-22 A/Panama/0475/2007 
 
Centers for Disease 
Control and Prevention 
EPI156056 NA El Salvador 2007-Aug-09 A/El Salvador/428/2007 
 
Centers for Disease 
Control and Prevention 
EPI156058 NA El Salvador 2007-Aug-15 A/El Salvador/507/2007 
 
Centers for Disease 
Control and Prevention 
EPI157580 NA El Salvador 2007-Sep-03 A/El Salvador/579/2007 
 
Centers for Disease 
Control and Prevention 
EPI161998 NA El Salvador 2007-Sep-03 A/El Salvador/579/2007 
 
Centers for Disease 
Control and Prevention 
EPI157586 NA El Salvador 2007-Sep-06 A/El Salvador/590/2007 
 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI162004 NA El Salvador 2007-Sep-06 A/El Salvador/590/2007 
 
Centers for Disease 
Control and Prevention 
EPI157632 NA Guatemala 2007-Aug-18 A/Guatemala/7562/2007 
 
Centers for Disease 
Control and Prevention 
EPI162057 NA Guatemala 2007-Aug-18 A/Guatemala/7562/2007 
 
Centers for Disease 
Control and Prevention 
EPI157659 NA Honduras 2007-Aug-26 A/Honduras/5560/2007 
 
Centers for Disease 
Control and Prevention 
EPI162060 NA Honduras 2007-Aug-26 A/Honduras/5560/2007 
 
Centers for Disease 
Control and Prevention 
EPI157663 NA Honduras 2007-Oct-27 A/Honduras/602/2007 
 
Centers for Disease 
Control and Prevention 
EPI162063 NA Honduras 2007-Oct-27 A/Honduras/602/2007 
 
Centers for Disease 
Control and Prevention 
EPI157665 NA Honduras 2007-Oct-05 A/Honduras/6374/2007 
 
Centers for Disease 
Control and Prevention 
EPI162065 NA Honduras 2007-Oct-05 A/Honduras/6374/2007 
 
Centers for Disease 
Control and Prevention 
EPI157671 NA Honduras 2007-Oct-11 A/Honduras/6453/2007 
 
Centers for Disease 
Control and Prevention 
EPI162071 NA Honduras 2007-Oct-11 A/Honduras/6453/2007 
 
Centers for Disease 
Control and Prevention 
EPI157957 NA Martinique 2007-Feb-09 A/Martinique/12/2007 
 
Centers for Disease 
Control and Prevention 
EPI162122 NA Martinique 2007-Feb-09 A/Martinique/12/2007 
 
Centers for Disease 
Control and Prevention 
EPI160188 NA Nicaragua 2007-Jun-21 A/Managua/17/2007 
 
Other Database Import 
EPI162129 NA Mexico 2008-Jan-17 A/Mexico/499/2008 
 
Centers for Disease 
Control and Prevention 
EPI162165 NA Nicaragua 2007-Jun-13 A/Managua/68.01/2007 
 
Centers for Disease 
Control and Prevention 
EPI163131 NA Guatemala 2008-May-19 A/Guatemala/494/2008 
 
Centers for Disease 
Control and Prevention 
EPI163133 NA Guatemala 2008-May-28 A/Guatemala/545/2008 
 
Centers for Disease 
Control and Prevention 
EPI163228 NA Honduras 2007-Nov-18 A/Honduras/1038/2007 
 
Centers for Disease 
Control and Prevention 
EPI172433 NA Costa Rica 2008-Jun-19 A/Costa Rica/7172/2008 
 
Centers for Disease 
Control and Prevention 
EPI173818 NA Nicaragua 2007-Aug-03 A/Managua/4902.01/2007 
 
Other Database Import 
EPI176127 NA Nicaragua 2007-Jun-24 A/Managua/1507.01/2007 
 
Other Database Import 
EPI176961 NA Australia 2007-Jan-01 A/Brisbane/10/2007 
 
Other Database Import 
EPI178232 NA Nicaragua 2007-Jun-05 A/Managua/4348.01/2007 
 
Other Database Import 
EPI185947 NA Trinidad and Tobago 2009-Jan-01 A/Trinidad/2940/2009 
 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
Control and Prevention 
EPI277439 NA Nicaragua 2010-Jun-08 A/Managua/5806.01/2010 
 
Other Database Import 
EPI463840 NA Mexico 2008-Nov-01 A/Mexico/24003/2008 
 
Other Database Import 
EPI463895 NA Mexico 2009-Apr-01 A/Mexico/24008/2009 
 
Other Database Import 
EPI463940 NA Mexico 2008-Dec-02 A/Mexico/24012/2008 
 
Other Database Import 
EPI463956 NA Mexico 2008-Dec-01 A/Mexico/24014/2008 
 
Other Database Import 
EPI464030 NA Mexico 2009-Apr-27 A/Mexico/24025/2009 
 
Other Database Import 
EPI285244 NA Nicaragua 2010-Jun-05 A/Managua/3192.01/2010 
 
Other Database Import 
EPI285260 NA Nicaragua 2010-Jun-08 A/Managua/5871.02/2010 
 
Other Database Import 
EPI285276 NA Nicaragua 2010-Jun-08 A/Managua/194.01/2010 
 
Other Database Import 
EPI285468 NA Nicaragua 2010-Jun-06 A/Managua/4456.02/2010 
 
Other Database Import 
EPI295198 NA Belize 2010-Jan-01 A/Belize/3715/2010 
 
Centers for Disease 
Control and Prevention 
EPI315766 NA Nicaragua 2010-Jun-06 A/Managua/5898.02/2010 
 
Other Database Import 
EPI315774 NA Nicaragua 2010-Jun-07 A/Managua/3209.01/2010 
 
Other Database Import 
EPI320630 NA Nicaragua 2010-Jul-02 A/Managua/2492.04/2010 
 
Other Database Import 
EPI320638 NA Nicaragua 2010-Jun-30 A/Managua/3424.01/2010 
 
Other Database Import 
EPI320646 NA Nicaragua 2011-Jan-28 A/Managua/38-11/2011 
 
Other Database Import 
EPI325803 NA Mexico 2010-Jan-26 A/Mexico City/WRAIR1752T/2010 
 
Other Database Import 
EPI325875 NA El Salvador 2010-Aug-11 A/San Salvador/WRAIR3537T/2010 
 
Other Database Import 
EPI325915 NA Mexico 2010-Dec-22 A/Mexico City/WRAIR3570T/2010 
 
Other Database Import 
EPI325931 NA Mexico 2010-Nov-22 A/Mexico City/WRAIR3571N/2010 
 
Other Database Import 
EPI325947 NA Mexico 2010-Dec-08 A/Mexico City/WRAIR3578N/2010 
 
Other Database Import 
EPI325963 NA Mexico 2010-Dec-09 A/Mexico City/WRAIR3579N/2010 
 
Other Database Import 
EPI325971 NA Mexico 2010-Dec-09 A/Mexico City/WRAIR3579T/2010 
 
Other Database Import 
EPI336098 NA Mexico 2008-Jan-21 A/Mexico/UASLP-013/2008 
 
Other Database Import 
EPI185801 NA Puerto Rico 2009-Feb-09 A/Puerto Rico/18/2009 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI193907 NA Puerto Rico 2009-May-26 A/Puerto Rico/25/2009 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI193919 NA Puerto Rico 2009-Jun-02 A/Puerto Rico/46/2009 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI295252 NA Puerto Rico 2010-Sep-17 A/Puerto Rico/02/2010 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI346467 NA Puerto Rico 2011-Aug-25 A/Puerto Rico/03/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI347535 NA Puerto Rico 2011-Oct-20 A/Puerto Rico/23/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI387762 NA Puerto Rico 2012-Jun-03 A/Puerto Rico/04/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI394786 NA Puerto Rico 2012-Jun-14 A/Puerto Rico/23/2012 
Puerto Rico Department of 
Health 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI394789 NA Puerto Rico 2012-Jun-26 A/Puerto Rico/34/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI486427 NA Puerto Rico 2013-Sep-15 A/Puerto Rico/19/2013 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI537014 NA United States 2012-Apr-15 A/Texas/50/2012 
Texas Department of State 
Health Services-Laboratory 
Services 
Centers for Disease 
Control and Prevention 
EPI309437 NA Guadeloupe 2010-Oct-20 A/Guadeloupe/129/2010 
National Influenza Center 
French Guiana and French Indies 
Centers for Disease 
Control and Prevention 
EPI342268 NA Guadeloupe 2010-Nov-30 A/Guadeloupe/200/2010 
National Influenza Center 
French Guiana and French Indies 
Centers for Disease 
Control and Prevention 
EPI342274 NA Guadeloupe 2010-Nov-30 A/Guadeloupe/201/2010 
National Influenza Center 
French Guiana and French Indies 
Centers for Disease 
Control and Prevention 
EPI378089 NA Martinique 2012-May-07 A/Martinique/201/2012 
National Influenza Center 
French Guiana and French Indies 
Centers for Disease 
Control and Prevention 
EPI279978 NA Barbados 2010-Aug-11 A/Barbados/170/2010 Public Health Laboratory 
Centers for Disease 
Control and Prevention 
EPI185783 NA Jamaica 2009-Apr-28 A/Jamaica/2970/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI193943 NA Anguilla 2009-Jun-10 A/Anguilla/4711/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI319647 NA Anguilla 2011-Jan-24 A/Anguilla/273/2011 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI391244 NA Dominica 2012-Mar-08 A/Dominica/616/2012 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI391258 NA Saint Lucia 2012-May-24 A/St. Lucia/2073/2012 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI394899 NA Bermuda 2012-Jun-13 A/Bermuda/1915/2012 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI459801 NA Anguilla 2013-Jan-10 A/Anguilla/104/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI459804 NA Dominica 2013-Jan-21 A/Dominica/653/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI459819 NA Trinidad and Tobago 2013-Feb-28 A/Trinidad/847/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI459822 NA Trinidad and Tobago 2013-Mar-19 A/Trinidad/1117/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI459831 NA Barbados 2013-Jan-12 A/Barbados/1031/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI459834 NA Barbados 2013-Feb-13 A/Barbados/4326/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI459843 NA Bermuda 2013-Jan-28 A/Bermuda/521/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
Control and Prevention 
EPI498070 NA Trinidad and Tobago 2013-Oct-27 A/Trinidad/3558/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI278759 NA Panama 2010-Jun-08 A/Panama/307149/2010 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI467431 NA Panama 2013-Jun-17 A/Panama/313131/2013 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI274473 NA Nicaragua 2010-Jun-02 A/Nicaragua/2145/2010 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI466924 NA Nicaragua 2013-Jun-20 A/Managua/1083/2013 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI465946 NA Nicaragua 2013-May-07 A/Esteli/816/2013 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI492693 NA Jamaica 2013-Oct-21 A/Jamaica/200/2013 University of the West Indies 
Centers for Disease 
Control and Prevention 
EPI185777 NA Honduras 2009-May-05 A/Honduras/56/2009 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI185780 NA Honduras 2009-May-06 A/Honduras/639/2009 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI193898 NA Honduras 2009-May-14 A/Honduras/105/2009 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI193975 NA Honduras 2009-Jun-30 A/Honduras/2243/2009 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI211350 NA Honduras 2009-Jul-13 A/Honduras/2426/2009 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI274452 NA Honduras 2010-Apr-13 A/Honduras/6065/2010 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI295258 NA Honduras 2010-Aug-17 A/Honduras/6705/2010 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI232462 NA Haiti 2009-Jul-01 A/Haiti/66/2009 
Laboratoire National de Sante 
Publique 
Centers for Disease 
Control and Prevention 
EPI193925 NA Guatemala 2009-Jun-03 A/Guatemala/1066/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI193981 NA Guatemala 2009-Jul-09 A/Guatemala/29/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI211338 NA Guatemala 2009-Jun-15 A/Guatemala/1913/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI232440 NA Guatemala 2009-Jun-14 A/Guatemala/1839/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI278774 NA Guatemala 2010-Jul-13 A/Guatemala/591/2010 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI295094 NA Guatemala 2010-Sep-02 A/Guatemala/690/2010 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
Guatemala Control and Prevention 
EPI326290 NA Guatemala 2011-Mar-02 A/Guatemala/51/2011 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI468140 NA Guatemala 2013-Jul-09 A/Guatemala/287/2013 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI211335 NA Australia 2009-Jan-01 A/Perth/16/2009 
WHO Collaborating Centre for 
Reference and Research on 
Influenza 
Centers for Disease 
Control and Prevention 
EPI513285 NA Australia 2011-Oct-24 A/Victoria/361/2011 
WHO Collaborating Centre for 
Reference and Research on 
Influenza 
Centers for Disease 
Control and Prevention 
EPI211267 NA Dominican Republic 2009-May-25 A/Dominican Republic/988/2009 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI254585 NA Dominican Republic 2009-Nov-12 A/Dominican Republic/3668/2009 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI278765 NA Dominican Republic 2010-Jul-20 A/Dominican Republic/4319/2010 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI376514 NA Dominican Republic 2012-Apr-13 A/Dominican Republic/6334/2012 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI211318 NA Costa Rica 2009-Jun-05 A/Costa Rica/5179/2009 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI232480 NA Costa Rica 2009-Jul-24 A/Costa Rica/5023/2009 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI291555 NA Costa Rica 2010-Jul-16 A/Costa Rica/6696/2010 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI349760 NA Costa Rica 2011-Nov-11 A/Costa Rica/8211/2011 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI397143 NA Costa Rica 2012-Jul-17 A/Costa Rica/9093/2012 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI484548 NA Costa Rica 2013-Jul-12 A/Costa Rica/2932/2013 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI484732 NA Costa Rica 2013-Jul-23 A/Costa Rica/4009/2013 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI485799 NA Costa Rica 2013-Jul-26 A/Costa Rica/4700/2013 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
Control and Prevention 
EPI295135 NA El Salvador 2010-Aug-24 A/El Salvador/1318/2010 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI347485 NA El Salvador 2011-Sep-21 A/El Salvador/1513/2011 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI459840 NA El Salvador 2013-Mar-18 A/El Salvador/433/2013 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI477436 NA El Salvador 2013-Jul-04 A/El Salvador/1307/2013 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI185798 NA Mexico 2009-Mar-11 A/Mexico/2779/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI243562 NA Mexico 2009-Sep-15 A/Mexico/5270/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI243568 NA Mexico 2009-Sep-05 A/Mexico/7880/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI270306 NA Mexico 2009-Aug-17 A/Mexico/5824/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI279987 NA Mexico 2010-Aug-13 A/Mexico/4056/2010 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI309386 NA Mexico 2010-Oct-11 A/Mexico/6605/2010 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI334632 NA Mexico 2010-Nov-04 A/Mexico/6998/2010 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI319722 NA Mexico 2011-Feb-18 A/Mexico/1664/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI331239 NA Mexico 2011-Apr-08 A/Mexico/2554/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
       H1        
EPI230497 HA Mexico 2009-Apr-01 A/swine/4/Mexico/2009 
 
Other Database Import 
EPI277889 HA Mexico 2009-Sep-23 A/Mexico City/WR1675T/2009 
 
Other Database Import 
EPI277881 HA Mexico 2009-Oct-05 A/Mexico City/WR1673N/2009 
 
Other Database Import 
EPI277873 HA Mexico 2009-Sep-23 A/Mexico City/WR1668T/2009 
 
Other Database Import 
EPI277665 HA Mexico 2009-Oct-22 A/Mexico City/WR1090N/2009 
 
Other Database Import 
EPI277657 HA Dominican Republic 2009-Jun-10 A/Santo Domingo/WR1072T/2009 
 
Other Database Import 
EPI275081 HA Nicaragua 2009-Jul-21 A/Managua/5364.01/2009 
 
Other Database Import 
EPI267000 HA Mexico 2009-May-02 A/Mexico City/026/2009 
 
Other Database Import 
EPI266992 HA Mexico 2009-May-01 A/Mexico City/025/2009 
 
Other Database Import 
EPI266952 HA Mexico 2009-Apr-30 A/Mexico City/020/2009 
 
Other Database Import 
EPI256738 HA Mexico 2009-May-16 A/Mexico city/CIA9/2009 
 
Other Database Import 
EPI249582 HA Nicaragua 2009-Aug-18 A/Managua/2323.02/2009 
 
Other Database Import 
EPI249092 HA Nicaragua 2009-Aug-15 A/Managua/3275.01/2009 
 
Other Database Import 
EPI249068 HA Nicaragua 2009-Jun-16 A/Managua/2330.02/2009 
 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI249036 HA Nicaragua 2009-Aug-18 A/Managua/164.01/2009 
 
Other Database Import 
EPI237350 HA Nicaragua 2009-Jun-01 A/Managua/4467.05/2009 
 
Other Database Import 
EPI217610 HA Mexico 2009-May-10 A/Mexico City/018/2009 
 
Other Database Import 
EPI217594 HA Mexico 2009-May-09 A/Mexico City/015/2009 
 
Other Database Import 
EPI217578 HA Mexico 2009-May-09 A/Mexico City/012/2009 
 
Other Database Import 
EPI217570 HA Mexico 2009-May-09 A/Mexico City/011/2009 
 
Other Database Import 
EPI217546 HA Mexico 2009-May-10 A/Mexico City/008/2009 
 
Other Database Import 
EPI217490 HA Mexico 2009-May-07 A/Mexico City/001/2009 
 
Other Database Import 
EPI215462 HA Dominican Republic 2009-Jun-25 A/Santo Domingo/WR1068N/2009 
 
Other Database Import 
EPI215454 HA Dominican Republic 2009-Jun-30 A/Santo Domingo/WR1059N/2009 
 
Other Database Import 
EPI215446 HA Dominican Republic 2009-Jul-02 A/Santo Domingo/WR1058N/2009 
 
Other Database Import 
EPI215438 HA Dominican Republic 2009-Jul-02 A/Santo Domingo/WR1057N/2009 
 
Other Database Import 
EPI215398 HA El Salvador 2009-Jun-09 A/San Salvador/WR0167N/2009 
 
Other Database Import 
EPI215390 HA El Salvador 2009-Jun-12 A/San Salvador/0169T/2009 
 
Other Database Import 
EPI215334 HA Mexico 2009-Sep-10 A/Mexico City/WR1311T/2009 
 
Other Database Import 
EPI215326 HA Mexico 2009-Sep-09 A/Mexico City/WR1310N/2009 
 
Other Database Import 
EPI215310 HA Mexico 2009-Sep-14 A/Mexico City/WR1307N/2009 
 
Other Database Import 
EPI215302 HA Mexico 2009-Sep-02 A/Mexico City/WR1306N/2009 
 
Other Database Import 
EPI215294 HA Mexico 2009-Sep-12 A/Mexico City/WR1301N/2009 
 
Other Database Import 
EPI215286 HA Mexico 2009-Sep-03 A/Mexico City/WR1297N/2009 
 
Other Database Import 
EPI215278 HA Mexico 2009-Jun-29 A/Mexico City/WR1100N/2009 
 
Other Database Import 
EPI215270 HA Mexico 2009-Jun-19 A/Mexico City/WR1087T/2009 
 
Other Database Import 
EPI190863 HA Mexico 2009-Apr-25 A/Mexico/48N/2009 
 
Other Database Import 
EPI190855 HA Nicaragua 2009-Jun-26 A/Managua/0536N/2009 
 
Other Database Import 
EPI186657 HA Dominican Republic 2009-May-26 A/Santo Domingo/565T/2009 
 
Other Database Import 
EPI186244 HA Dominican Republic 2009-May-24 A/Santo Domingo/572N/2009 
 
Other Database Import 
EPI180755 HA Mexico 2009-Apr-25 A/Mexico/47N/2009 
 
Other Database Import 
EPI179001 HA Mexico 2009-Jan-01 A/Mexico/InDRE4114/2009 
 
Other Database Import 
EPI273882 HA Mexico 2009-Dec-18 A/Mexico/5569/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI273879 HA Mexico 2010-Mar-01 A/Mexico/1762/2010 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI273925 HA Mexico 2009-Oct-18 A/Mexico/4178/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI243933 HA Mexico 2009-Oct-26 A/Mexico/1138/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI243905 HA Mexico 2009-Nov-18 A/Mexico/476/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI232961 HA Mexico 2009-Mar-12 A/Mexico/2964/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI231329 HA Mexico 2009-Jul-10 A/Mexico/2466/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI231326 HA Mexico 2009-Jun-30 A/Mexico/2445/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI179102 HA Mexico 2009-Apr-20 A/Mexico/4593/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI179080 HA Mexico 2009-Apr-03 A/Mexico/3955/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI177338 HA Mexico 2009-Apr-03 A/Mexico/4108/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI176587 HA Mexico 2009-Apr-14 A/Mexico/4482/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI183131 HA El Salvador 2009-May-13 A/El Salvador/351/2009 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI179074 HA El Salvador 2009-Apr-26 A/El Salvador/213/2009 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI227650 HA Costa Rica 2009-Jul-13 A/Costa Rica/3149/2009 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI216778 HA Costa Rica 2009-May-16 A/Costa Rica/6321/2009 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI216767 HA Costa Rica 2009-Jul-17 A/Costa Rica/3896/2009 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI181744 HA Costa Rica 2009-Apr-28 A/Costa Rica/4314/2009 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI247263 HA Dominican Republic 2009-Dec-15 A/Dominican Republic/3768/2009 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI183311 HA Netherlands 2009-Jan-01 A/Netherlands/602/2009 
Erasmus University of 
Rotterdam 
Centers for Disease 
Control and Prevention 
EPI231317 HA Guatemala 2009-Oct-26 A/Guatemala/4752/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI231315 HA Guatemala 2009-Sep-15 A/Guatemala/4360/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI216851 HA Guatemala 2009-Aug-03 A/Guatemala/3798/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI216848 HA Guatemala 2009-Jul-14 A/Guatemala/3185/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI194155 HA Guatemala 2009-Jun-02 A/Guatemala/1039/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI239674 HA Haiti 2009-Oct-19 A/Haiti/534/2009 
Laboratoire National de Sante 
Publique 
Centers for Disease 
Control and Prevention 
EPI216857 HA Haiti 2009-Aug-12 A/Haiti/265/2009 
Laboratoire National de Sante 
Publique 
Centers for Disease 
Control and Prevention 
EPI273771 HA Honduras 2010-May-19 A/Honduras/6132/2010 
Laboratorio Nacional de 
Virologia 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI216863 HA Honduras 2009-Jun-25 A/Honduras/2188/2009 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI191948 HA Honduras 2009-Jun-17 A/Honduras/2039/2009 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI273920 HA Jamaica 2009-Jul-07 A/Jamaica/6261/2009 University of the West Indies 
Centers for Disease 
Control and Prevention 
EPI273844 HA Nicaragua 2010-Apr-01 A/Nicaragua/322/2010 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI227690 HA Nicaragua 2009-Aug-25 A/Managua/6502/2009 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI227684 HA Nicaragua 2009-Jul-27 A/Managua/46601/2009 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI211485 HA Panama 2009-Jun-18 A/Panama/4252/2009 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI183241 HA Panama 2009-May-11 A/Panama/302869/2009 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI231353 HA Turks and Caicos Islands 2009-Oct-13 A/Turks And Caicos/9060/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI231350 HA Trinidad and Tobago 2009-Oct-22 A/Trinidad/9184/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI231341 HA Saint Lucia 2009-Sep-25 A/St. Lucia/9333/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI231312 HA Grenada 2009-Oct-23 A/Grenada/9302/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI231305 HA Dominican Republic 2009-Oct-23 A/Dominica/9250/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI231291 HA Belize 2009-Oct-08 A/Belize/8756/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI217091 HA Saint Lucia 2009-Jul-31 A/Saint Lucia/7178/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI217088 HA 
Saint Kitts and Nevis, 
Federation of 2009-Jul-29 A/Saint Kitts/7274/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI216730 HA Belize 2009-Jul-28 A/Belize/7121/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI211402 HA Barbados 2009-Sep-07 A/Barbados/7992/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI220980 HA British Virgin Islands 2009-Jun-15 A/British Virgin Islands/5437/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI186269 HA Bermuda 2009-Jun-03 A/Bermuda/4287/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI186266 HA Jamaica 2009-Jun-06 A/Jamaica/4423/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI216727 HA Barbados 2009-Sep-10 A/Barbados/280/2009 Public Health Laboratory 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI216724 HA Barbados 2009-Sep-04 A/Barbados/275/2009 Public Health Laboratory 
Centers for Disease 
Control and Prevention 
EPI189129 HA Martinique 2009-Jun-20 A/Martinique/15/2009 
National Influenza Center 
French Guiana and French Indies 
Centers for Disease 
Control and Prevention 
EPI273751 HA Puerto Rico 2009-Dec-18 A/Puerto Rico/20/2009 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI240403 HA Puerto Rico 2009-Dec-06 A/Puerto Rico/51/2009 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI217082 HA Puerto Rico 2009-Aug-07 A/Puerto Rico/50/2009 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI273937 HA Guatemala 2010-Jan-01 A/Guatemala/127/2010 
 
Centers for Disease 
Control and Prevention 
EPI186300 HA Trinidad and Tobago 2009-Jan-01 A/Trinidad/4601/2009 
 
Centers for Disease 
Control and Prevention 
EPI185355 HA Costa Rica 2009-May-02 A/Costa Rica/4857/2009 
 
Centers for Disease 
Control and Prevention 
EPI338314 HA Cuba 2010-Nov-01 A/swine/La Habana/130/2010 
 
Other Database Import 
EPI338288 HA Cuba 2010-Nov-01 A/swine/Pinar del Rio/3/2010 
 
Other Database Import 
EPI335977 HA Cuba 2010-Nov-01 A/swine/Villa Clara/84/2010 
 
Other Database Import 
EPI307826 HA Costa Rica 2010-Nov-01 A/swine/Costa Rica/000125-20/2010 
 
Other Database Import 
EPI307823 HA Costa Rica 2010-Nov-01 A/swine/Costa Rica/000125-19/2010 
 
Other Database Import 
EPI307820 HA Costa Rica 2010-Nov-01 A/swine/Costa Rica/000125-16/2010 
 
Other Database Import 
EPI307817 HA Costa Rica 2010-Nov-01 A/swine/Costa Rica/000125-15/2010 
 
Other Database Import 
EPI307814 HA Costa Rica 2010-Nov-01 A/swine/Costa Rica/000125-14/2010 
 
Other Database Import 
EPI307811 HA Costa Rica 2010-Nov-01 A/swine/Costa Rica/000125-3/2010 
 
Other Database Import 
EPI341574 HA United States 2009-Jan-01 A/California/04/2009 
 
Other Database Import 
EPI278009 HA Haiti 2009-Nov-13 A/Port Au Prince/WR2294T/2009 
 
Other Database Import 
EPI277993 HA Mexico 2009-Nov-19 A/Mexico City/WR1765N/2009 
 
Other Database Import 
EPI277977 HA Mexico 2009-Nov-09 A/Mexico City/WR1747N/2009 
 
Other Database Import 
EPI277969 HA Mexico 2009-Oct-09 A/Mexico City/WR1708T/2009 
 
Other Database Import 
EPI277961 HA Mexico 2009-Sep-18 A/Mexico City/WR1706T/2009 
 
Other Database Import 
EPI277937 HA Mexico 2009-Sep-15 A/Mexico City/WR1697T/2009 
 
Other Database Import 
EPI277929 HA Mexico 2009-Sep-17 A/Mexico City/WR1696T/2009 
 
Other Database Import 
EPI277921 HA Mexico 2009-Oct-01 A/Mexico City/WR1695N/2009 
 
Other Database Import 
EPI277905 HA Mexico 2009-Sep-23 A/Mexico City/WR1687T/2009 
 
Other Database Import 
EPI509496 HA Mexico 2013-Mar-01 A/Mexico/01/2013 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI508443 HA Mexico 2013-Aug-31 A/Mexico/2733/2013 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI504791 HA Mexico 2013-Dec-27 A/Mexico/06/2013 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI503827 HA Mexico 2013-Oct-21 A/Mexico/3280/2013 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI467233 HA Mexico 2013-Jul-13 A/Mexico/2410/2013 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI391298 HA Mexico 2012-Feb-13 A/Mexico/5698/2012 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI355516 HA Mexico 2011-Dec-12 A/Mexico/3752/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI353408 HA Mexico 2011-Dec-28 A/Mexico/52/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI353405 HA Mexico 2011-Dec-14 A/Mexico/3720/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI353402 HA Mexico 2012-Jan-08 A/Mexico/210/2012 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI331210 HA Mexico 2011-Mar-15 A/Mexico/2208/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI330992 HA Mexico 2011-Mar-22 A/Mexico/1946/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI320045 HA Mexico 2011-Feb-22 A/Mexico/1658/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI278878 HA Mexico 2010-Apr-07 A/Mexico/2880/2010 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI534020 HA El Salvador 2013-Nov-04 A/El Salvador/2260/2013 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI508446 HA El Salvador 2013-Nov-22 A/El Salvador/2360/2013 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI484974 HA El Salvador 2013-Jul-05 A/El Salvador/1396/2013 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI380014 HA El Salvador 2012-Apr-17 A/El Salvador/530/2012 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI295399 HA El Salvador 2010-Jul-13 A/El Salvador/798/2010 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI278888 HA El Salvador 2010-May-26 A/El Salvador/455/2010 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI482166 HA Costa Rica 2013-May-30 A/Costa Rica/5790/2013 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI482164 HA Costa Rica 2013-Jun-18 A/Costa Rica/8288/2013 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI397472 HA Costa Rica 2012-Jun-24 A/Costa Rica/6288/2012 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI376365 HA Costa Rica 2012-Jan-17 A/Costa Rica/4023/2012 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI350003 HA Costa Rica 2011-Oct-11 A/Costa Rica/8107/2011 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI348171 HA Costa Rica 2011-Oct-30 A/Costa Rica/6796/2011 
Laboratorio Nacional de 
Influenza 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI295456 HA Costa Rica 2010-Jul-16 A/Costa Rica/6692/2010 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI295453 HA Costa Rica 2010-May-07 A/Costa Rica/5529/2010 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI295450 HA Costa Rica 2010-May-06 A/Costa Rica/5458/2010 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI477445 HA Dominican Republic 2013-Jun-15 A/Dominican Republic/7626/2013 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI484726 HA Dominican Republic 2013-Jun-05 A/Dominican Republic/7548/2013 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI467203 HA Dominican Republic 2013-Jun-12 A/Dominican Republic/7603/2013 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI467200 HA Dominican Republic 2013-Jun-10 A/Dominican Republic/7703/2013 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI459759 HA Dominican Republic 2013-Apr-01 A/Dominican Republic/7238/2013 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI457503 HA Dominican Republic 2013-May-01 A/Dominican Republic/7293/2013 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI457456 HA Dominican Republic 2013-May-01 A/Dominican Republic/7291/2013 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI396139 HA Dominican Republic 2012-May-28 A/Dominican Republic/6493/2012 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI395238 HA Dominican Republic 2012-Jun-08 A/Dominican Republic/6551/2012 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI376381 HA Dominican Republic 2012-Feb-21 A/Dominican Republic/6188/2012 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
Amistad Dominico Japones 
(CEMADOJA) 
EPI335804 HA Dominican Republic 2011-Jul-18 A/Dominican Republic/5542/2011 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI320014 HA Dominican Republic 2011-Apr-11 A/Dominican Republic/5145/2011 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI320011 HA Dominican Republic 2011-Mar-28 A/Dominican Republic/5059/2011 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI362991 HA Guatemala 2012-Feb-12 A/Guatemala/18/2012 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI295471 HA Guatemala 2010-Sep-17 A/Guatemala/175/2010 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI295438 HA Guatemala 2010-Aug-27 A/Guatemala/287/2010 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI280305 HA Guatemala 2010-Jun-03 A/Guatemala/483/2010 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI278869 HA Guatemala 2010-Jul-19 A/Guatemala/598/2010 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI278866 HA Guatemala 2010-Jun-12 A/Guatemala/04/2010 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI278863 HA Guatemala 2010-Apr-28 A/Guatemala/358/2010 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI394852 HA Honduras 2012-Jun-26 A/Honduras/9746/2012 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI394737 HA Honduras 2012-Jun-14 A/Honduras/9720/2012 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI497702 HA Jamaica 2013-Oct-30 A/Jamaica/198/2013 University of the West Indies 
Centers for Disease 
Control and Prevention 
EPI391296 HA Jamaica 2012-Feb-13 A/Jamaica/764/2012 University of the West Indies 
Centers for Disease 
Control and Prevention 
EPI465462 HA Nicaragua 2013-Jun-14 A/Managua/30074.01/2013 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI465282 HA Nicaragua 2013-Apr-14 A/Managua/601/2013 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI465279 HA Nicaragua 2013-Apr-20 A/Managua/687/2013 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI346507 HA Nicaragua 2011-Oct-10 A/Managua/748/2011 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI468142 HA Panama 2013-Jun-13 A/Panama/313106/2013 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI467381 HA Panama 2013-Jun-25 A/Panama/313202/2013 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI394749 HA Panama 2012-Jun-05 A/Panama/310521/2012 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI335822 HA Panama 2011-Jun-10 A/Panama/309335/2011 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI278854 HA Panama 2010-Jun-14 A/Panama/307207/2010 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI278852 HA Panama 2010-Jun-07 A/Panama/307168/2010 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI497726 HA British Virgin Islands 2013-Oct-01 A/British Virgin Islands/3138/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI497720 HA Barbados 2013-Sep-19 A/Barbados/3024/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI497714 HA 
Saint Vincent and the 
Grenadines 2013-Oct-08 
A/St. Vincent and 
Grenadines/3292/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI497711 HA Belize 2013-Sep-23 A/Belize/3161/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI497649 HA Trinidad and Tobago 2013-Oct-24 A/Trinidad/3568/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI465708 HA Haiti 2013-Jun-02 A/Haiti/1792/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI465472 HA Haiti 2013-Jun-20 A/Haiti/2036/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI465403 HA Haiti 2013-Jun-18 A/Haiti/2030/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI465088 HA Haiti 2013-Jun-02 A/Haiti/1790/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI460142 HA Trinidad and Tobago 2013-Mar-01 A/Trinidad/979/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI459774 HA Trinidad and Tobago 2013-Mar-13 A/Trinidad/982/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI394847 HA Belize 2012-Jan-01 A/Belize/334/2012 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI335837 HA Trinidad and Tobago 2011-Jul-08 A/Trinidad/1648/2011 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI320155 HA Turks and Caicos Islands 2011-Jan-25 A/Turks and Caicos/211/2011 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI320005 HA Cayman Islands 2011-Jan-14 A/Cayman Islands/284/2011 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI319999 HA Barbados 2011-Jan-12 A/Barbados/104/2011 Caribbean Epidemiology Center 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI295492 HA Belize 2010-Aug-11 A/Belize/3342/2010 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI516535 HA United States 2009-Apr-09 A/California/07/2009 Naval Health Research Center 
Centers for Disease 
Control and Prevention 
EPI509486 HA Puerto Rico 2013-Dec-16 A/Puerto Rico/21/2013 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI486392 HA Puerto Rico 2013-Oct-01 A/Puerto Rico/18/2013 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI465269 HA Puerto Rico 2013-Jun-14 A/Puerto Rico/05/2013 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI465070 HA Puerto Rico 2013-Jun-14 A/Puerto Rico/01/2013 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI397629 HA Puerto Rico 2012-Jul-03 A/Puerto Rico/43/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI396142 HA Puerto Rico 2012-Jun-29 A/Puerto Rico/39/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI391293 HA Puerto Rico 2012-Jun-07 A/Puerto Rico/06/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI391282 HA Puerto Rico 2012-May-18 A/Puerto Rico/05/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI368690 HA Puerto Rico 2012-Feb-14 A/Puerto Rico/01/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI366314 HA Puerto Rico 2011-Aug-18 A/Puerto Rico/25/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI366308 HA Puerto Rico 2011-May-31 A/Puerto Rico/05/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI349362 HA Puerto Rico 2011-Nov-21 A/Puerto Rico/8233/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI347556 HA Puerto Rico 2011-Oct-22 A/Puerto Rico/21/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI346510 HA Puerto Rico 2011-Aug-03 A/Puerto Rico/04/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI341961 HA Puerto Rico 2011-Jun-24 A/Puerto Rico/02/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI316427 HA Puerto Rico 2011-Feb-04 A/Puerto Rico/01/2011 
Puerto Rico Department of 
Health 
Centers for Disease 




EPI338308 NA Cuba 2010-Nov-01 A/swine/Holguin/121/2010 
 
Other Database Import 
EPI338290 NA Cuba 2010-Nov-01 A/swine/Pinar del Rio/3/2010 
 
Other Database Import 
EPI335975 NA Cuba 2010-Nov-01 A/swine/Villa Clara/84/2010 
 
Other Database Import 
EPI307824 NA Costa Rica 2010-Nov-01 A/swine/Costa Rica/000125-19/2010 
 
Other Database Import 
EPI307818 NA Costa Rica 2010-Nov-01 A/swine/Costa Rica/000125-15/2010 
 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI307815 NA Costa Rica 2010-Nov-01 A/swine/Costa Rica/000125-14/2010 
 
Other Database Import 
EPI307812 NA Costa Rica 2010-Nov-01 A/swine/Costa Rica/000125-3/2010 
 
Other Database Import 
EPI230499 NA Mexico 2009-Apr-01 A/swine/4/Mexico/2009 
 
Other Database Import 
EPI492854 NA Jamaica 2013-Oct-30 A/Jamaica/198/2013 University of the West Indies 
Centers for Disease 
Control and Prevention 
EPI486391 NA Puerto Rico 2013-Oct-01 A/Puerto Rico/18/2013 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI485767 NA Costa Rica 2013-Jun-10 A/Costa Rica/7069/2013 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI484973 NA El Salvador 2013-Jul-05 A/El Salvador/1396/2013 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI484981 NA Costa Rica 2013-May-30 A/Costa Rica/5790/2013 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI484963 NA Costa Rica 2013-Jun-18 A/Costa Rica/8288/2013 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI477444 NA Dominican Republic 2013-Jun-15 A/Dominican Republic/7626/2013 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI477421 NA Dominican Republic 2013-Jun-05 A/Dominican Republic/7548/2013 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI467410 NA Panama 2013-Jun-13 A/Panama/313106/2013 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI467380 NA Panama 2013-Jun-25 A/Panama/313202/2013 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI467232 NA Mexico 2013-Jul-13 A/Mexico/2410/2013 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI467199 NA Dominican Republic 2013-Jun-10 A/Dominican Republic/7703/2013 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI465474 NA Haiti 2013-Jun-02 A/Haiti/1792/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI465471 NA Haiti 2013-Jun-20 A/Haiti/2036/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI465463 NA Nicaragua 2013-Jun-19 A/Matagalpa/1076/2013 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI465461 NA Nicaragua 2013-Jun-14 A/Managua/30074.01/2013 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI465402 NA Haiti 2013-Jun-18 A/Haiti/2030/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
Direccion de Microbiologia Control and Prevention 
EPI465087 NA Haiti 2013-Jun-02 A/Haiti/1790/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI465069 NA Puerto Rico 2013-Jun-14 A/Puerto Rico/01/2013 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI460141 NA Trinidad and Tobago 2013-Mar-01 A/Trinidad/979/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI459773 NA Trinidad and Tobago 2013-Mar-13 A/Trinidad/982/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI457455 NA Dominican Republic 2013-May-01 A/Dominican Republic/7291/2013 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI398006 NA Puerto Rico 2012-Jul-03 A/Puerto Rico/43/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI397471 NA Costa Rica 2012-Jun-24 A/Costa Rica/6288/2012 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI396138 NA Dominican Republic 2012-May-28 A/Dominican Republic/6493/2012 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI395237 NA Dominican Republic 2012-Jun-08 A/Dominican Republic/6551/2012 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI394846 NA Belize 2012-Jan-01 A/Belize/334/2012 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI394751 NA Panama 2012-Jun-26 A/Panama/310630/2012 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI394748 NA Panama 2012-Jun-05 A/Panama/310521/2012 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI394739 NA Honduras 2012-Jun-26 A/Honduras/9746/2012 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI394851 NA Honduras 2012-Jun-14 A/Honduras/9720/2012 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI392906 NA Puerto Rico 2012-Jun-12 A/Puerto Rico/20/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI391295 NA Jamaica 2012-Feb-13 A/Jamaica/764/2012 University of the West Indies 
Centers for Disease 
Control and Prevention 
EPI391292 NA Puerto Rico 2012-Jun-07 A/Puerto Rico/06/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI378077 NA El Salvador 2012-Apr-17 A/El Salvador/530/2012 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Control and Prevention 
EPI376364 NA Costa Rica 2012-Jan-17 A/Costa Rica/4023/2012 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI368448 NA Puerto Rico 2011-Dec-29 A/Puerto Rico/33/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI368446 NA Puerto Rico 2012-Feb-14 A/Puerto Rico/01/2012 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI366313 NA Puerto Rico 2011-Aug-18 A/Puerto Rico/25/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI366310 NA Puerto Rico 2011-Jul-19 A/Puerto Rico/09/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI366307 NA Puerto Rico 2011-May-31 A/Puerto Rico/05/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI366298 NA Mexico 2012-Jan-19 A/Mexico/689/2012 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI366289 NA Mexico 2012-Jan-21 A/Mexico/1818/2012 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI366286 NA Mexico 2012-Jan-26 A/Mexico/1474/2012 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI362990 NA Guatemala 2012-Feb-12 A/Guatemala/18/2012 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI355515 NA Mexico 2011-Dec-12 A/Mexico/3752/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI353442 NA Mexico 2012-Jan-02 A/Mexico/254/2012 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI353436 NA Mexico 2011-Dec-12 A/Mexico/3723/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI353410 NA Mexico 2011-Dec-30 A/Mexico/56/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI353404 NA Mexico 2011-Dec-14 A/Mexico/3720/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI353401 NA Mexico 2012-Jan-08 A/Mexico/210/2012 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI350002 NA Costa Rica 2011-Oct-11 A/Costa Rica/8107/2011 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI349361 NA Puerto Rico 2011-Nov-21 A/Puerto Rico/8233/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI348170 NA Costa Rica 2011-Oct-30 A/Costa Rica/6796/2011 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI347555 NA Puerto Rico 2011-Oct-22 A/Puerto Rico/21/2011 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
Health Control and Prevention 
EPI346506 NA Nicaragua 2011-Oct-10 A/Managua/748/2011 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI341572 NA United States 2009-Jan-01 A/California/04/2009 
 
Other Database Import 
EPI335836 NA Trinidad and Tobago 2011-Jul-08 A/Trinidad/1648/2011 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI335821 NA Panama 2011-Jun-10 A/Panama/309335/2011 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI335803 NA Dominican Republic 2011-Jul-18 A/Dominican Republic/5542/2011 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI331209 NA Mexico 2011-Mar-15 A/Mexico/2208/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI320154 NA Turks and Caicos Islands 2011-Jan-25 A/Turks and Caicos/211/2011 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI320047 NA Mexico 2011-Mar-22 A/Mexico/1946/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI320044 NA Mexico 2011-Feb-22 A/Mexico/1658/2011 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI320010 NA Dominican Republic 2011-Mar-28 A/Dominican Republic/5059/2011 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI320004 NA Cayman Islands 2011-Jan-14 A/Cayman Islands/284/2011 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI319998 NA Barbados 2011-Jan-12 A/Barbados/104/2011 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI295491 NA Belize 2010-Aug-11 A/Belize/3342/2010 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI295455 NA Costa Rica 2010-Jul-16 A/Costa Rica/6692/2010 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI295437 NA Guatemala 2010-Aug-27 A/Guatemala/287/2010 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI295398 NA El Salvador 2010-Jul-13 A/El Salvador/798/2010 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI278887 NA El Salvador 2010-May-26 A/El Salvador/455/2010 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI278877 NA Mexico 2010-Apr-07 A/Mexico/2880/2010 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI278862 NA Guatemala 2010-Apr-28 A/Guatemala/358/2010 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI278851 NA Panama 2010-Jun-07 A/Panama/307168/2010 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI278011 NA Haiti 2009-Nov-13 A/Port Au Prince/WR2294T/2009 
 
Other Database Import 
EPI277995 NA Mexico 2009-Nov-19 A/Mexico City/WR1765N/2009 
 
Other Database Import 
EPI277979 NA Mexico 2009-Nov-09 A/Mexico City/WR1747N/2009 
 
Other Database Import 
EPI277963 NA Mexico 2009-Sep-18 A/Mexico City/WR1706T/2009 
 
Other Database Import 
EPI277659 NA Dominican Republic 2009-Jun-10 A/Santo Domingo/WR1072T/2009 
 
Other Database Import 
EPI275083 NA Nicaragua 2009-Jul-21 A/Managua/5364.01/2009 
 
Other Database Import 
EPI273936 NA Guatemala 2010-Jan-01 A/Guatemala/127/2010 
 
Centers for Disease 
Control and Prevention 
EPI273919 NA Jamaica 2009-Jul-07 A/Jamaica/6261/2009 University of the West Indies 
Centers for Disease 
Control and Prevention 
EPI273878 NA Mexico 2010-Mar-01 A/Mexico/1762/2010 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI273843 NA Nicaragua 2010-Apr-01 A/Nicaragua/322/2010 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI273770 NA Honduras 2010-May-19 A/Honduras/6132/2010 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI267002 NA Mexico 2009-May-02 A/Mexico City/026/2009 
 
Other Database Import 
EPI256740 NA Mexico 2009-May-16 A/Mexico city/CIA9/2009 
 
Other Database Import 
EPI256704 NA Mexico 2009-Jul-06 A/Mexico city/CIA3/2009 
 
Other Database Import 
EPI256697 NA Mexico 2009-Jul-06 A/Mexico city/CIA2/2009 
 
Other Database Import 
EPI273924 NA Mexico 2009-Oct-18 A/Mexico/4178/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI254050 NA Puerto Rico 2009-Dec-18 A/Puerto Rico/20/2009 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI249640 NA Nicaragua 2009-Jun-15 A/Managua/4935.03/2009 
 
Other Database Import 
EPI249616 NA Nicaragua 2009-Jun-26 A/Managua/462.01/2009 
 
Other Database Import 
EPI249592 NA Nicaragua 2009-Aug-18 A/Managua/3435.01/2009 
 
Other Database Import 
EPI249584 NA Nicaragua 2009-Aug-18 A/Managua/2323.02/2009 
 
Other Database Import 
EPI249118 NA Nicaragua 2009-Aug-15 A/Managua/473.02/2009 
 
Other Database Import 
EPI247262 NA Dominican Republic 2009-Dec-15 A/Dominican Republic/3768/2009 
Laboratorio de Investigacion / 
Centro de Educacion Medica y 
Amistad Dominico Japones 
(CEMADOJA) 
Centers for Disease 
Control and Prevention 
EPI243932 NA Mexico 2009-Oct-26 A/Mexico/1138/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI240402 NA Puerto Rico 2009-Dec-06 A/Puerto Rico/51/2009 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI239673 NA Haiti 2009-Oct-19 A/Haiti/534/2009 
Laboratoire National de Sante 
Publique 
Centers for Disease 
Control and Prevention 
EPI231352 NA Turks and Caicos Islands 2009-Oct-13 A/Turks And Caicos/9060/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI231349 NA Trinidad and Tobago 2009-Oct-22 A/Trinidad/9184/2009 Caribbean Epidemiology Center 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI231340 NA Saint Lucia 2009-Sep-25 A/St. Lucia/9333/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI231328 NA Mexico 2009-Jul-10 A/Mexico/2466/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI347040 NA Guatemala 2009-Oct-26 A/Guatemala/4752/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI231314 NA Guatemala 2009-Sep-15 A/Guatemala/4360/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI231311 NA Grenada 2009-Oct-23 A/Grenada/9302/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI231304 NA Dominican Republic 2009-Oct-23 A/Dominica/9250/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI231290 NA Belize 2009-Oct-08 A/Belize/8756/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI227689 NA Nicaragua 2009-Aug-25 A/Managua/6502/2009 
Laboratorio de Virologia, 
Direccion de Microbiologia 
Centers for Disease 
Control and Prevention 
EPI227649 NA Costa Rica 2009-Jul-13 A/Costa Rica/3149/2009 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI227627 NA Bermuda 2009-Oct-23 A/Bermuda/9261/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI217612 NA Mexico 2009-May-10 A/Mexico City/018/2009 
 
Other Database Import 
EPI217604 NA Mexico 2009-May-09 A/Mexico City/017/2009 
 
Other Database Import 
EPI217596 NA Mexico 2009-May-09 A/Mexico City/015/2009 
 
Other Database Import 
EPI217524 NA Mexico 2009-May-08 A/Mexico City/005/2009 
 
Other Database Import 
EPI217090 NA Saint Lucia 2009-Jul-31 A/Saint Lucia/7178/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI216862 NA Honduras 2009-Jun-25 A/Honduras/2188/2009 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI216856 NA Haiti 2009-Aug-12 A/Haiti/265/2009 
Laboratoire National de Sante 
Publique 
Centers for Disease 
Control and Prevention 
EPI216836 NA El Salvador 2009-Jul-16 A/El Salvador/1644/2009 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI216821 NA El Salvador 2009-Jul-14 A/El Salvador/1553/2009 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI216774 NA Costa Rica 2009-Jul-22 A/Costa Rica/4635/2009 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI216729 NA Belize 2009-Jul-28 A/Belize/7121/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI216726 NA Barbados 2009-Sep-10 A/Barbados/280/2009 Public Health Laboratory 
Centers for Disease 
Control and Prevention 
EPI216723 NA Barbados 2009-Sep-04 A/Barbados/275/2009 Public Health Laboratory 
Centers for Disease 
Control and Prevention 
EPI215400 NA El Salvador 2009-Jun-09 A/San Salvador/WR0167N/2009 
 
Other Database Import 
EPI215328 NA Mexico 2009-Sep-09 A/Mexico City/WR1310N/2009 
 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI194156 NA Guatemala 2009-Jun-02 A/Guatemala/1039/2009 
Laboratorio Nacional De Salud 
Guatemala 
Centers for Disease 
Control and Prevention 
EPI191949 NA Honduras 2009-Jun-17 A/Honduras/2039/2009 
Laboratorio Nacional de 
Virologia 
Centers for Disease 
Control and Prevention 
EPI190865 NA Mexico 2009-Apr-25 A/Mexico/48N/2009 
 
Other Database Import 
EPI190857 NA Nicaragua 2009-Jun-26 A/Managua/0536N/2009 
 
Other Database Import 
EPI186659 NA Dominican Republic 2009-May-26 A/Santo Domingo/565T/2009 
 
Other Database Import 
EPI186301 NA Trinidad and Tobago 2009-Jan-01 A/Trinidad/4601/2009 
 
Centers for Disease 
Control and Prevention 
EPI186277 NA Mexico 2009-Apr-20 A/Mexico/4635/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI186267 NA Bermuda 2009-Jun-03 A/Bermuda/4287/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI186265 NA Jamaica 2009-Jun-06 A/Jamaica/4423/2009 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI183240 NA Panama 2009-May-11 A/Panama/302869/2009 
Instituto Conmemorativo Gorgas 
de Estudios de la Salud 
Centers for Disease 
Control and Prevention 
EPI183130 NA El Salvador 2009-May-13 A/El Salvador/351/2009 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI181742 NA Costa Rica 2009-Apr-28 A/Costa Rica/4314/2009 
Laboratorio Nacional de 
Influenza 
Centers for Disease 
Control and Prevention 
EPI180757 NA Mexico 2009-Apr-25 A/Mexico/47N/2009 
 
Other Database Import 
EPI179101 NA Mexico 2009-Apr-20 A/Mexico/4575/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI179076 NA El Salvador 2009-Apr-26 A/El Salvador/213/2009 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI177291 NA Netherlands 2009-Jan-01 A/Netherlands/602/2009 
 
Erasmus University of 
Rotterdam 
EPI176588 NA Mexico 2009-Apr-14 A/Mexico/4482/2009 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI221062 NA United States 2009-Apr-09 A/California/07/2009 Naval Health Research Center 
Centers for Disease 
Control and Prevention 
EPI508440 NA Puerto Rico 2013-Dec-16 A/Puerto Rico/21/2013 
Puerto Rico Department of 
Health 
Centers for Disease 
Control and Prevention 
EPI497648 NA Trinidad and Tobago 2013-Oct-24 A/Trinidad/3568/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI497710 NA Belize 2013-Sep-23 A/Belize/3161/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI497713 NA 
Saint Vincent and the 
Grenadines 2013-Oct-08 
A/St. Vincent and 
Grenadines/3292/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI497716 NA 
Saint Vincent and the 
Grenadines 2013-Oct-07 
A/St. Vincent and 
Grenadines/3291/2013 Caribbean Epidemiology Center 
Centers for Disease 
Control and Prevention 
EPI497719 NA Barbados 2013-Sep-19 A/Barbados/3024/2013 Caribbean Epidemiology Center 
Centers for Disease 




Segment ID Segment Country Collection date Isolate name Originating Lab Submitting Lab 
EPI504751 NA El Salvador 2013-Nov-28 A/El Salvador/2388/2013 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI534019 NA El Salvador 2013-Nov-04 A/El Salvador/2260/2013 Contiguo a Hospital Rosales 
Centers for Disease 
Control and Prevention 
EPI503826 NA Mexico 2013-Oct-21 A/Mexico/3280/2013 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI504790 NA Mexico 2013-Dec-27 A/Mexico/06/2013 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI508442 NA Mexico 2013-Aug-31 A/Mexico/2733/2013 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 
Control and Prevention 
EPI508466 NA Mexico 2013-Oct-08 A/Mexico/3093/2013 
Laboratorio de Virus 
Respiratorio 
Centers for Disease 



































Figure 0.1. Maximum likelihood inference of the phylogenetic relationships between global human and human-like H3N2 viruses, 2010-2012. 
The virus of Guatemala is shown in green, and the name of the vaccine strains is indicated in black. Bootstrap support values are shown. Scale-bar depicts 






Figure 0.2 Bayesian phylogenetic inference of the relationships between global human and human-like H3N2 viruses, 2010-2012. 
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